Â© 2000-2024 QIAGEN. All rights reserved.

Ingenuity Canonical Pathways	 -log(p-value)	Ratio	z-score	Molecules	
Eukaryotic Translation Initiation	6.58E01	6.8E-01	-9.110	EIF2B2,EIF2B4,EIF2S1,EIF2S2,EIF3D,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3L,EIF3M,EIF4A1,EIF4EBP1,EIF4H,FAU,PABPC1,RPL10,RPL10A,RPL11,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA	
SRP-dependent cotranslational protein targeting to membrane	6.17E01	6.78E-01	-8.832	DDOST,FAU,RPL10,RPL10A,RPL11,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPN1,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA,SEC11A,SEC11C,SEC61B,SEC61G,SPCS1,SPCS2,SRP14,SRP19,SRP9,SSR2,SSR4	
Eukaryotic Translation Elongation	5.79E01	7.26E-01	-8.307	EEF1A1,EEF1B2,EEF1D,EEF2,FAU,RPL10,RPL10A,RPL11,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA	
Eukaryotic Translation Termination	5.38E01	7.02E-01	-8.124	FAU,RPL10,RPL10A,RPL11,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA,TRMT112	
Nonsense-Mediated Decay (NMD)	5.38E01	6.24E-01	-8.544	EIF4A3,FAU,MAGOH,NCBP2,PABPC1,PNRC2,RBM8A,RNPS1,RPL10,RPL10A,RPL11,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA,UPF3A	
EIF2 Signaling	5.35E01	4.35E-01	-6.656	ACTB,AKT1,ATF4,EIF1AY,EIF2B2,EIF2B4,EIF2S1,EIF2S2,EIF3D,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3L,EIF3M,EIF4A1,EIF4A3,FAU,HRAS,HSPA5,KRAS,MAP2K2,MAPK3,PABPC1,PPP1CA,PPP1R15A,RASD1,RPL10,RPL10A,RPL11,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,Rpl22l1,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,Rpl34 (includes others),RPL35,RPL35A,Rpl36,Rpl36a,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL7L1,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA,RRAS	
Response of EIF2AK4 (GCN2) to amino acid deficiency	5.26E01	6.6E-01	-8.246	ATF4,EIF2S1,EIF2S2,FAU,RPL10,RPL10A,RPL11,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA	
Selenoamino acid metabolism	4.69E01	6.07E-01	-8.062	FAU,RPL10,RPL10A,RPL11,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA	
Major pathway of rRNA processing in the nucleolus and cytosol	4.34E01	4.35E-01	-9.000	C1D,CSNK1E,EBNA1BP2,EMG1,EXOSC3,EXOSC4,EXOSC7,EXOSC8,FAU,FCF1,IMP3,NIP7,RPL10,RPL10A,RPL11,RPL13,RPL13A,RPL14,RPL15,RPL17,RPL18,RPL18A,RPL19,RPL21,RPL22,RPL23,RPL24,RPL26,RPL27,RPL27A,RPL28,RPL3,RPL30,RPL35,RPL35A,RPL36AL,RPL37,RPL37A,RPL38,RPL39,RPL4,RPL41,RPL5,RPL6,RPL7,RPL7A,RPL8,RPL9,RPLP0,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA,RRP36,RRP7A,SNU13,UTP11,UTP3	
Mitochondrial translation	3.65E01	5.62E-01	-7.348	AURKAIP1,CHCHD1,GADD45GIP1,MRPL11,MRPL12,MRPL14,MRPL15,MRPL17,MRPL18,MRPL2,MRPL20,MRPL21,MRPL22,MRPL24,MRPL27,MRPL28,MRPL30,MRPL32,MRPL33,MRPL34,MRPL35,MRPL36,MRPL38,MRPL39,MRPL4,MRPL41,MRPL43,MRPL46,MRPL49,MRPL50,MRPL51,MRPL52,MRPL53,MRPL54,MRPL55,MRPL9,MRPS12,MRPS14,MRPS15,MRPS16,MRPS17,MRPS18A,MRPS18C,MRPS21,MRPS23,MRPS24,MRPS26,MRPS30,MRPS33,MRPS34,MRPS36,MRPS6,MRPS7,TSFM	
Electron transport, ATP synthesis, and heat production by uncoupling proteins	3.35E01	4.61E-01	-7.681	COQ10B,COX14,COX19,COX20,COX4I1,COX5A,COX6B1,COX7A2L,COX7B,COX8A,CYC1,CYCS,ETFB,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFAF3,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFC1,NDUFC2,NDUFS2,NDUFS3,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,SDHB,SDHD,SURF1,UCP2,UQCR10,UQCR11,UQCRB,UQCRC1,UQCRC2,UQCRFS1,UQCRHL	
Oxidative Phosphorylation	3.19E01	4.82E-01	-7.280	COX17,COX4I1,COX5A,COX6B1,Cox6c,COX7A2,COX7A2L,COX7B,COX8A,CYB5A,CYC1,CYCS,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,SDHB,SDHD,SURF1,UQCR10,UQCR11,UQCRB,UQCRC1,UQCRC2,UQCRFS1,UQCRHL	
Sirtuin Signaling Pathway	2.87E01	2.85E-01	2.673	AKT1,ATG101,BAX,CYC1,GABARAP,GABARAPL2,GADD45G,H3-3A/H3-3B,JUN,LDHA,MAP1LC3A,MAP1LC3B,MAPK3,NAMPT,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NFE2L2,NOS2,NOS3,PAM16,PGAM1,POLR1D,POLR2F,PPID,SDHB,SDHD,SIRT2,SIRT7,SLC25A4,SLC25A5,SLC2A1,SOD2,TIMM13,TIMM17A,TIMM17B,TIMM23,TIMM50,TIMM8B,TOMM20,TOMM22,TOMM40,Tomm5,TOMM6,TOMM7,TSPO,TUBA1A,TUBA1B,UCP2,UQCRC2,UQCRFS1,VDAC1,VDAC2,VDAC3	
Regulation of Apoptosis	2.59E01	6.42E-01	-5.831	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC	
NIK-->noncanonical NF-kB signaling	2.59E01	6E-01	-6.000	NEDD8,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC,UBE2M	
Mitochondrial Dysfunction	2.59E01	2.53E-01	6.254	APH1A,ATF4,ATP1B3,BAD,BAX,BBC3,Calm1 (includes others),CAPNS1,COX17,COX4I1,COX5A,COX6B1,Cox6c,COX7A2,COX7A2L,COX7B,COX8A,CREB3,CYB5A,CYC1,CYCS,FIS1,GPX1,GPX4,GPX7,GSTM1,GSTM2,HSD17B10,MGST3,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NFE2L2,PARK7,PRDX6,PRKAB1,PRKAG1,PSEN2,PSENEN,SDHB,SDHD,SOD2,SURF1,TOMM20,TOMM22,TOMM40,TOMM7,UCP2,UQCR10,UQCR11,UQCRB,UQCRC1,UQCRC2,UQCRFS1,UQCRHL,VDAC1,VDAC2,VDAC3	
Metabolism of polyamines	2.5E01	5.93E-01	-5.916	OAZ1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,SAT1,SEM1,SMOX	
TNFR2 non-canonical NF-kB pathway	2.45E01	5.44E-01	-6.083	CD40,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,TNFRSF12A,TNFSF12,UBC	
BAG2 Signaling Pathway	2.44E01	4.82E-01	-0.905	ANXA2,CDKN1A,CTSB,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,MAPK3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,SEM1,STUB1	
FAT10 Signaling Pathway	2.44E01	5.96E-01	NaN	MAP1LC3B,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,SEM1,SQSTM1	
Processing of Capped Intron-Containing Pre-mRNA	2.4E01	2.65E-01	-8.718	BCAS2,C9orf78,CCDC12,CWC15,DDX39B,DDX5,EIF4A3,FAM32A,FAM50A,HNRNPF,HNRNPK,HNRNPM,HSPA8,LSM2,LSM3,LSM5,LSM6,LSM7,LSM8,MAGOH,MFAP1,NCBP2,NUDT21,NXT1,PCBP1,PDCD7,PHF5A,PLRG1,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,PUF60,RAE1,RBM22,RBM42,RBM7,RBM8A,RNPS1,SAP18,SARNP,SEC13,SF3B4,SF3B5,SF3B6,SMNDC1,SMU1,SNRNP27,SNRNP40,SNRPB,SNRPB2,SNRPD1,SNRPD2,SNRPD3,SNRPF,SNU13,SNW1,SRSF10,SRSF2,SRSF3,SRSF7,SRSF9,SYF2,THOC1,THOC7,TXNL4A,UBL5,YBX1,ZCRB1,ZMAT2,ZNF830	
Signaling by NOTCH4	2.38E01	4.82E-01	-6.325	AKT1,APH1A,HES1,PSEN2,PSENEN,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,SNW1,UBC	
Cellular response to hypoxia	2.37E01	5.07E-01	-6.164	EGLN2,ELOC,HIGD1A,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC,UBE2D3	
Huntington's Disease Signaling	2.3E01	2.61E-01	-2.000	AKT1,AP2A2,ATF4,BAX,CAPNS1,CDK5,CLTA,CLTB,CREB3,CTSD,CYCS,GNA11,GNB2,GNG5,GPAA1,HRAS,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,JUN,MAPK3,NAPA,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SDHB,SDHD,SEM1,SGK1,TGM2,Ubb,UBC,UBE2S,VAMP3,VTI1B	
Protein Ubiquitination Pathway	2.2E01	2.6E-01	NaN	ANAPC11,DNAJA1,DNAJB11,DNAJB2,DNAJB6,DNAJB9,DNAJC30,ELOC,HLA-A,HLA-E,HSP90AB1,HSPA12B,HSPA1A/HSPA1B,HSPA5,HSPA8,HSPB1,HSPB8,HSPD1,HSPE1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,STUB1,SUGT1,TAP1,TAP2,Ubb,UBC,UBE2A,UBE2B,UBE2D3,UBE2E3,UBE2G2,UBE2I,UBE2J1,UBE2M,UBE2N,UBE2S,UBE2V1,UBE2V2,UCHL3,USP53	
KEAP1-NFE2L2 pathway	2.19E01	4.4E-01	-6.325	AKT1,CDKN1A,CSNK2B,MAP1LC3B,NFE2L2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,SQSTM1,UBC	
Hedgehog ligand biogenesis	2.18E01	5.23E-01	-5.831	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC	
Regulation of mitotic cell cycle	2.16E01	4.43E-01	-6.245	ANAPC11,ANAPC16,BUB3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,PTTG1,RPS27A,SEM1,UBC,UBE2S	
Regulation of RUNX2 expression and activity	2.08E01	4.79E-01	-5.916	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,STUB1,UBC	
PTEN Regulation	1.99E01	3.27E-01	-5.898	AKT1,CSNK2B,JUN,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,MAPK3,MBD3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RBBP4,RBBP7,RHEB,RPS27A,RRAGA,SEM1,STUB1,UBC,VAPA	
Transcriptional regulation by RUNX3	1.99E01	4.06E-01	-6.164	CDKN1A,HES1,KRAS,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,SNW1,TGFB1,UBC	
Regulation of eIF4 and p70S6K Signaling	1.95E01	2.93E-01	-2.449	AKT1,EIF1AY,EIF2B2,EIF2B4,EIF2S1,EIF2S2,EIF3D,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3L,EIF3M,EIF4A1,EIF4A3,EIF4EBP1,FAU,HRAS,KRAS,MAP2K2,MAPK3,PABPC1,RASD1,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA,RRAS	
S Phase	1.91E01	3.9E-01	-5.284	AKT1,CDKN1A,E2F4,LIN37,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RBBP4,RPS27A,SEM1,UBC	
Inhibition of ARE-Mediated mRNA Degradation Pathway	1.9E01	3.07E-01	-1.342	AKT1,CNOT3,EXOSC3,EXOSC4,EXOSC7,EXOSC8,MAPK3,POMC,PRKAG1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,SEM1,TNFRSF1A,TNFSF12,TNFSF13,YWHAB,YWHAE,YWHAH,YWHAQ,ZFP36,ZFP36L2	
MAPK6/MAPK4 signaling	1.87E01	4.02E-01	NaN	CDC42EP5,HSPB1,JUN,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC	
Neddylation	1.85E01	2.52E-01	-7.874	CDKN1A,COMMD2,COMMD3,COMMD4,COMMD7,COMMD8,COMMD9,COPS4,COPS5,COPS6,COPS7A,COPS8,DCUN1D5,DDA1,ELOC,FBXO6,GPS1,NAE1,NEDD8,NFE2L2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RBBP7,RNF7,RPS27A,SEM1,SOCS2,SQSTM1,UBC,UBE2D3,UBE2M,UCHL3,WSB1	
Granzyme A Signaling	1.84E01	4.46E-01	5.745	HMGB2,NDUFA1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3	
mTOR Signaling	1.83E01	2.66E-01	-2.673	AKT1,Cdc42,DDIT4,EIF3D,EIF3E,EIF3F,EIF3G,EIF3H,EIF3I,EIF3J,EIF3K,EIF3L,EIF3M,EIF4A1,EIF4A3,EIF4EBP1,FAU,FKBP1A,HRAS,KRAS,MAPK3,PRKAB1,PRKAG1,RASD1,RHEB,RHOA,RHOB,RHOC,RHOG,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA,RRAS	
ABC-family proteins mediated transport	1.8E01	3.76E-01	-6.164	DERL1,EIF2S1,EIF2S2,PEX3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC	
Hedgehog 'off' state	1.78E01	3.54E-01	-5.831	ADCY4,GNAS,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,TUBA1A,TUBA1B,TUBB2A,TUBB4B,UBC	
Degradation of beta-catenin by the destruction complex	1.78E01	3.91E-01	-6.000	CTBP2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,TLE5,UBC	
Estrogen Receptor Signaling	1.76E01	2E-01	-4.522	ADCY4,AKT1,ATF4,BAD,CAV1,CDK8,CDKN1A,CFL1,CFL2,CREB3,CTBP2,CYC1,DDX5,EIF2B2,EIF2B4,EIF4EBP1,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,GPS2,GSK3A,HES1,HRAS,HSP90AB1,JUN,KRAS,MAP2K2,MAPK3,MED10,MED21,MED4,MYL12A,MYL12B,MYL6,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NOS3,PDIA3,PRKAB1,PRKAG1,RASD1,RHOA,RRAS,SDHB,SDHD,SHF,SOD2,SRA1,UQCRC2,UQCRFS1	
Signaling by ROBO receptors	1.74E01	3.45E-01	-6.325	ELOC,NCK1,PAK4,PFN1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RHOA,RPS27A,SEM1,UBC,VASP	
Hedgehog 'on' state	1.7E01	3.95E-01	-5.831	PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC	
DNA Replication Pre-Initiation	1.66E01	3.56E-01	-6.083	ANAPC11,ANAPC16,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC,UBE2S	
Mitotic G2-G2/M phases	1.64E01	2.61E-01	-7.211	CDKN1A,CETN2,CSNK1E,DCTN2,DCTN3,DYNLL1,HSP90AB1,LIN37,MZT1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RAB8A,RBBP4,RPS27A,SEM1,SSNA1,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,UBC,YWHAE	
Interleukin-1 family signaling	1.63E01	3.18E-01	-6.403	IL1R1,MAP3K8,NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,SIGIRR,SQSTM1,UBC,UBE2N,UBE2V1	
Microautophagy Signaling Pathway	1.63E01	2.87E-01	-6.708	CHMP2A,CHMP5,CHMP6,HSPA8,MAP1LC3A,MAP1LC3B,PRKAB1,PRKAG1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,SEC13,SNF8,SQSTM1,TOMM20,VAMP8,VPS28,VTA1	
Synthesis of DNA	1.61E01	3.28E-01	-6.245	ANAPC11,ANAPC16,POLD4,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPA3,RPS27A,SEM1,UBC,UBE2S	
TCR signaling	1.59E01	3.17E-01	-6.325	BCL10,NCK1,NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC,UBE2N,UBE2V1,VASP	
C-type lectin receptors (CLRs)	1.58E01	2.97E-01	-6.403	BCL10,HRAS,ICAM2,KRAS,NEDD8,NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC,UBE2M,UBE2N,UBE2V1	
Mitotic Metaphase and Anaphase	1.56E01	2.38E-01	-7.483	ANAPC11,ANAPC16,BANF1,BUB3,CHMP2A,CHMP2B,CHMP6,DYNLL1,EMD,IST1,NUDC,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,PTTG1,RAN,RPS27A,SEC13,SEM1,SIRT2,SUMO1,TUBA1A,TUBA1B,TUBB2A,TUBB4B,UBC,UBE2I,UBE2S	
Neutrophil degranulation	1.55E01	1.81E-01	-9.274	ACAA1,ACTR10,ADGRE5,ALAD,ALDOA,ANXA2,AP1M1,AP2A2,APRT,ARL8A,ATP6AP2,ATP6V0C,BRI3,CCT2,CCT8,CNN2,COMMD3,COMMD9,CSNK2B,CST3,CSTB,CTSB,CTSC,CTSD,CTSH,CTSZ,CYBA,DDOST,DYNLL1,EEF1A1,EEF2,FTH1,FTL,FUCA1,GOLGA7,GSDMD,HMOX2,HSP90AB1,HSPA1A/HSPA1B,HSPA8,IMPDH2,IST1,JUP,LAMP1,LAMTOR2,LAMTOR3,NDUFC2,NME2,NPC2,OSTF1,PA2G4,PDAP1,PFKL,PGAM1,PGLYRP1,PGRMC1,PKM,PLAUR,PNP,PPIA,PRCP,PRDX6,PSMA2,PSMA5,PSMB1,PSMC2,PSMC3,PSMD12,PSMD13,PSMD6,QSOX1,RAB18,RAB24,RAB4B,RHOA,RHOG,RNASET2,SERPINB6,SRP14,SURF4,TTR,TUBB,TUBB4B,VAMP8,VAPA,YPEL5	
Mitotic G1 phase and G1/S transition	1.53E01	3.05E-01	-5.916	AKT1,CDKN1A,CDKN2D,E2F4,LIN37,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RBBP4,RPS27A,SEM1,UBC	
Deubiquitination	1.51E01	2.24E-01	-7.681	ACTB,ACTL6A,ADRM1,FKBP8,INO80B,INO80E,JOSD2,MAT2B,MCRS1,NEDD8,NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RAD23A,RCE1,RHOA,RPS27A,SEM1,SNX3,TADA3,TAF10,TFPT,TGFB1,TOMM20,UBC,UCHL3,VDAC1,VDAC2,VDAC3,YY1	
Glucocorticoid Receptor Signaling	1.51E01	1.67E-01	NaN	ACTB,AKT1,CAV1,CDKN1A,CREBZF,CYC1,DUSP1,FKBP4,FOS,GTF2A2,GTF2B,GTF2H5,H2-T22,H3-3A/H3-3B,HLA-A,HLA-E,HRAS,HSP90AB1,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,ICAM1,IL10RB,IL11RA,IL1R1,IL2RG,JUN,KRAS,MAP2K2,MAPK3,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NFKBIA,NOS2,NOS3,PLA2G4A,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,POMC,PRKAB1,PRKAG1,PTGES3,RASD1,RRAS,SDHB,SDHD,SGK1,SMARCB1,SRA1,SUMO1,TAF10,TAF11,TAF7,TGFB1,TSC22D3,UBE2I,UQCRC2,UQCRFS1,VCAM1,YWHAH	
TP53 Regulates Metabolic Genes	1.3E01	3.41E-01	-5.477	AKT1,COX14,COX19,COX20,COX4I1,COX5A,COX6B1,COX7A2L,COX7B,COX8A,CYCS,DDIT4,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,NDUFA4,PRDX1,PRDX2,PRDX5,PRKAB1,PRKAG1,RHEB,RRAGA,SURF1,TXN,YWHAB,YWHAE,YWHAH,YWHAQ	
Mitochondrial protein import	1.25E01	3.91E-01	-5.000	CHCHD2,COX17,COX19,CYC1,GRPEL1,HSPD1,IDH3G,MTX1,NDUFB8,PAM16,PMPCB,SLC25A4,TIMM10B,TIMM13,TIMM17A,TIMM17B,TIMM23,TIMM50,TIMM8B,TOMM20,TOMM22,TOMM40,TOMM6,TOMM7,VDAC1	
Signaling by the B Cell Receptor (BCR)	1.25E01	2.47E-01	-6.481	BCL10,FKBP1A,HRAS,KRAS,NCK1,NFKBIA,ORAI1,PPIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC	
Transcriptional regulation by RUNX1	1.22E01	2.57E-01	-6.245	ACTL6A,CLDN5,CSNK2B,LMO2,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,SMARCB1,UBC	
Class I MHC mediated antigen processing and presentation	1.2E01	1.79E-01	-8.185	ANAPC11,ANAPC13,BCAP31,CYBA,ELOC,FBXO6,HLA-A,HLA-E,HSPA5,PDIA3,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RNF115,RNF126,RNF7,RPS27A,S100A1,SAR1B,SEC13,SEM1,STUB1,TAP1,TAP2,UBC,UBE2A,UBE2B,UBE2D3,UBE2E3,UBE2G2,UBE2J1,UBE2M,UBE2N,UBE2S,UBE2V1,UBE2V2,VAMP3,VAMP8,WSB1	
Nucleotide Excision Repair	1.18E01	3.09E-01	-5.477	CETN2,COPS4,COPS5,COPS6,COPS7A,COPS8,GPS1,GTF2H5,HMGN1,POLD4,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,RAD23A,RPA3,RPS27A,SUMO1,SUMO2,SUMO3,UBC,UBE2I,UBE2N,UBE2V2,ZNF830	
Neutrophil Extracellular Trap Signaling Pathway	1.12E01	1.7E-01	-8.246	AKT1,CYC1,GSDMD,MAP2K2,MAPK3,MCL1,NDUFA10,NDUFA11,NDUFA12,NDUFA13,NDUFA2,NDUFA3,NDUFA4,NDUFA5,NDUFA6,NDUFA7,NDUFA8,NDUFA9,NDUFAB1,NDUFB10,NDUFB11,NDUFB2,NDUFB3,NDUFB4,NDUFB5,NDUFB6,NDUFB7,NDUFB8,NDUFB9,NDUFS2,NDUFS3,NDUFS6,NDUFS7,NDUFS8,NDUFV1,NDUFV2,NDUFV3,NOS2,ORAI1,PAM16,PDIA3,PLA2G4A,PLAAT3,PPID,PRDX6,SDHB,SDHD,SLC25A4,SLC25A5,SLC2A1,TIMM13,TIMM17A,TIMM17B,TIMM23,TIMM50,TIMM8B,TOMM20,TOMM22,TOMM40,Tomm5,TOMM6,TOMM7,TSPO,UQCRC2,UQCRFS1,VDAC1,VDAC2,VDAC3	
RNA Polymerase II Transcription	1.11E01	2.48E-01	-6.083	CDK9,DDX39B,EIF4A3,ELOC,GTF2A2,GTF2B,GTF2H5,LSM10,MAGOH,NCBP2,NELFE,NUDT21,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,RBM8A,RNPS1,SARNP,SNRPB,SNRPD3,SNRPF,SRSF2,SRSF3,SRSF7,SRSF9,SUPT4H1,TAF10,TAF11,TAF7,THOC1,THOC7	
RAF/MAP kinase cascade	1.07E01	1.95E-01	-7.071	ACTB,ACTG1,DUSP1,DUSP8,HRAS,IL2RG,KRAS,LAMTOR2,LAMTOR3,MAP2K2,MAPK3,PDGFA,PDGFB,PEBP1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RGL2,RPS27A,SEM1,UBC,VWF,YWHAB	
Cachexia Signaling Pathway	1.05E01	1.71E-01	-6.677	ADCY4,AKT1,CAPNS1,CEBPD,DDIT4,EIF2B2,EIF2B4,EIF2S1,EIF2S2,GNAS,GSK3A,HSP90AB1,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,IFNGR1,IL1R1,MALAT1,MAP1LC3B,MAPK3,NOS2,POMC,PRKAB1,PRKAG1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,S1PR1,TGFB1,TNFRSF12A,TNFRSF1A,TNFSF12,TNFSF13,XBP1	
Fc epsilon receptor (FCERI) signaling	1.01E01	2.09E-01	-6.403	BCL10,FOS,HRAS,JUN,KRAS,MAPK3,NFKBIA,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,UBC,UBE2N,UBE2V1	
TCF dependent signaling in response to WNT	1.01E01	2.11E-01	-6.481	AKT1,CAV1,CSNK1E,CSNK2B,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPS27A,SEM1,SOX17,SOX7,TLE5,UBC,WNT5A	
Phagosome Maturation	9.83E00	2.26E-01	NaN	ATP6AP1,ATP6AP2,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,CTSB,CTSC,CTSD,CTSF,CTSH,CTSZ,DCTN4,Dync1i2,DYNLL1,DYNLRB1,GPAA1,HLA-A,HLA-E,LAMP1,NAPA,PRDX1,PRDX2,PRDX5,PRDX6,RAB5A,TAP1,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,VAMP3,VPS28,VTI1B	
Cell Cycle Checkpoints	9.58E00	1.84E-01	-7.071	ANAPC11,ANAPC16,BUB3,CDKN1A,DYNLL1,NUDC,PIAS4,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSMC1,PSMC2,PSMC3,PSMC4,PSMC5,PSMC6,PSMD12,PSMD13,PSMD4,PSMD5,PSMD6,PSMD8,PSMD9,PSME1,PSME2,RPA3,RPS27A,SEC13,SEM1,UBC,UBE2N,UBE2S,UBE2V2,YWHAB,YWHAE,YWHAH,YWHAQ	
Protein folding	9.4E00	2.76E-01	-5.196	ACTB,ARL2,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CSNK2B,FBXO6,GNA11,GNB2,GNG5,PFDN1,PFDN2,PFDN5,PFDN6,TBCA,TBCB,TBCC,TCP1,TUBA1A,TUBA1B,TUBB2A,TUBB4B,VBP1	
Coronavirus Pathogenesis Pathway	9.17E00	2.01E-01	3.592	ATF4,ATP6AP1,BAX,E2F4,EEF1A1,FAU,FOS,JUN,MAPK3,NFKBIA,NPM1,PA2G4,RPS10,RPS11,RPS12,RPS13,RPS14,RPS15A,RPS16,RPS18,RPS19,RPS2,RPS20,RPS21,RPS23,RPS24,RPS25,RPS26,RPS27A,RPS27L,RPS28,RPS29,RPS3,RPS4Y1,RPS5,RPS7,RPS8,RPS9,RPSA,SIGMAR1,TGFB1	
Hypoxia Signaling in the Cardiovascular System	8.98E00	3.03E-01	-2.828	AKT1,ATF4,COPS5,CREB3,EDN1,HSP90AB1,JUN,LDHA,NFKBIA,NOS3,SUMO1,UBE2A,UBE2B,UBE2D3,UBE2E3,UBE2G2,UBE2I,UBE2J1,UBE2M,UBE2N,UBE2S,UBE2V1,UBE2V2	
HSP90 chaperone cycle for steroid hormone receptors in the presence of ligand	8.61E00	3.45E-01	-4.359	ACTR10,CAPZA2,DCTN2,DCTN3,DCTN4,DCTN6,DNAJA1,DNAJA2,DYNLL1,FKBP4,HSP90AB1,HSPA1A/HSPA1B,HSPA8,PTGES3,STIP1,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
EPH-Ephrin signaling	8.4E00	2.66E-01	-5.000	ACTB,ACTG1,AP2A2,Ap2b1,AP2M1,AP2S1,APH1A,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,CFL1,CLTA,CLTB,EFNA1,EPHB4,GIT1,HRAS,MYL12A,MYL12B,MYL6,PSEN2,PSENEN,RHOA	
Integrin Signaling	8.13E00	1.89E-01	-3.550	ACTB,ACTG1,ACTN1,AKT1,ARF1,Arf2,ARF4,ARF5,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,CAPNS1,CAV1,Cdc42,GIT1,HRAS,ILK,ILKAP,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,NCK1,PAK4,PDGFB,PFN1,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TSPAN4,VASP,ZYX	
NER (Nucleotide Excision Repair, Enhanced Pathway)	8.02E00	2.64E-01	-1.964	CETN2,COPS4,COPS5,COPS6,COPS7A,COPS8,GPS1,GTF2H5,HMGN1,NEDD8,POLD4,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,RBBP4,RPA3,UBE2I,UBE2N	
NRF2-mediated Oxidative Stress Response	7.68E00	1.77E-01	-4.491	ACTB,ACTG1,AKR1A1,AKT1,ATF4,CCT7,DNAJA1,DNAJA2,DNAJB11,DNAJB2,DNAJB6,DNAJB9,ERP29,FMO1,FOS,FTH1,FTL,GCLM,GSTM1,GSTM2,GSTM5,HERPUD1,HRAS,HSP90AB1,HSPB8,JUN,JUNB,JUND,KRAS,MAP2K2,MAPK3,MGST3,NFE2L2,PPIB,PRDX1,RASD1,RRAS,SOD2,SQSTM1,STIP1,TXN,UBE2E3	
Ferroptosis Signaling Pathway	7.66E00	2.21E-01	-2.043	ARF1,Arf2,ARF4,ARF5,ARF6,ATF4,CDKN1A,CTSB,FTH1,FTL,G3BP1,GCH1,GPX4,HRAS,HSPB1,KRAS,MAP2K2,MAPK3,NCOA4,NFE2L2,PEBP1,PRKAB1,PRKAG1,RASD1,RRAS,SAT1,SLC3A2,SQSTM1,VDAC2	
COPI-mediated anterograde transport	7.62E00	2.45E-01	-5.000	ACTR10,ARF1,ARF4,ARF5,ARFGAP2,BET1,CAPZA2,COG8,COPE,COPZ2,DCTN2,DCTN3,DCTN4,DCTN6,DYNLL1,KDELR1,KDELR2,NAPA,TMED2,TMED3,TMED9,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
ROBO SLIT Signaling Pathway	6.79E00	2.13E-01	1.732	AKT1,ARF1,Arf2,ARF4,ARF5,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,CDK5,CDKN1A,FOS,GIT1,HES1,JUN,MYL12A,MYL12B,NCK1,NDFIP1,PAK4,PRDM16,PRKAG1,RHOA,TGFB1	
Cellular response to heat stress	6.78E00	2.37E-01	-4.472	BAG5,DNAJB6,EEF1A1,FKBP4,HIKESHI,HSBP1,HSP90AB1,HSPA12B,HSPA1A/HSPA1B,HSPA5,HSPA8,HSPB1,HSPB8,MAPK3,MRPL18,PTGES3,RAE1,RPA3,RPS19BP1,SEC13,SERPINH1,ST13,YWHAE	
TP53 Regulates Transcription of DNA Repair Genes	6.7E00	2.71E-01	-4.359	AP1M1,AP1S1,AP1S2,CDK9,ELOC,FOS,GTF2H5,JUN,NELFE,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,SUPT4H1	
Intra-Golgi and retrograde Golgi-to-ER traffic	6.69E00	1.77E-01	-6.000	ACTR10,ARF1,ARF4,ARF5,ARFGAP2,ARFRP1,ARL1,CAPZA2,COG8,COPE,COPZ2,CYTH2,DCTN2,DCTN3,DCTN4,DCTN6,DYNLL1,KDELR1,KDELR2,NAA38,NAPA,PLA2G4A,PLIN3,RAB18,RAB9A,SURF4,SYS1,TMED2,TMED3,TMED9,TUBA1A,TUBA1B,TUBB2A,TUBB4B,USE1,VAMP3	
Macroautophagy	6.52E00	2.77E-01	-4.243	ATG101,CHMP2A,CHMP2B,CHMP6,DYNLL1,GABARAP,GABARAPL2,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,MAP1LC3A,MAP1LC3B,PRKAB1,PRKAG1,RHEB,RRAGA,WDR45B	
Mitophagy	6.46E00	4E-01	-3.464	CSNK2B,MAP1LC3A,MAP1LC3B,RPS27A,SQSTM1,TOMM20,TOMM22,TOMM40,TOMM6,TOMM7,UBC,VDAC1	
MHC class II antigen presentation	6.3E00	2.06E-01	-5.099	ACTR10,AP1M1,AP1S1,AP1S2,AP2A2,AP2M1,AP2S1,ARF1,CAPZA2,CLTA,CTSB,CTSC,CTSD,CTSF,CTSH,DCTN2,DCTN3,DCTN4,DCTN6,DYNLL1,SAR1B,SEC13,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
CLEAR Signaling Pathway	6.23E00	1.54E-01	2.412	AKT1,ATF4,ATP6AP1,ATP6AP2,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,BLOC1S1,CASTOR1,CREB3,CTSB,CTSD,CTSF,DDIT4,GABARAP,GLMP,GSK3A,HRAS,KRAS,LAMP1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,MAPK3,PDGFB,PIP4P1,PRKAB1,PRKAG1,RASD1,RHEB,RRAGA,RRAS,SEC13,STUB1,TGFB1,TNFRSF1A,YWHAB,YWHAE,YWHAH,YWHAQ	
Detoxification of Reactive Oxygen Species	6.18E00	3.51E-01	-3.606	ATOX1,CYBA,CYCS,GPX1,GPX7,PRDX1,PRDX2,PRDX3,PRDX5,PRDX6,SOD2,TXN,TXN2	
Cytoprotection by HMOX1	6.13E00	2.74E-01	-4.123	COX14,COX19,COX20,COX4I1,COX5A,COX6B1,COX7A2L,COX7B,COX8A,CYCS,HMOX2,NDUFA4,NFE2L2,SIN3B,STAP2,SURF1,TXNIP	
Assembly of RNA Polymerase II Complex	6.03E00	3E-01	-3.873	GTF2A2,GTF2B,GTF2H5,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,TAF10,TAF11,TAF7	
Regulation of mRNA stability by proteins that bind AU-rich elements	6.01E00	3.18E-01	-3.742	AKT1,EXOSC3,EXOSC4,EXOSC7,EXOSC8,HSPA1A/HSPA1B,HSPA8,HSPB1,PABPC1,RPS27A,TNFSF13,UBC,YWHAB,ZFP36	
Translocation of SLC2A4 (GLUT4) to the plasma membrane	5.9E00	2.54E-01	-4.243	ACTB,ACTG1,AKT1,ASPSCR1,PRKAB1,PRKAG1,RAB11A,RAB13,RAB4A,RAB8A,TUBA1A,TUBA1B,TUBB2A,TUBB4B,YWHAB,YWHAE,YWHAH,YWHAQ	
Iron uptake and transport	5.84E00	2.76E-01	-4.000	ABCG2,ALAD,ATP6AP1,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,FTH1,FTL,GLRX3,HMOX2,NEDD8,RPS27A,UBC	
ESR-mediated signaling	5.75E00	2.03E-01	-4.899	CDK9,CTSD,DDX5,FKBP4,FOS,GTF2A2,HSP90AB1,JUN,JUND,MAPK3,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,PPID,PRMT1,PTGES3,USF1,YY1	
mRNA Capping	5.7E00	3.79E-01	-3.317	GTF2H5,NCBP2,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L	
MicroRNA Biogenesis Signaling Pathway	5.67E00	1.71E-01	-5.657	AKT1,DDX5,DNAJA2,EXOSC3,EXOSC4,EXOSC7,EXOSC8,HRAS,HSP90AB1,HSPA8,KRAS,MAPK3,PDGFB,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,PTGES3,RAE1,RAN,RASD1,RRAS,SEC13,SRSF3,ST13,TGFB1,TSN	
Signaling by TGF-beta Receptor Complex	5.67E00	2.83E-01	-3.873	BAMBI,F11R,FKBP1A,LTBP4,NEDD8,PMEPA1,PPP1CA,PPP1R15A,RHOA,RPS27A,STRAP,STUB1,TGFB1,UBC,UBE2M	
Remodeling of Epithelial Adherens Junctions	5.52E00	2.5E-01	-2.828	ACTB,ACTG1,ACTN1,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,RAB5A,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,ZYX	
RNA polymerase II transcribes snRNA genes	5.47E00	2.29E-01	-4.359	CDK9,GTF2A2,GTF2B,INTS11,NABP2,NCBP2,PHAX,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,SNAPC5,SUPT4H1,TAF11	
Intrinsic Pathway for Apoptosis	5.45E00	2.73E-01	-3.873	AKT1,BAD,BAX,BBC3,C1QBP,CYCS,DIABLO,DYNLL1,GSDMD,MAPK3,NMT1,YWHAB,YWHAE,YWHAH,YWHAQ	
Deadenylation-dependent mRNA decay	5.45E00	2.73E-01	-3.873	CNOT3,EIF4A1,EIF4A3,EXOSC3,EXOSC4,EXOSC7,EXOSC8,LSM1,LSM2,LSM3,LSM5,LSM6,LSM7,NT5C3B,PABPC1	
Cargo recognition for clathrin-mediated endocytosis	5.4E00	2.06E-01	-4.690	AP2A2,Ap2b1,AP2M1,AP2S1,CLTA,CLTB,COPS4,COPS5,COPS6,COPS7A,COPS8,GPS1,NECAP2,NEDD8,RPS27A,SH3GL1,TOR1A,UBC,VAMP3,VAMP7,VAMP8,WNT5A	
Gene and protein expression by JAK-STAT signaling after IL-12 stimulation	5.33E00	3.24E-01	0.000	AIP,ANXA2,ARF1,CFL1,CNN2,HNRNPF,PPIA,PSME2,RPLP0,SOD2,TALDO1,TCP1	
Renal Cell Carcinoma Signaling	5.19E00	2.28E-01	-3.000	AKT1,ELOC,FH,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,PAK4,PDGFB,RASD1,RPS27A,RRAS,SLC2A1,TGFB1,Ubb,UBC	
Germ Cell-Sertoli Cell Junction Signaling	5.17E00	1.71E-01	NaN	ACTB,ACTG1,ACTN1,AKT1,Cdc42,CFL1,CFL2,HRAS,ILK,JUP,KRAS,MAP2K2,MAP3K8,MAPK3,PAK4,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TGFB1,TNFRSF1A,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,ZYX	
14-3-3-mediated Signaling	5.16E00	1.89E-01	-3.153	AKT1,BAD,BAX,FOS,GSK3A,HRAS,JUN,KRAS,MAP2K2,MAPK3,PDIA3,RASD1,RRAS,TNFRSF1A,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,VIM,YWHAB,YWHAE,YWHAH,YWHAQ	
Clathrin-mediated Endocytosis Signaling	5.09E00	1.59E-01	NaN	ACTB,ACTG1,AP1M1,AP1S1,AP1S2,AP2A2,Ap2b1,AP2M1,AP2S1,APOD,APOE,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,CLTA,CLTB,CSNK2B,HSPA8,PDGFA,PDGFB,RAB11A,RAB11B,RAB4A,RAB4B,RAB5A,RPS27A,SH3GL1,Ubb,UBC	
Insertion of tail-anchored proteins into the endoplasmic reticulum membrane	5.08E00	4.09E-01	-3.000	CAMLG,CYB5A,EMD,PRNP,SEC61B,SEC61G,SGTA,UBL4A,VAPA	
Signaling by FGFR2	5.07E00	2.33E-01	-4.123	HNRNPF,HNRNPM,HRAS,KRAS,MAPK3,NCBP2,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,RPS27A,UBC	
Necroptosis Signaling Pathway	5.03E00	1.74E-01	-4.811	CAPNS1,FKBP1A,PAM16,PLA2G4A,PPID,SLC25A3,SLC25A4,SLC25A5,TIMM13,TIMM17A,TIMM17B,TIMM23,TIMM50,TIMM8B,TNFRSF1A,TOMM20,TOMM22,TOMM40,Tomm5,TOMM6,TOMM7,TRADD,TSPO,UBC,VDAC1,VDAC2,VDAC3	
trans-Golgi Network Vesicle Budding	4.98E00	2.3E-01	-4.123	AP1M1,AP1S1,AP1S2,ARF1,BLOC1S1,BLOC1S4,CHMP2A,CLTA,CLTB,CTSZ,FTH1,FTL,HSPA8,NAPA,TPD52L1,VAMP7,VAMP8	
Clathrin-mediated endocytosis	4.98E00	1.85E-01	-4.899	ACTB,ACTG1,AP2A2,Ap2b1,AP2M1,AP2S1,ARF6,ARPC1A,ARPC2,ARPC3,ARPC4,CLTA,CLTB,HSPA8,NECAP2,RAB5A,RPS27A,SH3GL1,TRIP10,UBC,VAMP3,VAMP7,VAMP8,WNT5A	
MTOR signalling	4.96E00	3.57E-01	-3.162	AKT1,EIF4EBP1,FKBP1A,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,RHEB,RRAGA,YWHAB	
Late endosomal microautophagy	4.92E00	3.24E-01	-3.317	CHMP2A,CHMP2B,CHMP6,HSPA8,MVB12A,PARK7,PLIN3,RPS27A,UBC,VIM,VPS28	
Nucleotide Excision Repair Pathway	4.79E00	3.14E-01	NaN	GTF2H5,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,RPA3	
Amino acids regulate mTORC1	4.75E00	2.55E-01	-3.742	ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,CASTOR1,LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,RHEB,RRAGA,SEC13	
RAS processing	4.71E00	3.75E-01	-3.000	ABHD17A,ARL2,FNTA,GOLGA7,HRAS,KRAS,RCE1,RPS27A,UBC	
RHO GTPases Activate WASPs and WAVEs	4.66E00	3.06E-01	-3.317	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,BAIAP2,BRK1,MAPK3,NCK1	
Endosomal Sorting Complex Required For Transport (ESCRT)	4.51E00	3.23E-01	-3.162	CHMP2A,CHMP2B,CHMP5,CHMP6,MVB12A,RPS27A,SNF8,UBC,VPS28,VTA1	
Polyamine Regulation in Colon Cancer	4.38E00	2.37E-01	-2.138	AKT1,CSNK2B,DOHH,EIF5A,FOS,JUN,KRAS,MAP2K2,MAPK3,OAZ1,RHOA,SAT1,SLC3A2,SMOX	
Protein Sorting Signaling Pathway	4.35E00	1.57E-01	-5.292	ADCY4,AP1M1,AP1S1,AP1S2,ARF1,CLTA,CLTB,COPE,COPZ2,GNAS,KDELR1,KDELR2,PRKAG1,RAB11A,RAB11B,RER1,SEC13,SERPINH1,SNX15,SNX17,SNX21,SNX3,SURF4,TMED2,TMED3,TMED4,TMED9,VPS29	
Androgen Signaling	4.34E00	1.6E-01	-2.449	Calm1 (includes others),GNA11,GNAI2,GNAS,GNB2,GNG5,GTF2A2,GTF2B,GTF2H5,H3-3A/H3-3B,JUN,MAPK3,NCOA4,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,PRKAG1,TAF10,TAF11,TAF7,TGFB1I1	
HER-2 Signaling in Breast Cancer	4.3E00	1.45E-01	1.257	AKT1,ARF1,Arf2,ARF4,ARF5,ARF6,BAD,CDKN1A,COPS6,COX17,COX4I1,COX5A,COX6B1,Cox6c,COX7A2,COX7A2L,COX7B,COX8A,CYB5A,FOS,GSK3A,HRAS,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,RAE1,RASD1,RHEB,RRAS,SEC13,SURF1	
Spliceosomal Cycle	4.27E00	2.45E-01	-3.464	BCAS2,CWC15,DDX39B,EIF4A3,HSPA8,MAGOH,PLRG1,PRPF40B,RBM8A,SF3B4,SF3B5,SF3B6,ZNF830	
HIF1Î± Signaling	4.25E00	1.48E-01	-1.826	AKT1,CAMK1,CDKN1A,COPS5,EDN1,EGLN2,EIF4EBP1,ELOC,HRAS,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,JUN,KRAS,LDHA,MAP2K2,MAPK3,NAA10,NOS2,PDGFB,PKM,RACK1,RAN,RASD1,RRAS,SAT1,SLC2A1,STUB1,TGFB1,VIM	
Actin Nucleation by ARP-WASP Complex	4.17E00	1.94E-01	-3.873	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAIAP2,Cdc42,HRAS,KRAS,NCK1,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,VASP	
Ephrin Receptor Signaling	4.14E00	1.49E-01	-5.000	AKT1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,ATF4,CFL1,CFL2,CREB3,EFNA1,EPHB4,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,NCK1,PAK4,PDGFA,PDGFB,RASD1,RHOA,RRAS,SH2D3C	
Chaperone Mediated Autophagy	4.13E00	3.64E-01	-2.828	EEF1A1,HSP90AB1,HSPA8,PARK7,PLIN3,RPS27A,UBC,VIM	
RHO GTPases activate PKNs	4.1E00	3.21E-01	-3.000	MYL12B,MYL6,RHOA,RHOB,RHOC,YWHAB,YWHAE,YWHAH,YWHAQ	
The citric acid (TCA) cycle and respiratory electron transport	4.09E00	2.36E-01	-3.606	BSG,FH,GLO1,HAGH,IDH3G,LDHA,MDH2,MPC1,MPC2,SDHB,SDHD,SUCLG1,VDAC1	
E3 ubiquitin ligases ubiquitinate target proteins	4.09E00	2.36E-01	-3.606	BCL10,DERL1,HLA-A,PEX13,RNF181,RPS27A,RRAGA,UBC,UBE2A,UBE2B,UBE2D3,UBE2N,UBE2V2	
Sumoylation Pathway	4.07E00	1.84E-01	1.000	ARHGDIA,ARHGDIB,Cdc42,CTBP2,FOS,JUN,NFKBIA,PIAS4,RAN,RHOA,RHOB,RHOC,RHOG,SERBP1,STUB1,SUMO1,SUMO2,SUMO3,UBE2I	
Role of MAPK Signaling in Promoting the Pathogenesis of Influenza	3.94E00	1.75E-01	-3.771	ATP6AP1,ATP6AP2,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,BAX,HRAS,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,PLA2G4A,PLAAT3,PRDX6,RASD1,RRAS	
Mitochondrial iron-sulfur cluster biogenesis	3.89E00	4.62E-01	-2.449	FDX1,FDX2,GLRX5,ISCA1,ISCA2,ISCU	
RNA Polymerase I Transcription	3.89E00	2.4E-01	-3.464	CAVIN1,GTF2H5,MAPK3,MBD3,POLR1D,POLR2E,POLR2F,POLR2K,POLR2L,RBBP4,RBBP7,TAF1D	
Regulation of Actin-based Motility by Rho	3.88E00	1.74E-01	-4.243	ACTB,ARHGDIA,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAIAP2,Cdc42,CFL1,MYL12A,MYL12B,MYL6,PAK4,PFN1,RHOA,RHOB,RHOC,RHOG	
RHOA Signaling	3.88E00	1.69E-01	-4.472	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAIAP2,CDC42EP1,CDC42EP5,CFL1,CFL2,EZR,MYL12A,MYL12B,MYL6,NRP2,PFN1,RDX,RHOA	
Aggrephagy	3.87E00	2.56E-01	-3.317	DYNLL1,PARK7,RPS27A,TUBA1A,TUBA1B,TUBB2A,TUBB4B,UBC,UBE2N,UBE2V1,VIM	
ERK5 Signaling	3.81E00	2.03E-01	-3.207	AKT1,ATF4,BAD,CREB3,FOS,HRAS,KRAS,MAP3K8,RASD1,RRAS,SGK1,YWHAB,YWHAE,YWHAH,YWHAQ	
VEGF Signaling	3.81E00	1.82E-01	-2.714	ACTB,ACTG1,ACTN1,AKT1,BAD,EIF1AY,EIF2B2,EIF2B4,EIF2S1,EIF2S2,HRAS,KRAS,MAP2K2,MAPK3,NOS3,RASD1,RRAS,YWHAE	
Sertoli Cell-Germ Cell Junction Signaling Pathway (Enhanced)	3.62E00	1.36E-01	-2.828	ACTB,ACTG1,AKT1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,CLDN5,F11R,FOS,GSK3A,HRAS,ICAM1,IL1R1,ILK,JUN,JUP,KRAS,MAP2K2,MAP3K8,MAPK3,NOS2,PRKAB1,PRKAG1,RASD1,RRAS,TGFB1,TNFRSF1A,UBE2J1,ZYX	
Signaling by Rho Family GTPases	3.61E00	1.31E-01	-4.914	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAIAP2,Cdc42,CDC42EP1,CDC42EP5,CFL1,CFL2,EZR,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,JUN,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,PAK4,RDX,RHOA,RHOB,RHOC,RHOG,STMN1,VIM	
FcÎ³ Receptor-mediated Phagocytosis in Macrophages and Monocytes	3.6E00	1.81E-01	-4.123	ACTB,ACTG1,AKT1,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,EZR,MAPK3,NCK1,RAB11A,RAB11B,VAMP3,VASP	
Epithelial Adherens Junction Signaling	3.59E00	1.52E-01	-2.041	AKT1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAIAP2,CFL1,CFL2,HRAS,KRAS,MYL12A,MYL12B,PAK4,PRKAB1,PRKAG1,RASD1,RHOA,RRAS,YWHAB,YWHAE,YWHAH,YWHAQ	
Apelin Endothelial Signaling Pathway	3.5E00	1.56E-01	-3.771	ADCY4,AKT1,Calm1 (includes others),FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,ICAM1,JUN,KLF2,KRAS,MAP2K2,MAPK3,NOS3,PRKAB1,PRKAG1,RASD1,RRAS,VCAM1	
Metabolism of nitric oxide: NOS3 activation and regulation	3.48E00	4E-01	-2.449	AKT1,CAV1,DDAH1,DDAH2,NOS3,SPR	
PI3K/AKT Signaling	3.47E00	1.4E-01	-2.837	AKT1,BAD,CDC37,CDKN1A,EIF4EBP1,GSK3A,HRAS,HSP90AB1,IL10RB,IL11RA,IL1R1,IL2RG,ILK,INPP5K,KRAS,MAP2K2,MAP3K8,MAPK3,MCL1,NFKBIA,NOS3,RASD1,RHEB,RRAS,YWHAB,YWHAE,YWHAH,YWHAQ	
Hereditary Breast Cancer Signaling	3.46E00	1.55E-01	NaN	ACTB,AKT1,CDKN1A,GADD45G,HRAS,KRAS,NPM1,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,RASD1,RPS27A,RRAS,SMARCB1,Ubb,UBC	
Gap junction trafficking and regulation	3.39E00	2.65E-01	-3.000	ACTB,ACTG1,AP2M1,CLTA,CLTB,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Unfolded protein response	3.34E00	1.78E-01	-3.162	ATF4,CEBPD,DNAJA1,DNAJA2,DNAJB11,DNAJB2,DNAJB6,DNAJB9,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,NFE2L2,PDIA6,PPP1R15A,XBP1	
Ceramide Signaling	3.28E00	1.76E-01	-3.207	AKT1,BAD,CTSD,CYCS,DIABLO,FOS,HRAS,JUN,KRAS,MAPK3,RASD1,RRAS,S1PR1,S1PR4,SMPD2,TNFRSF1A	
SUMOylation of immune response proteins	3.27E00	4.55E-01	-2.236	NFKBIA,PIAS4,SUMO1,SUMO3,UBE2I	
Signaling by Insulin receptor	3.21E00	2.33E-01	-3.162	ATP6AP1,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,HRAS,KRAS,MAPK3	
Energy dependent regulation of mTOR by LKB1-AMPK	3.2E00	2.76E-01	-2.828	LAMTOR2,LAMTOR3,LAMTOR4,LAMTOR5,PRKAB1,PRKAG1,RHEB,RRAGA	
CXCR4 Signaling	3.19E00	1.43E-01	-3.900	ADCY4,AKT1,Cdc42,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,JUN,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,PAK4,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
TCA Cycle II (Eukaryotic)	3.14E00	3.04E-01	-2.646	FH,IDH3G,MDH1,MDH2,SDHB,SDHD,SUCLG1	
TBC/RABGAPs	3.13E00	2.27E-01	-3.162	ARF6,GABARAP,GABARAPL2,MAP1LC3B,RAB11A,RAB11B,RAB4A,RAB5A,RAB8A,TBC1D10A	
RHO GTPase cycle	3.1E00	1.11E-01	-7.071	ACTB,ACTG1,ACTN1,ARFGAP2,ARHGDIA,ARHGDIB,ATP6AP1,BAIAP2,BCAP31,BRK1,C1QBP,CAV1,CAVIN1,CCT2,CCT6A,CCT7,CDC37,CDC42EP1,CDC42EP5,COPS4,CYBA,DDRGK1,DDX39B,EMC3,EMD,GIT1,GPS1,HMOX2,HSP90AB1,HSPE1,JUP,MTX1,NCK1,NDUFA5,NDUFS3,NSFL1C,NUDC,PAK4,RHOA,RHOB,RHOC,RHOG,STIP1,TMEM59,TPM3,TRIP10,TUBA1B,TXNL1,VAMP3,VIM	
Regulation of TP53 Activity through Acetylation	3.09E00	2.67E-01	-2.828	AKT1,ING2,MBD3,MEAF6,PIN1,PIP4P1,RBBP4,RBBP7	
Protein ubiquitination	3.09E00	2.67E-01	-2.828	RPS27A,UBC,UBE2A,UBE2B,UBE2E3,UBE2G2,UBE2S,UCHL3	
ILK Signaling	3.09E00	1.34E-01	-4.264	ACTB,ACTG1,ACTN1,AKT1,ATF4,Cdc42,CFL1,CFL2,CREB3,FOS,GSK3A,ILK,ILKAP,JUN,LIMS2,MAPK3,MYL6,NACA,NOS2,PPP1R14B,RHOA,RHOB,RHOC,RHOG,TGFB1I1,TNFRSF1A,VIM	
Response to elevated platelet cytosolic Ca2+	3.07E00	1.52E-01	-4.472	ACTN1,ALDOA,ANXA5,CD9,CFL1,ECM1,GAS6,HSPA5,MANF,PDGFA,PDGFB,PFN1,PPIA,QSOX1,TAGLN2,TEX264,TGFB1,VTI1B,VWF,WDR1	
Coronavirus Replication Pathway	3.05E00	2.22E-01	-1.897	COPE,GSK3A,IFITM2,IFITM3,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,ZCRB1	
IGF-1 Signaling	3.02E00	1.62E-01	-2.309	AKT1,BAD,CSNK2B,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,PRKAG1,RASD1,RRAS,SOCS2,YWHAB,YWHAE,YWHAH,YWHAQ	
Unfolded Protein Response (UPR)	2.99E00	3.33E-01	-2.449	ATF4,CREB3,EIF2S1,EIF2S2,HSPA5,XBP1	
UFMylation Signaling Pathway	2.97E00	1.94E-01	-2.887	AKT1,DDRGK1,EIF4A1,EIF4A3,GPX4,H3-3A/H3-3B,PABPC1,RPL26,RPN1,UFC1,UFM1,XBP1	
PPAR Signaling	2.93E00	1.59E-01	3.000	AIP,FOS,HRAS,HSP90AB1,IL1R1,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,PDGFA,PDGFB,RASD1,RRAS,SNW1,SRA1,TNFRSF1A	
NGF-stimulated transcription	2.92E00	2.31E-01	-2.828	CDK5,FOS,ID1,ID2,ID3,JUNB,JUND,LYL1,SGK1	
Antigen Presentation Pathway	2.92E00	2.31E-01	NaN	HLA-A,HLA-E,PDIA3,PSMB5,PSMB6,PSMB8,PSMB9,TAP1,TAP2	
Role of PKR in Interferon Induction and Antiviral Response	2.91E00	1.47E-01	0.000	BAX,CYC1,CYCS,EIF2S1,FOS,HSP90AB1,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,IFNGR1,IRF1,JUN,MAPK3,METAP2,NFKBIA,NPM1,PDGFA,PDGFB,TNFRSF1A	
Metabolism of non-coding RNA	2.89E00	2E-01	-3.317	GEMIN7,NCBP2,PHAX,RAE1,SEC13,SMN1/SMN2,SNRPB,SNRPD1,SNRPD2,SNRPD3,SNRPF	
COPII-mediated vesicle transport	2.88E00	1.81E-01	-3.606	BET1,CNIH1,CTSC,CTSZ,MCFD2,NAPA,SAR1B,SEC13,TMED2,TRAPPC2,TRAPPC3,TRAPPC4,TRAPPC5	
Mitochondrial calcium ion transport	2.88E00	3.85E-01	-2.236	MCUB,SMDT1,VDAC1,VDAC2,VDAC3	
Processing of SMDT1	2.88E00	3.85E-01	-2.236	MAIP1,MCUB,PHB2,PMPCB,SMDT1	
Synaptogenesis Signaling Pathway	2.87E00	1.17E-01	-4.459	ADCY4,AKT1,AP2A2,Ap2b1,AP2M1,AP2S1,APOE,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,ATF4,BAD,Calm1 (includes others),CDK5,CFL1,CREB3,EFNA1,EIF4EBP1,EPHB4,GPAA1,HRAS,HSPA8,KRAS,MAPK3,NAPA,PRKAG1,RAB5A,RASD1,RHOA,RRAS,SGTA,SHF,VAMP3,VTI1B	
Activation of anterior HOX genes in hindbrain during early embryogenesis	2.87E00	1.73E-01	-3.742	DPY30,JUN,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,RBBP4,RBBP7,YY1	
HMGB1 Signaling	2.86E00	1.38E-01	-3.900	AKT1,Cdc42,FOS,HRAS,ICAM1,IFNGR1,IL1R1,JUN,KRAS,MAP2K2,MAPK3,RASD1,RBBP7,RHOA,RHOB,RHOC,RHOG,RRAS,TGFB1,TNFRSF1A,TNFSF12,TNFSF13,VCAM1	
Virus Entry via Endocytic Pathways	2.86E00	1.53E-01	NaN	ACTB,ACTG1,AP1M1,AP1S1,AP1S2,AP2A2,Ap2b1,AP2M1,AP2S1,CAV1,CLTA,CLTB,HLA-A,HLA-E,HRAS,KRAS,RASD1,RRAS	
RHO GTPases Activate ROCKs	2.85E00	3.16E-01	-2.449	CFL1,MYL12B,MYL6,RHOA,RHOB,RHOC	
Extra-nuclear estrogen signaling	2.82E00	1.78E-01	-3.606	AKT1,CAV1,CAV2,FOS,GNAI2,GNB2,GNG5,HRAS,HSPB1,KRAS,MAPK3,NOS3,PRMT1	
RHOGDI Signaling	2.81E00	1.27E-01	3.128	ACTB,ACTG1,ARHGDIA,ARHGDIB,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,Cdc42,CFL1,CFL2,EZR,GNA11,GNAI2,GNAS,GNB2,GNG5,MYL12A,MYL12B,MYL6,PAK4,RDX,RHOA,RHOB,RHOC,RHOG	
IL-8 Signaling	2.8E00	1.29E-01	-4.146	AKT1,BAX,Cdc42,CSTB,EIF4EBP1,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,ICAM1,JUN,KRAS,MAP2K2,MAPK3,MYL12B,NFKBIA,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,VASP,VCAM1	
Adipogenesis pathway	2.79E00	1.44E-01	2.683	ACVRL1,AKT1,CDK5,CEBPD,CTBP2,GTF2H5,KLF3,NR2F2,RBBP4,RBBP7,RBP1,SAP18,SAP30L,SIN3B,SIRT2,TGFB1,TNFRSF1A,TXNIP,WNT5A,XBP1	
CGAS-STING Signaling Pathway	2.75E00	1.43E-01	-4.025	ATP6AP1,ATP6AP2,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,BAX,CDKN1A,GSDMD,ICAM1,IRF1,MAP1LC3A,MAP1LC3B,NFKBIA,SURF4,TGFB1,TNFSF12,TNFSF13	
Insulin Receptor Signaling	2.75E00	1.43E-01	-2.183	AKT1,BAD,EIF2B2,EIF2B4,EIF4EBP1,GSK3A,HRAS,INPP5K,KRAS,MAP2K2,MAPK3,NCK1,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,RASD1,RRAS,SGK1,TRIP10	
Actin Cytoskeleton Signaling	2.74E00	1.23E-01	-4.426	ACTB,ACTG1,ACTN1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAIAP2,BRK1,CFL1,CFL2,EZR,GIT1,HRAS,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,PAK4,PDGFA,PDGFB,PFN1,RASD1,RDX,RHOA,RRAS	
fMLP Signaling in Neutrophils	2.72E00	1.45E-01	-3.500	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,Calm1 (includes others),GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,NFKBIA,RASD1,RRAS	
SUMOylation of transcription factors	2.72E00	3E-01	-2.449	FOXL2,PIAS4,SUMO1,SUMO2,SUMO3,UBE2I	
NAD Signaling Pathway	2.72E00	1.39E-01	-3.464	AKT1,HSPD1,LDHA,NAMPT,PDGFB,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,PRKAB1,PRKAG1,SIRT2,SIRT7,SLC29A1,SOD2,TGFB1	
Urate Biosynthesis/Inosine 5'-phosphate Degradation	2.71E00	3.57E-01	-2.236	IMPDH2,NT5C,NT5C3B,NT5M,PNP	
Pyroptosis	2.69E00	2.59E-01	-2.646	BAX,CHMP2A,CHMP2B,CHMP6,CYCS,GSDMD,IRF1	
Cilium Assembly	2.66E00	1.27E-01	-4.899	ARF4,BBIP1,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,CETN2,CSNK1E,DCTN2,DCTN3,DYNLL1,DYNLRB1,IFT20,RAB11A,RAB8A,SSNA1,TCP1,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,YWHAE	
RHO GTPases Activate Rhotekin and Rhophilins	2.65E00	4.44E-01	-2.000	RHOA,RHOB,RHOC,TAX1BP3	
Lipophagy	2.65E00	4.44E-01	-2.000	HSPA8,PLIN3,PRKAB1,PRKAG1	
IL-10 Signaling	2.61E00	1.36E-01	-0.655	AKT1,ATF4,BCL3,CDKN1A,CDKN2D,CREB3,DDIT4,DUSP1,FOS,HLA-A,HLA-E,ICAM1,IFNGR1,IL10RB,IL1R1,JUN,NFKBIA,NOS2,PKM,PRKAB1,PRKAG1	
Amyloid Processing	2.61E00	1.96E-01	0.000	AKT1,APH1A,CAPNS1,CDK5,CSNK1E,CSNK2B,MAPK3,PRKAG1,PSEN2,PSENEN	
Glutathione Redox Reactions I	2.59E00	2.5E-01	-2.646	GPX1,GPX4,GPX7,GSTM1,GSTM2,MGST3,PRDX6	
Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors	2.54E00	2.22E-01	-1.414	APOE,CDKN1A,HSPD1,NPM1,SUMO1,UBE2I,YEATS4,YY1	
Interferon Signaling	2.54E00	2.22E-01	-2.828	BAX,IFI35,IFITM2,IFITM3,IFNGR1,IRF1,PSMB8,TAP1	
SUMOylation of transcription cofactors	2.53E00	2.05E-01	-3.000	DDX5,ING2,NPM1,PARK7,PIAS4,SUMO1,SUMO2,SUMO3,UBE2I	
PAK Signaling	2.5E00	1.45E-01	-2.673	CFL1,CFL2,GIT1,HRAS,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,NCK1,PAK1IP1,PAK4,PDGFA,PDGFB,RASD1,RRAS	
RAC Signaling	2.5E00	1.39E-01	-4.243	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAIAP2,BRK1,CFL1,CFL2,HRAS,JUN,KRAS,MAP2K2,MAPK3,PAK4,RASD1,RHOA,RRAS	
Serotonin Receptor Signaling	2.5E00	1.04E-01	-6.143	ADCY4,AKT1,ATF4,Calm1 (includes others),CAV1,CAV2,Cdc42,CDK5,COPS5,CREB3,EDN1,EIF4EBP1,GCH1,GNA11,GNAI2,GNAS,GNB2,GNG5,H3-3A/H3-3B,HRAS,JUN,KRAS,MAP1LC3B,MAP2K2,MAPK3,NFKBIA,ORAI1,PAK4,PDIA3,PLA2G4A,PLAAT3,PLAUR,PRDX6,PRKAG1,QDPR,RAB4A,RAB4B,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,SMOX,SPR,SQSTM1,TGFB1,TGM2,VWF	
Insulin Secretion Signaling Pathway	2.5E00	1.16E-01	-5.303	ADCY4,ATF4,CREB3,EIF2B2,EIF2B4,EIF2S1,EIF2S2,EIF4A1,EIF4A3,EIF4EBP1,GNA11,GNAS,GPAA1,MAPK3,NAPA,PABPC1,PDIA3,PRKAG1,SEC11A,SEC11C,SEC61B,SEC61G,SLC2A1,SPCS1,SPCS2,SRP14,SRP19,SRP9,SSR2,SSR4,VAMP3,VTI1B	
Signaling by VEGF	2.47E00	1.48E-01	-4.000	AAMP,ACTB,ACTG1,AKT1,BAIAP2,BRK1,CAV1,CYBA,HRAS,HSPB1,JUP,KRAS,NCK1,NOS3,NRP2,RHOA	
Iron homeostasis signaling pathway	2.46E00	1.38E-01	NaN	ATP6AP1,ATP6AP2,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,CIAO1,CIAO2A,CIAO2B,FTH1,FTL,HMOX2,ISCU,MAPK3,PCBP1,PDGFA,PDGFB	
IL-2 Signaling	2.46E00	1.77E-01	-2.828	AKT1,CSNK2B,FOS,HRAS,IL2RG,JUN,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Chemokine Signaling	2.41E00	1.6E-01	-2.887	Calm1 (includes others),CAMK1,CFL1,FOS,GNAI2,HRAS,JUN,KRAS,MAP2K2,MAPK3,RASD1,RHOA,RRAS	
Ephrin B Signaling	2.4E00	1.67E-01	-2.828	CFL1,CFL2,EPHB4,GNA11,GNAI2,GNAS,GNB2,GNG5,HNRNPK,HRAS,MAPK3,RHOA	
MSP-RON Signaling in Cancer Cells Pathway	2.39E00	1.36E-01	-3.900	AKT1,ATF4,CREB3,FOS,HRAS,JUN,KLK8,KRAS,MAP2K2,MAPK3,NFKBIA,PLAUR,RASD1,RRAS,VIM,YWHAB,YWHAE,YWHAH,YWHAQ	
Gap Junction Signaling	2.38E00	1.11E-01	-4.000	ACTB,ACTG1,ADCY4,AKT1,ATF4,Calm1 (includes others),CAV1,CREB3,CSNK1E,GNAI2,GNAS,GSK3A,HRAS,HSPA8,KRAS,MAP2K2,MAPK3,NPR1,NT5C,P2RY1,PDIA3,PLA2G4A,PRKAG1,RASD1,RRAS,TGFB1,TNFRSF1A,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,VDAC1,VDAC2,VDAC3,YBX3	
Formaldehyde Oxidation II (Glutathione-dependent)	2.31E00	1E00	NaN	ADH5,ESD	
Cardiac Hypertrophy Signaling	2.3E00	1.15E-01	-4.041	ADCY4,AKT1,Calm1 (includes others),Cdc42,EIF2B2,EIF2B4,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,HSPB1,JUN,KRAS,MAP2K2,MAP3K8,MAPK3,MYL12A,MYL12B,MYL6,PDIA3,PRKAG1,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TGFB1	
Protein methylation	2.3E00	2.94E-01	-2.236	EEF1A1,EEF2,ETFB,HSPA8,RPS2	
RAB geranylgeranylation	2.3E00	1.69E-01	-3.317	RAB11A,RAB11B,RAB13,RAB18,RAB24,RAB4A,RAB4B,RAB5A,RAB8A,RAB9A,RABGGTB	
Induction of Apoptosis by HIV1	2.3E00	1.69E-01	-2.530	BAX,BBC3,CYC1,CYCS,DIABLO,NFKBIA,SLC25A3,SLC25A4,SLC25A5,TNFRSF1A,TRADD	
P2Y Purigenic Receptor Signaling Pathway	2.28E00	1.35E-01	-3.500	ADCY4,AKT1,ATF4,CREB3,FOS,GNAI2,GNB2,GNG5,HRAS,JUN,KRAS,MAP2K2,MAPK3,P2RY1,PDIA3,PRKAG1,RASD1,RRAS	
Processing and activation of SUMO	2.28E00	3.64E-01	-2.000	SUMO1,SUMO2,SUMO3,UBE2I	
Pexophagy	2.28E00	3.64E-01	-2.000	MAP1LC3B,RPS27A,SQSTM1,UBC	
Dolichyl-diphosphooligosaccharide Biosynthesis	2.28E00	3.64E-01	-2.000	ALG5,DPM1,DPM2,DPM3	
Transcriptional regulation of white adipocyte differentiation	2.27E00	1.55E-01	-2.496	CDK8,CEBPD,KLF4,MED10,MED21,MED28,MED29,MED4,MED7,MED8,MED9,NR2F2,TGFB1	
Apelin Muscle Signaling Pathway	2.27E00	1.88E-01	-2.236	AKT1,GNA11,GNAI2,GNAS,GNB2,GNG5,NOS3,PRKAB1,PRKAG1	
Apoptosis Signaling	2.24E00	1.44E-01	-0.277	BAD,BAX,CAPNS1,CYC1,CYCS,DIABLO,HRAS,KRAS,MAP2K2,MAPK3,MCL1,NFKBIA,RASD1,RRAS,TNFRSF1A	
L1CAM interactions	2.21E00	1.36E-01	-4.123	ACTB,ACTG1,AP2A2,AP2M1,AP2S1,CLTA,CSNK2B,EZR,HSPA8,MAP2K2,MAPK3,NRP2,RDX,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Transcriptional activity of SMAD2/SMAD3:SMAD4 heterotrimer	2.2E00	1.84E-01	-2.333	CDK8,CDK9,E2F4,JUNB,MAPK3,RPS27A,SNW1,UBC,YBX1	
Sleep NREM Signaling Pathway	2.2E00	1.39E-01	3.500	ADCY4,ATF4,CREB3,GNAI2,GNAS,HRAS,KRAS,MAP2K2,MAPK3,PRKAG1,RASD1,RRAS,YWHAB,YWHAE,YWHAH,YWHAQ	
Adrenomedullin signaling pathway	2.2E00	1.21E-01	-4.264	ADCY4,AKT1,BAD,BAX,Calm1 (includes others),CFH,FOS,GNA11,GNAS,GSK3A,HRAS,KRAS,MAP2K2,MAPK3,NOS3,NPR1,NT5C,PDIA3,PRKAG1,RAMP2,RAMP3,RASD1,RRAS,SHF	
Mechanisms of Viral Exit from Host Cells	2.17E00	1.95E-01	NaN	ACTB,ACTG1,CHMP2A,CHMP2B,CHMP6,SH3GL1,SNF8,VPS28	
Signal amplification	2.16E00	2.12E-01	-2.646	AAMP,GNA11,GNAI2,GNB2,GNG5,P2RY1,PLA2G4A	
Melanoma Signaling	2.15E00	1.8E-01	-1.414	AKT1,BAD,CDKN1A,HRAS,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
PDGF Signaling	2.14E00	1.49E-01	-2.887	CAV1,CSNK2B,FOS,HRAS,INPP5K,JUN,KRAS,MAP2K2,MAPK3,PDGFA,PDGFB,RASD1,RRAS	
Opioid Signaling Pathway	2.12E00	1.11E-01	-3.530	ADCY4,AKT1,AP2A2,Ap2b1,AP2M1,AP2S1,ATF4,BAD,Calm1 (includes others),CAMK1,CLTA,CLTB,CREB3,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,NFKBIA,NOS3,OGFR,POMC,PRKAG1,RASD1,RRAS,SIGMAR1	
UVC-Induced MAPK Signaling	2.09E00	1.76E-01	-2.828	FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,RASD1,RRAS,SMPD2	
RHO GTPases activate CIT	2.08E00	2.63E-01	-2.236	MYL12B,MYL6,RHOA,RHOB,RHOC	
FOXO-mediated transcription	2.08E00	2.63E-01	-2.236	AKT1,TXN,TXNIP,YWHAB,YWHAQ	
Purine Nucleotides Degradation II (Aerobic)	2.08E00	2.63E-01	-2.236	IMPDH2,NT5C,NT5C3B,NT5M,PNP	
Protein Kinase A Signaling	2.06E00	1.02E-01	-0.667	ADCY4,ANAPC11,ANAPC13,ATF4,BAD,Calm1 (includes others),CREB3,DUSP1,DUSP11,DUSP8,GDE1,GNAI2,GNAS,GNB2,GNG5,GSK3A,H3-3A/H3-3B,KDELR1,KDELR2,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,NFKBIA,NOS3,PDIA3,PGP,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,PTPRR,RHOA,SMPDL3A,TGFB1,TIMM50,VASP,YWHAB,YWHAE,YWHAH,YWHAQ	
Aldosterone Signaling in Epithelial Cells	2.05E00	1.22E-01	-2.236	DNAJA1,DNAJB11,DNAJB2,DNAJB6,DNAJB9,DNAJC30,DUSP1,HSP90AB1,HSPA12B,HSPA1A/HSPA1B,HSPA5,HSPA8,HSPB1,HSPB8,HSPD1,HSPE1,KRAS,MAP2K2,MAPK3,PDIA3,SGK1	
Semaphorin Signaling in Neurons	2.04E00	1.64E-01	NaN	Cdc42,CDK5,CFL1,CFL2,MAPK3,PAK4,RHOA,RHOB,RHOC,RHOG	
Autophagy	2.02E00	1.15E-01	-3.266	AKT1,ATF4,ATG101,BAD,Calm1 (includes others),CREB3,DAPK3,FOS,GABARAP,GABARAPL2,GSK3A,JUN,LAMP1,MAP1LC3A,MAP1LC3B,MAP2K2,MAPK3,PDGFB,PRKAB1,PRKAG1,SLC3A2,SQSTM1,TGFB1,TNFRSF1A,VAMP8	
Interleukin-4 and Interleukin-13 signaling	2.02E00	1.36E-01	-3.873	AKT1,CDKN1A,CEBPD,FOS,HSPA8,ICAM1,IL2RG,JUNB,MCL1,NOS2,POMC,S1PR1,TGFB1,VCAM1,VIM	
ATF4 activates genes in response to endoplasmic reticulum stress	2.02E00	2.22E-01	0.816	ATF4,EXOSC3,EXOSC4,EXOSC7,EXOSC8,HERPUD1	
Glycolysis I	2.02E00	2.22E-01	-2.449	ALDOA,ENO1,GAPDH,PFKL,PGAM1,PKM	
Gluconeogenesis I	2.02E00	2.22E-01	-2.449	ALDOA,ENO1,GAPDH,MDH1,MDH2,PGAM1	
Aryl hydrocarbon receptor signalling	2.02E00	4.29E-01	NaN	AIP,HSP90AB1,PTGES3	
Axonal Guidance Signaling	2.01E00	9.8E-02	NaN	ADAM15,AKT1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAIAP2,CDK5,CFL1,CFL2,COPS5,EFNA1,EIF3F,EIF3H,EPHB4,GIT1,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,NCK1,NRP2,PAK4,PDGFA,PDGFB,PDIA3,PFN1,PMPCB,PRKAG1,RASD1,RHOA,RRAS,RTN4,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,VASP,WNT5A	
Dissolution of Fibrin Clot	1.99E00	3.08E-01	-2.000	ANXA2,PLAUR,S100A10,SERPINB6	
Guanosine Nucleotides Degradation III	1.99E00	3.08E-01	-2.000	NT5C,NT5C3B,NT5M,PNP	
Signaling by NTRK1 (TRKA)	1.99E00	1.48E-01	-3.464	AP2A2,AP2M1,AP2S1,CLTA,DNAL4,HRAS,KRAS,MAP2K2,MAPK3,RHOA,RIT1,YWHAB	
Apelin Adipocyte Signaling Pathway	1.98E00	1.43E-01	-3.051	ADCY4,GNA11,GNAI2,GPX1,GPX4,GPX7,GSTM1,GSTM2,MAPK3,MGST3,PRDX6,PRKAB1,PRKAG1	
Synthesis, secretion, and deacylation of Ghrelin	1.98E00	2.5E-01	-2.236	KLF4,SEC11A,SEC11C,SPCS1,SPCS2	
JAK/STAT Signaling	1.95E00	1.46E-01	-1.508	AKT1,CDKN1A,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,PIAS4,RASD1,RRAS,SOCS2	
Sertoli Cell-Sertoli Cell Junction Signaling	1.94E00	1.11E-01	-5.196	ACTB,ACTG1,ACTN1,AKT1,ATF4,CLDN5,CREB3,F11R,HRAS,ICAM1,IL1R1,JUN,JUP,KRAS,MAP2K2,MAP3K8,MAPK3,PAK4,RASD1,RRAS,TNFRSF1A,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,YBX3	
Glioma Invasiveness Signaling	1.92E00	1.51E-01	-3.000	Cdc42,HRAS,KRAS,MAPK3,PLAUR,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
CCR3 Signaling in Eosinophils	1.91E00	1.27E-01	-2.828	Calm1 (includes others),CFL1,CFL2,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,PAK4,PLA2G4A,RASD1,RHOA,RRAS	
Prostate Cancer Signaling	1.88E00	1.32E-01	NaN	AKT1,ATF4,BAD,CDKN1A,CREB3,E2F4,HRAS,HSP90AB1,KRAS,MAP2K2,MAPK3,NFKBIA,PA2G4,RASD1,RRAS	
Glioma Signaling	1.87E00	1.28E-01	-3.162	AKT1,Calm1 (includes others),CAMK1,CDKN1A,CDKN2D,E2F4,HRAS,IDH3G,KRAS,MAP2K2,MAPK3,PA2G4,PDGFA,PDGFB,RASD1,RRAS	
Processing of Capped Intronless Pre-mRNA	1.87E00	2.07E-01	-2.449	LSM10,NCBP2,NUDT21,SNRPB,SNRPD3,SNRPF	
SUMOylation of nuclear envelope proteins	1.86E00	6.67E-01	NaN	SUMO1,UBE2I	
NADH Repair	1.86E00	6.67E-01	NaN	GAPDH,NAXE	
Methylglyoxal Degradation I	1.86E00	6.67E-01	NaN	GLO1,HAGH	
Tetrahydrobiopterin Biosynthesis I	1.86E00	6.67E-01	NaN	GCH1,SPR	
Hypusine Biosynthesis	1.86E00	6.67E-01	NaN	DOHH,EIF5A	
Adenine and Adenosine Salvage I	1.86E00	6.67E-01	NaN	APRT,PNP	
Tetrahydrobiopterin Biosynthesis II	1.86E00	6.67E-01	NaN	GCH1,SPR	
S-adenosyl-L-methionine Biosynthesis	1.86E00	6.67E-01	NaN	MAT2A,MAT2B	
ERB2-ERBB3 Signaling	1.85E00	1.54E-01	-1.414	AKT1,BAD,GSK3A,HRAS,JUN,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Tight Junction Signaling	1.84E00	1.17E-01	NaN	ACTB,ACTG1,AKT1,CLDN5,F11R,FOS,GPAA1,JUN,MYL6,NAPA,NUDT21,PRKAG1,RAB13,RHOA,TGFB1,TNFRSF1A,VAMP3,VAPA,VASP,VTI1B,YBX3	
Colorectal Cancer Metastasis Signaling	1.83E00	1.07E-01	-3.545	ADCY4,AKT1,BAD,BAX,Cdc42,E2F4,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,IFNGR1,JUN,KRAS,MAP2K2,MAPK3,NOS2,PRKAG1,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TGFB1,TNFRSF1A,WNT5A	
Gene Silencing by RNA	1.83E00	1.37E-01	-3.606	POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,RAE1,RAN,SEC13,TSN	
NLR signaling pathways	1.83E00	1.61E-01	-3.000	AAMP,HSP90AB1,RPS27A,SUGT1,TXN,TXNIP,UBC,UBE2N,UBE2V1	
Aryl Hydrocarbon Receptor Signaling	1.82E00	1.19E-01	0.277	AIP,ALDH2,BAX,CDKN1A,CTSD,FOS,GSTM1,GSTM2,GSTM5,HSP90AB1,HSPB1,JUN,MAPK3,MGST3,NEDD8,NFE2L2,PTGES3,TGFB1,TGM2	
ERK/MAPK Signaling	1.81E00	1.12E-01	-1.606	ATF4,BAD,CREB3,DUSP1,EIF4EBP1,FOS,H3-3A/H3-3B,HRAS,HSPB1,KRAS,LAMTOR3,MAP2K2,MAPK3,PAK4,PLA2G4A,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,RASD1,RRAS,YWHAB,YWHAH,YWHAQ	
Signaling by CSF3 (G-CSF)	1.8E00	2E-01	-2.449	ELOC,KRAS,RNF7,RPS27A,UBC,UBE2D3	
Plasma lipoprotein assembly, remodeling, and clearance	1.79E00	1.45E-01	-3.317	AP2A2,AP2M1,AP2S1,APOE,CLTA,LSR,NPC2,PLTP,RPS27A,SAR1B,UBC	
Angiopoietin Signaling	1.79E00	1.45E-01	-1.897	AKT1,BAD,HRAS,KRAS,NCK1,NFKBIA,NOS3,PAK4,RASD1,RRAS,TIE1	
GDNF Family Ligand-Receptor Interactions	1.79E00	1.45E-01	-3.000	DOK4,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,NCK1,PDLIM7,RASD1,RRAS	
Response of EIF2AK1 (HRI) to heme deficiency	1.76E00	2.67E-01	-2.000	ATF4,EIF2S1,EIF2S2,PPP1R15A	
Antiproliferative Role of Somatostatin Receptor 2	1.75E00	1.43E-01	-1.890	CDKN1A,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,NPR1,NT5C,RASD1,RRAS	
Cancer Drug Resistance by Drug Efflux	1.73E00	1.55E-01	-3.000	ABCG2,AKT1,HRAS,KRAS,MAP2K2,MAPK3,RASD1,RRAS,YBX1	
RHO GTPases activate IQGAPs	1.73E00	1.94E-01	-2.449	ACTB,ACTG1,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Acute Phase Response Signaling	1.72E00	1.14E-01	-3.153	AKT1,FOS,FTL,HMOX2,HNRNPK,HRAS,IL1R1,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,RASD1,RBP1,RRAS,SOCS2,SOD2,TNFRSF1A,TRADD,TTR,VWF	
ERBB4 Signaling	1.72E00	1.47E-01	-2.449	AKT1,APH1A,HRAS,KRAS,MAP2K2,MAPK3,PSEN2,PSENEN,RASD1,RRAS	
Apelin Cardiac Fibroblast Signaling Pathway	1.71E00	2.17E-01	-1.342	AKT1,NOS3,PRKAB1,PRKAG1,TGFB1	
Neurotrophin/TRK Signaling	1.71E00	1.41E-01	-3.162	AKT1,ATF4,CREB3,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Î±-Adrenergic Signaling	1.71E00	1.28E-01	-2.828	ADCY4,Calm1 (includes others),GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,PRKAG1,RASD1,RRAS	
Sphingosine-1-phosphate Signaling	1.7E00	1.25E-01	-3.207	ADCY4,AKT1,Cdc42,GNAI2,MAPK3,PDGFA,PDGFB,PDIA3,RHOA,RHOB,RHOC,RHOG,S1PR1,S1PR4,SMPD2	
Signaling by ERBB4	1.69E00	1.53E-01	-3.000	APH1A,APOE,HRAS,KRAS,PSEN2,PSENEN,RPS27A,STMN1,UBC	
RAB GEFs exchange GTP for GDP on RABs	1.68E00	1.35E-01	-3.464	AKT1,CCZ1/CCZ1B,RAB13,RAB18,RAB5A,RAB8A,RAB9A,TRAPPC2,TRAPPC3,TRAPPC4,TRAPPC5,YWHAE	
Hepatic Fibrosis Signaling Pathway	1.67E00	9.69E-02	-4.323	AKT1,ATF4,BAMBI,Calm1 (includes others),CD40,Cdc42,CREB3,CSNK1E,EDN1,FOS,FTH1,FTL,GNAI2,HRAS,ICAM1,IL1R1,JUN,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,NFKBIA,PDGFA,PDGFB,PRKAG1,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,SDHB,SDHD,SOD2,TGFB1,TNFRSF1A,TRADD,VCAM1,WNT5A	
Signaling by ERBB2	1.67E00	1.6E-01	-2.828	AKT1,CDC37,HRAS,KRAS,RHOA,RPS27A,STUB1,UBC	
Signaling by NOTCH3	1.67E00	1.6E-01	-2.828	APH1A,HES1,PSEN2,PSENEN,RPS27A,SNW1,UBC,YBX1	
p75 NTR receptor-mediated signalling	1.66E00	1.3E-01	-3.606	APH1A,ARHGDIA,BAD,NFKBIA,PSEN2,PSENEN,RHOA,RPS27A,RTN4,SMPD2,SQSTM1,UBC,YWHAE	
Adenosine Nucleotides Degradation II	1.66E00	2.5E-01	-2.000	NT5C,NT5C3B,NT5M,PNP	
Eicosanoid Signaling	1.66E00	1.04E-01	-4.642	ADCY4,AKT1,AP1M1,AP1S1,AP1S2,ATF4,BAD,CREB3,GNA11,GNAI2,GNAS,GNB2,GNG5,GSK3A,HRAS,HSPB1,KLF4,KRAS,LTC4S,MAP2K2,MAPK3,PDIA3,PLA2G4A,PLAAT3,PRDX6,PRKAG1,RASD1,RHOA,RRAS	
Transport of vitamins, nucleosides, and related molecules	1.65E00	1.71E-01	-2.646	APOD,ARL2,ARL2BP,PDZD11,SLC25A4,SLC25A5,SLC29A1	
RNA Polymerase III Transcription	1.65E00	1.71E-01	-2.646	GTF3A,POLR1D,POLR2E,POLR2F,POLR2K,POLR2L,SNAPC5	
Immunogenic Cell Death Signaling Pathway	1.65E00	1.33E-01	-3.464	ATF4,BAX,BCAP31,DAPK3,HSP90AB1,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,IFNGR1,PDIA3,TNFRSF1A	
Endometrial Cancer Signaling	1.64E00	1.5E-01	-2.121	AKT1,BAD,HRAS,ILK,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Mitochondrial Fatty Acid Beta-Oxidation	1.64E00	2.08E-01	-2.236	ACOT9,ECHS1,ECI1,MCEE,NDUFAB1	
Relaxin Signaling	1.63E00	1.16E-01	-2.887	ADCY4,AKT1,FOS,GDE1,GNA11,GNAI2,GNAS,GNB2,GNG5,JUN,MAPK3,NFKBIA,NOS2,NOS3,NPR1,NT5C,PRKAG1,SMPDL3A	
ISG15 antiviral mechanism	1.6E00	1.41E-01	-3.162	EIF4A1,EIF4A3,EIF4E2,MAPK3,PIN1,RAE1,RPS27A,SEC13,UBC,UBE2N	
Beta-catenin independent WNT signaling	1.6E00	1.27E-01	-3.606	AP2A2,AP2M1,AP2S1,CLTA,CLTB,GNB2,GNG5,KRAS,PFN1,RHOA,RPS27A,UBC,WNT5A	
Tumor Microenvironment Pathway	1.6E00	1.12E-01	-3.130	AKT1,BAD,CSF1,FOS,HLA-A,HLA-E,HRAS,ICAM1,JUN,KRAS,MAP2K2,MAPK3,NOS2,PDGFA,PDGFB,RASD1,RRAS,SLC2A1,TGFB1,TNFRSF1A	
Production of Nitric Oxide and Reactive Oxygen Species in Macrophages	1.58E00	1.1E-01	-3.130	AKT1,APOD,APOE,Cdc42,CYBA,FOS,IFNGR1,IRF1,JUN,MAP3K8,MAPK3,NFKBIA,NOS2,PPP1CA,PPP1R11,PPP1R14B,RHOA,RHOB,RHOC,RHOG,TNFRSF1A	
ABRA Signaling Pathway	1.58E00	1.3E-01	-1.732	ACTB,ACTG1,ACTN1,CFL1,CFL2,FOS,JUNB,JUND,PPP1CA,RHOA,Tpm1,TPM3	
Cell junction organization	1.58E00	1.3E-01	-3.464	ACTB,ACTG1,ACTN1,ANG,CD151,CLDN5,F11R,ILK,JUP,LIMS2,SDK1,VASP	
Spermine and Spermidine Degradation I	1.58E00	5E-01	NaN	SAT1,SMOX	
Glutathione Redox Reactions II	1.58E00	5E-01	NaN	PDIA3,TXNDC12	
N-acetylglucosamine Degradation II	1.58E00	5E-01	NaN	GNPDA2,NAGK	
FLT3 Signaling in Hematopoietic Progenitor Cells	1.57E00	1.34E-01	-1.897	AKT1,ATF4,BAD,CREB3,EIF4EBP1,HRAS,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Estrogen-Dependent Breast Cancer Signaling	1.57E00	1.34E-01	-3.000	AKT1,ATF4,CREB3,FOS,HRAS,HSD17B10,JUN,KRAS,MAPK3,RASD1,RRAS	
FOXO-mediated transcription of cell cycle genes	1.57E00	2.35E-01	-2.000	BTG1,CAV1,CDKN1A,KLF4	
ATF6 (ATF6-alpha) activates chaperone genes	1.55E00	3E-01	NaN	ATF4,HSPA5,XBP1	
Signaling by NOTCH2	1.54E00	1.76E-01	-2.449	APH1A,HES1,PSEN2,PSENEN,RPS27A,UBC	
Oncogene Induced Senescence	1.54E00	1.76E-01	-2.000	CDKN2D,ERF,ID1,MAPK3,RPS27A,UBC	
SUMOylation of SUMOylation proteins	1.54E00	1.76E-01	-2.449	PIAS4,RAE1,SEC13,SUMO1,SUMO2,UBE2I	
Cargo concentration in the ER	1.54E00	1.76E-01	-2.449	CNIH1,CTSC,CTSZ,MCFD2,SAR1B,TMED2	
Senescence-Associated Secretory Phenotype (SASP)	1.52E00	1.37E-01	-3.162	ANAPC11,ANAPC16,CDKN1A,CDKN2D,FOS,JUN,MAPK3,RPS27A,UBC,UBE2S	
Peroxisomal protein import	1.52E00	1.43E-01	-3.000	ACAA1,ECH1,HMGCL,NOS2,PEX13,RPS27A,SCP2,UBC,UBE2D3	
PPARÎ±/RXRÎ± Activation	1.52E00	1.08E-01	0.728	ACAA1,ADCY4,AIP,AP2A2,BCL3,GNA11,GNAS,HRAS,HSP90AB1,IL1R1,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,PDIA3,PRKAB1,PRKAG1,RASD1,RRAS,TGFB1	
Interferon gamma signaling	1.52E00	1.28E-01	-3.464	GBP2,GBP4,GBP5,GBP6,HLA-A,HLA-E,ICAM1,IFNGR1,IRF1,SUMO1,TRIM8,VCAM1	
TP53 Regulates Transcription of Cell Death Genes	1.5E00	1.59E-01	-2.646	BAX,BBC3,BNIP3L,PRELID1,RABGGTB,TMEM219,TRIAP1	
Endocannabinoid Developing Neuron Pathway	1.5E00	1.18E-01	-2.887	ADCY4,AKT1,ATF4,CREB3,GNAI2,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,PRKAG1,RASD1,RHOA,RRAS	
Activation of NMDA receptors and postsynaptic events	1.5E00	1.31E-01	-3.317	CAMK1,GIT1,HRAS,KRAS,MAPK3,PRKAB1,PRKAG1,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Role of MAPK Signaling in the Pathogenesis of Influenza	1.5E00	1.31E-01	NaN	AKT1,BAX,HRAS,KRAS,MAP2K2,MAPK3,PLA2G4A,PLAAT3,PRDX6,RASD1,RRAS	
VEGF Family Ligand-Receptor Interactions	1.5E00	1.31E-01	-3.000	AKT1,FOS,HRAS,KRAS,MAP2K2,MAPK3,NOS3,NRP2,PLA2G4A,RASD1,RRAS	
Semaphorin interactions	1.48E00	1.41E-01	-3.000	CDK5,CFL1,HSP90AB1,MYL12B,MYL6,RHOA,RHOB,RHOC,RRAS	
SUMOylation of DNA replication proteins	1.45E00	1.56E-01	-2.646	PIAS4,RAE1,SEC13,SUMO1,SUMO2,SUMO3,UBE2I	
IL-6 Signaling	1.45E00	1.16E-01	-3.207	AKT1,CSNK2B,FOS,HRAS,HSPB1,IL1R1,JUN,KRAS,MAP2K2,MAPK3,MCL1,NFKBIA,RASD1,RRAS,TNFRSF1A	
Lymphotoxin Î² Receptor Signaling	1.44E00	1.45E-01	-1.890	AKT1,CYC1,CYCS,DIABLO,MAPK3,NFKBIA,TRAF5,VCAM1	
Corticotropin Releasing Hormone Signaling	1.43E00	1.12E-01	-3.742	ADCY4,ATF4,Calm1 (includes others),CREB3,FOS,GNAI2,GNAS,JUN,JUND,MAP2K2,MAPK3,NOS2,NOS3,NPR1,NT5C,POMC,PRKAG1	
FLT3 Signaling	1.43E00	1.67E-01	-2.449	AKT1,HRAS,KRAS,RPS27A,SOCS2,UBC	
SUMOylation of DNA damage response and repair proteins	1.42E00	1.32E-01	-3.162	CETN2,NSMCE3,NSMCE4A,PIAS4,RAE1,SEC13,SUMO1,SUMO2,SUMO3,UBE2I	
Macropinocytosis Signaling	1.42E00	1.32E-01	-2.236	ARF6,CSF1,HRAS,KRAS,PDGFA,PDGFB,RAB5A,RASD1,RHOA,RRAS	
Metabolism of cofactors	1.4E00	2.11E-01	-2.000	AKT1,GCH1,NOS3,SPR	
NFE2L2 regulating anti-oxidant/detoxification enzymes	1.4E00	2.11E-01	-2.000	ATF4,GCLM,NFE2L2,PRDX1	
Melanocyte Development and Pigmentation Signaling	1.4E00	1.22E-01	-3.317	ADCY4,ATF4,CREB3,GNAS,HRAS,KRAS,MAP2K2,MAPK3,POMC,PRKAG1,RASD1,RRAS	
NGF Signaling	1.39E00	1.17E-01	-3.606	AKT1,ATF4,BAX,CREB3,HRAS,KRAS,MAP2K2,MAP3K8,MAPK3,RASD1,RHOA,RHOG,RRAS,SMPD2	
SUMOylation of intracellular receptors	1.37E00	1.79E-01	-2.236	PIAS4,SUMO1,SUMO2,SUMO3,UBE2I	
Tetrapyrrole Biosynthesis II	1.37E00	4E-01	NaN	ALAD,ALAS1	
CMP-N-acetylneuraminate Biosynthesis I (Eukaryotes)	1.37E00	4E-01	NaN	NAGK,NANS	
Myo-inositol Biosynthesis	1.37E00	4E-01	NaN	IMPA1,ISYNA1	
Citrulline-Nitric Oxide Cycle	1.37E00	4E-01	NaN	NOS2,NOS3	
Synaptic Long Term Potentiation	1.37E00	1.14E-01	-2.138	ATF4,Calm1 (includes others),CREB3,GNA11,HRAS,KRAS,MAP2K2,MAPK3,PDIA3,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,RASD1,RRAS	
Thrombin Signaling	1.37E00	1.02E-01	-3.357	ADCY4,AKT1,CAMK1,Cdc42,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,PDIA3,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
iNOS Signaling	1.36E00	1.49E-01	-2.236	Calm1 (includes others),FOS,IFNGR1,IRF1,JUN,NFKBIA,NOS2	
TNF signaling	1.36E00	1.4E-01	-2.828	RACK1,RPS27A,SMPD2,STUB1,TNFRSF1A,TRADD,UBC,UBE2D3	
CD27 Signaling in Lymphocytes	1.36E00	1.4E-01	-1.342	CYC1,CYCS,FOS,JUN,MAP2K2,MAP3K8,NFKBIA,TRAF5	
Docosahexaenoic Acid (DHA) Signaling	1.35E00	1E-01	-1.225	ADCY4,AKT1,APH1A,ATF4,BAD,BAX,CREB3,CYCS,GNAS,GSK3A,MAP2K2,MAPK3,MFSD2A,NFE2L2,PDGFB,PDIA3,PLA2G4A,PLAAT3,PRDX6,PRKAB1,PRKAG1,PSEN2,PSENEN,TGFB1,TNFRSF1A	
GNRH Signaling	1.34E00	1.05E-01	-4.123	ADCY4,ATF4,Calm1 (includes others),CREB3,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,JUN,KRAS,MAP2K2,MAP3K8,MAPK3,PAK4,PRKAG1,RASD1,RRAS	
Notch Signaling	1.33E00	1.58E-01	-0.447	APH1A,HES1,LFNG,MFNG,PSEN2,PSENEN	
Reversible hydration of carbon dioxide	1.33E00	2.5E-01	NaN	CA14,CA2,CA4	
Vitamin D (calciferol) metabolism	1.33E00	2.5E-01	NaN	PIAS4,SUMO2,UBE2I	
XBP1(S) activates chaperone genes	1.32E00	1.46E-01	-2.646	DNAJB11,DNAJB9,GSK3A,MYDGF,PDIA6,XBP1,YIF1A	
IL-3 Signaling	1.32E00	1.27E-01	-2.333	AKT1,BAD,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Role of JAK family kinases in IL-6-type Cytokine Signaling	1.32E00	1.27E-01	-3.162	CEBPD,FOS,HSP90AB1,IL11RA,IRF1,JUNB,MAPK3,MCL1,POMC,TGFB1	
STAT3 Pathway	1.3E00	1.11E-01	-2.111	CDKN1A,HRAS,IL10RB,IL11RA,IL1R1,IL2RG,KRAS,MAP2K2,MAPK3,NDUFA13,PDGFB,RASD1,RRAS,SOCS2,TGFB1	
Sensory processing of sound by inner hair cells of the cochlea	1.3E00	1.3E-01	-3.000	ACTB,ACTG1,CAPZA2,CTBP2,EPS8L2,EZR,RDX,TRIOBP,TWF2	
Agrin Interactions at Neuromuscular Junction	1.3E00	1.3E-01	-2.828	ACTB,ACTG1,HRAS,JUN,KRAS,MAPK3,PAK4,RASD1,RRAS	
SPINK1 General Cancer Pathway	1.3E00	1.3E-01	-1.414	AKT1,HRAS,KRAS,MAP2K2,MAPK3,Mt1,Mt2,RASD1,RRAS	
Endocannabinoid Cancer Inhibition Pathway	1.29E00	1.09E-01	-0.500	ADCY4,AKT1,ATF4,BAD,CDKN1A,CREB3,GNAI2,MAP2K2,MAPK3,NOS2,NOS3,PRKAB1,PRKAG1,RHOA,SMPD2,VIM	
Dopamine Receptor Signaling	1.29E00	1.25E-01	NaN	ADCY4,COMT,GCH1,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,QDPR,SMOX,SPR	
Metabolism of water-soluble vitamins and cofactors	1.29E00	1.36E-01	-2.828	AASDHPPT,CD320,CYB5A,PDZD11,RFK,SLC2A1,SLC52A3,TCN2	
DNA Double Strand Break Response	1.29E00	1.36E-01	-2.828	PIAS4,RPS27A,SUMO1,UBC,UBE2I,UBE2N,UBE2V2,UBXN1	
Acute Myeloid Leukemia Signaling	1.28E00	1.21E-01	-1.890	AKT1,BAD,EIF4EBP1,HRAS,IDH3G,JUP,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Endothelin-1 Signaling	1.28E00	1.03E-01	-3.638	ADCY4,EDN1,FOS,GNA11,GNAI2,GNAS,HRAS,JUN,KRAS,MAPK3,NOS2,NOS3,NPR1,PDIA3,PLA2G4A,PLAAT3,PRDX6,RASD1,RRAS,SHF	
PFKFB4 Signaling Pathway	1.28E00	1.43E-01	-2.449	ATF4,CREB3,GNAS,MAP2K2,MAPK3,PRKAG1,TGFB1	
Glioblastoma Multiforme Signaling	1.27E00	1.05E-01	-3.357	AKT1,Cdc42,CDKN1A,E2F4,HRAS,KRAS,MAP2K2,MAPK3,PDGFA,PDGFB,PDIA3,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,WNT5A	
Endoplasmic Reticulum Stress Pathway	1.26E00	1.9E-01	-2.000	ATF4,EIF2S1,HSPA5,XBP1	
Advanced glycosylation endproduct receptor signaling	1.24E00	2.31E-01	NaN	CAPZA2,DDOST,MAPK3	
Azathioprine ADME	1.24E00	2.31E-01	NaN	GSTM1,IMPDH2,SLC29A1	
Assembly of RNA Polymerase I Complex	1.24E00	2.31E-01	NaN	POLR1D,POLR2F,TAF1D	
MYC Mediated Apoptosis Signaling	1.24E00	1.4E-01	-1.890	BAX,BBC3,CYCS,MCL1,PRKAG1,TNFRSF1A,TRADD	
CDK5 Signaling	1.24E00	1.13E-01	-1.155	ADCY4,CDK5,GNAS,HRAS,KRAS,MAP2K2,MAPK3,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,RASD1,RRAS	
Interferon alpha/beta signaling	1.24E00	1.27E-01	-3.000	GBP2,HLA-A,HLA-E,IFI35,IFITM2,IFITM3,IRF1,PSMB8,XAF1	
Netrin Signaling	1.23E00	1.04E-01	-3.300	AKT1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,FMO1,GPAA1,MAP2K2,MAPK3,NAPA,NCK1,PRKAG1,RHOA,VAMP3,VASP,VTI1B	
Regulation of TP53 Activity through Phosphorylation	1.23E00	1.18E-01	-3.317	CDK5,CSNK2B,PIN1,PRKAB1,PRKAG1,RPA3,RPS27A,TAF10,TAF11,TAF7,UBC	
ERBB Signaling	1.23E00	1.18E-01	-3.162	AKT1,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,NCK1,PAK4,RASD1,RRAS	
TNFR1 Signaling	1.2E00	1.37E-01	-2.646	CYCS,FOS,JUN,NFKBIA,PAK4,TNFRSF1A,TRADD	
Pyroptosis Signaling Pathway	1.2E00	1.17E-01	-2.111	BAX,GAS5,GBP2,GBP4,GBP5,GSDMD,IL1R1,PRKAG1,RHOA,TNFRSF1A,TXNIP	
Non-Small Cell Lung Cancer Signaling	1.2E00	1.17E-01	-2.121	AKT1,BAD,E2F4,HRAS,KRAS,MAP2K2,MAPK3,PA2G4,RASD1,RASSF1,RRAS	
Interconversion of nucleotide di- and triphosphates	1.2E00	1.82E-01	-2.000	CMPK1,DTYMK,NME2,TXN	
Gamma carboxylation, hypusine formation and arylsulfatase activation	1.2E00	1.46E-01	-2.449	DOHH,DPH3,EEF2,EIF5A,GAS6,TPST2	
G Beta Gamma Signaling	1.18E00	1.09E-01	-3.464	AKT1,CAV1,CAV2,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAPK3,PRKAG1,RASD1,RRAS	
Amyloid fiber formation	1.17E00	1.23E-01	-3.000	APH1A,APOE,CST3,ITM2B,MFGE8,PSENEN,RPS27A,TTR,UBC	
B-WICH complex positively regulates rRNA expression	1.16E00	1.35E-01	-2.646	ACTB,POLR1D,POLR2E,POLR2F,POLR2K,POLR2L,TAF1D	
UVB-Induced MAPK Signaling	1.16E00	1.35E-01	-2.449	AKT1,BAD,EIF4EBP1,FOS,H3-3A/H3-3B,JUN,MAPK3	
Toll Like Receptor 3 (TLR3) Cascade	1.16E00	1.56E-01	-2.236	RPS27A,UBC,UBE2D3,UBE2N,UBE2V1	
RIPK1-mediated regulated necrosis	1.16E00	1.56E-01	-2.236	CDC37,RPS27A,STUB1,TRADD,UBC	
Metabolism of vitamin K	1.16E00	1E00	NaN	VKORC1	
Acyl Carrier Protein Metabolism	1.16E00	1E00	NaN	AASDHPPT	
MyD88:MAL(TIRAP) cascade initiated on plasma membrane	1.16E00	1.43E-01	-2.449	RPS27A,S100A1,SIGIRR,UBC,UBE2N,UBE2V1	
Thrombopoietin Signaling	1.15E00	1.27E-01	-2.646	FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
IL-1 Signaling	1.15E00	1.15E-01	-2.449	ADCY4,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,IL1R1,JUN,NFKBIA,PRKAG1	
Death Receptor Signaling	1.15E00	1.15E-01	-1.897	ACTB,ACTG1,ARHGDIB,CYC1,CYCS,DIABLO,HSPB1,NFKBIA,TNFRSF1A,TNFSF12,TRADD	
TGF-Î² Signaling	1.15E00	1.15E-01	-2.333	FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,PIAS4,PMEPA1,RASD1,RRAS,TGFB1	
Cholecystokinin/Gastrin-mediated Signaling	1.14E00	1.09E-01	-3.317	Cdc42,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS	
RAF-independent MAPK1/3 activation	1.14E00	1.74E-01	-2.000	DUSP1,DUSP8,MAP2K2,MAPK3	
Metabolism of porphyrins	1.14E00	1.74E-01	-2.000	ABCG2,ALAD,ALAS1,HMOX2	
Smooth Muscle Contraction	1.12E00	1.4E-01	-2.449	ALDH2,ANXA2,MYL12A,MYL12B,MYL6,TPM3	
Oncostatin M Signaling	1.12E00	1.4E-01	-2.236	HRAS,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Myelination Signaling Pathway	1.11E00	9.17E-02	-3.286	ACVRL1,AKT1,APH1A,ARF6,ATF4,Calm1 (includes others),CREB3,EIF4EBP1,FKBP1A,FOS,HRAS,ID2,ILK,JUN,KRAS,MAP2K2,MAPK3,PDGFA,PDGFB,PRKAG1,PSEN2,PSENEN,RASD1,RHEB,RHOA,RRAS,SLC2A1,WNT5A,XAF1,YY1	
GABA Receptor Signaling	1.11E00	1.06E-01	NaN	ADCY4,AP2A2,Ap2b1,AP2M1,AP2S1,GABARAP,GNA11,GNAI2,GNAS,GNB2,GNG5,RPS27A,Ubb,UBC	
RAR Activation	1.11E00	8.86E-02	-3.893	ACTB,ADCY4,AKT1,ATF4,Cdc42,CDKN1A,CREB3,CSNK2B,DUSP1,F11R,FOS,GDE1,GNA11,GTF2H5,JUN,KLF2,MAPK3,NR2F2,NR2F6,PRDM16,PRKAG1,PRMT1,PSMC5,RBP1,RDH14,RHOA,RHOB,RHOC,RHOG,RPL7A,SMARCB1,SMPDL3A,SNW1,SRA1,TGFB1,TGM2,TNFSF12,TNFSF13	
Erythrocytes take up oxygen and release carbon dioxide	1.09E00	2.86E-01	NaN	CA2,CA4	
TYSND1 cleaves peroxisomal proteins	1.09E00	2.86E-01	NaN	ACAA1,SCP2	
Ceramide Biosynthesis	1.09E00	2.86E-01	NaN	DEGS2,SPTSSA	
Aspartate Degradation II	1.09E00	2.86E-01	NaN	MDH1,MDH2	
Atherosclerosis Signaling	1.09E00	1.05E-01	NaN	APOD,APOE,CD40,CSF1,ICAM1,PDGFA,PDGFB,PLA2G4A,PLAAT3,PRDX6,TGFB1,TNFRSF12A,TNFSF12,VCAM1	
Xenobiotic Metabolism AHR Signaling Pathway	1.09E00	1.15E-01	-0.632	ABCG2,AIP,ALDH2,GSTM1,GSTM2,GSTM5,HSP90AB1,MGST3,PTGES3,SUMO1	
AMPK Signaling	1.08E00	9.5E-02	-1.807	ACTB,AKT1,ATF4,CDKN1A,CREB3,EEF2,EIF4EBP1,GNA11,GNAI2,GNAS,GNB2,GNG5,ILKAP,NOS3,ORAI1,PFKL,PPM1G,PRKAB1,PRKAG1,RAB11A,RAB8A,SLC2A1,SMARCB1	
MIF Regulation of Innate Immunity	1.08E00	1.36E-01	-2.449	FOS,JUN,MAPK3,NFKBIA,NOS2,PLA2G4A	
Fatty Acid Î²-oxidation I	1.07E00	1.47E-01	-2.236	ACAA1,ECHS1,ECI1,HSD17B10,SCP2	
Circadian Rhythm Signaling	1.07E00	9.33E-02	NaN	ADCY4,ATF4,CIRBP,CREB3,CSNK1E,EIF4EBP1,GNA11,GNAI2,GNAS,GNB2,GNG5,GSK3A,H3-3A/H3-3B,HRAS,KRAS,MAP2K2,MAPK3,NPR1,NT5C,PDIA3,PRKAB1,PRKAG1,RACK1,RASD1,RRAS	
Signaling by PTK6	1.06E00	1.27E-01	-2.646	AKT1,HRAS,KRAS,RHOA,RPS27A,STAP2,UBC	
Sensory processing of sound by outer hair cells of the cochlea	1.06E00	1.27E-01	-2.646	ACTB,ACTG1,EPS8L2,EZR,RDX,TRIOBP,TWF2	
Carboxyterminal post-translational modifications of tubulin	1.04E00	1.33E-01	-2.449	SVBP,TPGS1,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Incretin synthesis, secretion, and inactivation	1.03E00	1.6E-01	-2.000	SEC11A,SEC11C,SPCS1,SPCS2	
MyD88 cascade initiated on plasma membrane	1.03E00	1.6E-01	-2.000	RPS27A,UBC,UBE2N,UBE2V1	
Signaling by NOTCH1	1.03E00	1.15E-01	-3.000	APH1A,CDK8,HES1,PSEN2,PSENEN,RPS27A,SNW1,TLE5,UBC	
IL-7 Signaling Pathway	1.03E00	1.15E-01	-0.333	AKT1,BAD,BAX,GSK3A,IL2RG,JUN,MAPK3,MCL1,SLC2A1	
CSDE1 Signaling Pathway	1.03E00	1.25E-01	-2.646	AKT1,FOS,PABPC1,PABPC4,RPL9,TGFB1,VIM	
Metabolism of steroid hormones	1.03E00	1.43E-01	-2.236	FDX1,FDX2,POMC,STARD3NL,TSPO	
CD40 Signaling	1.03E00	1.19E-01	-2.121	CD40,FOS,ICAM1,JUN,MAP2K2,MAPK3,NFKBIA,TRAF5	
Pancreatic Secretion Signaling Pathway	1.01E00	9.31E-02	-3.545	ADCY4,AKT1,ARHGDIA,ARHGDIB,CA14,CA2,CA4,EIF4EBP1,GNAS,GPAA1,MAPK3,NAPA,ORAI1,PAK4,PDIA3,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,RHOA,SLC6A6,VAMP3,VTI1B	
Thyroid Cancer Signaling	1E00	1.14E-01	-3.000	AKT1,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
SUMOylation of RNA binding proteins	1E00	1.3E-01	-2.449	HNRNPK,RAE1,SEC13,SUMO1,SUMO2,UBE2I	
CNTF Signaling	9.96E-01	1.23E-01	-2.449	AKT1,HRAS,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
NFE2L2 regulates pentose phosphate pathway genes	9.87E-01	2.5E-01	NaN	NFE2L2,TALDO1	
Superoxide Radicals Degradation	9.87E-01	2.5E-01	NaN	GPX7,SOD2	
FXR/RXR Activation	9.83E-01	9.63E-02	-1.886	AKT1,APOE,GCLM,GSTM1,GSTM2,GSTM5,ICAM1,MGST3,Mt1,NCK1,NFE2L2,PLTP,PRKAB1,PRKAG1,TGFB1,TNFSF12,TNFSF13,TXNIP	
Glucose metabolism	9.78E-01	1.13E-01	-3.000	ALDOA,GNPDA2,MDH1,MDH2,PFKL,PKM,RAE1,SEC13,SLC25A11	
PTEN Signaling	9.73E-01	9.93E-02	1.604	AKT1,BAD,CDKN1A,CSNK2B,GSK3A,HRAS,ILK,INPP5K,KRAS,MAP2K2,MAPK3,MCRS1,RASD1,RRAS,YWHAH	
RHO GTPases Activate Formins	9.72E-01	1.01E-01	-3.742	ACTB,ACTG1,BUB3,DYNLL1,NUDC,PFN1,RHOA,RHOB,RHOC,SEC13,TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Cell Cycle: G1/S Checkpoint Regulation	9.7E-01	1.16E-01	-1.633	CDKN1A,CDKN2D,E2F4,PA2G4,PAK1IP1,RPL11,RPL5,TGFB1	
Pulmonary Fibrosis Idiopathic Signaling Pathway	9.68E-01	8.9E-02	-4.426	ACTB,ACTG1,AKT1,BAX,BBC3,CAV1,EDN1,EIF4EBP1,EPHB4,FOS,HES1,HRAS,IL11RA,ILK,JUN,KRAS,MAPK3,PDGFA,PDGFB,PEX13,RASD1,RBBP4,RBBP7,RHOA,RRAS,TGFB1,VIM,WNT5A,YY1	
Signaling by NTRK3 (TRKC)	9.54E-01	1.76E-01	NaN	BAX,HRAS,KRAS	
GÎ±i Signaling	9.54E-01	1E-01	-1.897	ADCY4,CAV1,GNA11,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAPK3,PRKAG1,RASD1,RRAS,S1PR1	
MyD88-independent TLR4 cascade	9.47E-01	1.35E-01	-2.236	RPS27A,UBC,UBE2D3,UBE2N,UBE2V1	
TWEAK Signaling	9.47E-01	1.35E-01	-1.342	CYCS,NFKBIA,TNFRSF12A,TNFSF12,TRADD	
Noradrenaline and Adrenaline Degradation	9.47E-01	1.35E-01	-2.236	ADH5,AKR1A1,ALDH2,COMT,SMOX	
GM-CSF Signaling	9.43E-01	1.14E-01	-2.646	AKT1,HRAS,KRAS,MAP2K2,MAPK3,RACK1,RASD1,RRAS	
Tryptophan Degradation X (Mammalian, via Tryptamine)	9.36E-01	1.48E-01	-2.000	AKR1A1,ALDH2,RDH14,SMOX	
DNA Damage Bypass	9.36E-01	1.25E-01	-2.449	MAD2L2,POLD4,RPA3,RPS27A,UBC,UBE2B	
Chronic Myeloid Leukemia Signaling	9.33E-01	8.99E-02	-2.600	AKT1,BAD,Calm1 (includes others),CDKN1A,CTBP2,E2F4,FOS,HES1,HRAS,HSP90AB1,JUN,KLF4,KRAS,MAP2K2,MAPK3,MCL1,PA2G4,PDIA3,PRKAB1,PRKAG1,RAN,RASD1,RRAS,TGFB1,WNT5A	
SUMOylation of ubiquitinylation proteins	9.1E-01	1.32E-01	-2.236	PIAS4,RAE1,SEC13,SUMO1,UBE2I	
Fanconi Anemia Pathway	9.1E-01	1.32E-01	-2.236	CENPX,FAAP20,RPA3,RPS27A,UBC	
Glutathione-mediated Detoxification	9.1E-01	1.32E-01	-2.236	Gsta4,GSTM1,GSTM2,GSTM5,MGST3	
Regulation of the Epithelial Mesenchymal Transition by Growth Factors Pathway	9.05E-01	9.38E-02	-3.300	AKT1,FOS,HRAS,ID2,JUN,KRAS,MAP2K2,MAPK3,PDGFA,PDGFB,RASD1,RHOA,RRAS,TGFB1,TNFRSF1A,TNFSF12,TNFSF13,VIM	
TP53 Regulates Transcription of Cell Cycle Genes	9.04E-01	1.22E-01	-2.449	BAX,CDKN1A,CNOT3,E2F4,NPM1,PRMT1	
Xenobiotic Metabolism General Signaling Pathway	9E-01	9.79E-02	-3.742	AKT1,FTL,GSTM1,GSTM2,GSTM5,HRAS,KRAS,MAP2K2,MAP3K8,MAPK3,MGST3,NFE2L2,RASD1,RRAS	
Prolactin Signaling	8.99E-01	1.05E-01	-2.333	FOS,HRAS,IRF1,JUN,KRAS,MAP2K2,MAPK3,RASD1,RRAS,SOCS2	
Heme Biosynthesis II	8.98E-01	2.22E-01	NaN	ALAD,ALAS1	
Metabolism of Angiotensinogen to Angiotensins	8.97E-01	1.67E-01	NaN	ATP6AP2,CTSD,CTSZ	
Branched-chain amino acid catabolism	8.97E-01	1.67E-01	NaN	BCKDK,ECHS1,HSD17B10	
Gastrin-CREB signalling pathway via PKC and MAPK	8.97E-01	1.67E-01	NaN	HRAS,KRAS,MAPK3	
Paxillin Signaling	8.96E-01	1.03E-01	-3.162	ACTB,ACTG1,ACTN1,ARF1,ARF6,HRAS,KRAS,NCK1,PAK4,RASD1,RRAS	
Regulation of lipid metabolism by PPARalpha	8.95E-01	1.01E-01	-2.714	ALAS1,CDK8,GPS2,MED10,MED21,MED28,MED29,MED4,MED7,MED8,MED9,SIN3B	
MSP-RON Signaling in Macrophages Pathway	8.95E-01	1.01E-01	-2.309	ATF4,CREB3,FOS,HRAS,IFNGR1,JUN,KLK8,KRAS,MAPK3,NOS2,RASD1,RRAS	
Xenobiotic Metabolism Signaling	8.93E-01	8.84E-02	NaN	AIP,ALDH2,CAMK1,ESD,FMO1,FTL,GSTM1,GSTM2,GSTM5,HRAS,HS3ST1,HSP90AB1,KRAS,MAP2K2,MAP3K8,MAPK3,MGST3,NFE2L2,NOS2,PTGES3,RASD1,RRAS,SMOX,SNW1,SRA1,SUMO1	
Role of Macrophages, Fibroblasts and Endothelial Cells in Rheumatoid Arthritis	8.87E-01	8.71E-02	NaN	AKT1,ATF4,Calm1 (includes others),CEBPD,CREB3,CSF1,CSNK1E,FOS,HRAS,ICAM1,IL1R1,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,NOS2,PDGFA,PDGFB,PDIA3,RASD1,RHOA,RRAS,TGFB1,TNFRSF1A,TRADD,TRAF5,VCAM1,WNT5A	
Oxytocin Signaling Pathway	8.83E-01	8.87E-02	-5.000	AKT1,ATF4,Calm1 (includes others),CREB3,EEF2,FOS,GNA11,GNAI2,GNB2,GNG5,HRAS,HSPB1,KRAS,MAPK3,MYL6,NFE2L2,NOS3,NPR1,NT5C,PLA2G4A,PRKAB1,PRKAG1,RASD1,RHOA,RRAS	
PEDF Signaling	8.82E-01	1.07E-01	-1.134	AKT1,HRAS,KRAS,MAPK3,NFKBIA,RASD1,RHOA,RRAS,SOD2	
Telomerase Signaling	8.76E-01	1.02E-01	-2.828	AKT1,CDKN1A,HRAS,HSP90AB1,IL2RG,KRAS,MAP2K2,MAPK3,PTGES3,RASD1,RRAS	
MAP kinase activation	8.75E-01	1.28E-01	-2.236	MAP3K8,RPS27A,UBC,UBE2N,UBE2V1	
Signaling by EGFR	8.74E-01	1.2E-01	-2.449	AAMP,HRAS,KRAS,RPS27A,SH3GL1,UBC	
FAT10 Cancer Signaling Pathway	8.74E-01	1.2E-01	-1.633	AKT1,EEF1A1,MAD2L2,NFKBIA,TGFB1,TNFRSF1A	
Lipoate Biosynthesis and Incorporation II	8.7E-01	5E-01	NaN	LIAS	
L-DOPA Degradation	8.7E-01	5E-01	NaN	COMT	
Flavin Biosynthesis IV (Mammalian)	8.7E-01	5E-01	NaN	RFK	
Xanthine and Xanthosine Salvage	8.7E-01	5E-01	NaN	PNP	
Thyroid Hormone Biosynthesis	8.7E-01	5E-01	NaN	CTSD	
Glycine Degradation (Creatine Biosynthesis)	8.7E-01	5E-01	NaN	GATM	
Cardiolipin Biosynthesis II	8.7E-01	5E-01	NaN	PTPMT1	
GÎ±12/13 Signaling	8.61E-01	9.77E-02	-3.317	AKT1,HRAS,JUN,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,NFKBIA,RASD1,RHOA,RRAS	
LPS-stimulated MAPK Signaling	8.59E-01	1.06E-01	-2.828	FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,RASD1,RRAS	
Renin-Angiotensin Signaling	8.58E-01	9.92E-02	-3.162	ADCY4,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,PAK4,PRKAG1,RASD1,RRAS,SHF	
Regulation of TP53 Activity through Methylation	8.44E-01	1.58E-01	NaN	RPS27A,SMYD2,UBC	
Cell Cycle: G2/M DNA Damage Checkpoint Regulation	8.44E-01	1.18E-01	-1.000	CDKN1A,PTPMT1,YWHAB,YWHAE,YWHAH,YWHAQ	
Signaling by FGFR3	8.41E-01	1.25E-01	-2.236	HRAS,KRAS,MAPK3,RPS27A,UBC	
Oxidative Stress Induced Senescence	8.37E-01	1.05E-01	-3.000	CDKN2D,FOS,JUN,MAPK3,RBBP4,RBBP7,RPS27A,TXN,UBC	
DNA Methylation and Transcriptional Repression Signaling	8.36E-01	1.02E-01	-3.000	CDK5,CDK8,CDK9,E2F4,GADD45G,MBD3,RBBP4,RBBP7,SAP18,TCF15	
UVA-Induced MAPK Signaling	8.36E-01	1.02E-01	-2.236	CYCS,FOS,HRAS,JUN,KRAS,MAPK3,PDIA3,RASD1,RRAS,SMPD2	
Neurotransmitter clearance	8.21E-01	2E-01	NaN	ALDH2,COMT	
RHOBTB3 ATPase cycle	8.21E-01	2E-01	NaN	PLIN3,RAB9A	
Caveolar-mediated Endocytosis Signaling	8.19E-01	1.07E-01	NaN	ACTB,ACTG1,CAV1,CAVIN1,COPE,HLA-A,HLA-E,RAB5A	
Natural Killer Cell Signaling	8.18E-01	9.09E-02	-2.357	AKT1,CFL1,CFL2,HLA-A,HLA-E,HRAS,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,KRAS,MAP2K2,MAP3K8,MAPK3,NCK1,PAK4,RASD1,RRAS	
Sleep REM Signaling Pathway	8.18E-01	9.91E-02	-0.302	ATF4,CFL1,CFL2,CREB3,FOS,MAPK3,Mt1,PRKAG1,TGFB1,TNFSF12,TNFSF13	
IL-17A Signaling in Fibroblasts	8.16E-01	1.03E-01	-3.000	CEBPD,FOS,JUN,MAPK3,NFKBIA,P4HA2,SERPINH1,TGFB1,VCAM1	
HIPPO signaling	8.16E-01	1.03E-01	1.342	CSNK1E,PPP1CA,PPP1R11,PPP1R14B,RASSF1,YWHAB,YWHAE,YWHAH,YWHAQ	
Apelin Cardiomyocyte Signaling Pathway	8.16E-01	1.01E-01	-2.530	AKT1,GNA11,GNAI2,MAPK3,MYL12A,MYL12B,MYL6,NOS3,PDIA3,TGFB1	
Signaling by FGFR4	8.08E-01	1.22E-01	-2.236	HRAS,KRAS,MAPK3,RPS27A,UBC	
Class I peroxisomal membrane protein import	7.95E-01	1.5E-01	NaN	FIS1,PEX13,PEX3	
DHCR24 Signaling Pathway	7.93E-01	9.49E-02	-3.051	AKT1,APOD,APOE,HRAS,KRAS,PDGFA,PDGFB,PLTP,POMC,RASD1,RRAS,TTR,VCAM1	
Adrenergic Receptor Signaling Pathway (Enhanced)	7.91E-01	9E-02	-2.828	ADCY4,ATP6AP1,ATP6AP2,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,COMT,GNAI2,GNAS,PDIA3,PRKAG1,SMOX,TGFB1,TNFSF12,TNFSF13	
ID1 Signaling Pathway	7.78E-01	8.96E-02	-2.828	ACVRL1,AKT1,BAX,BCL3,CAV1,CDKN1A,HRAS,ID1,KRAS,MAPK3,PARK7,RASD1,RHOC,RRAS,TGFB1,TGM2,TNFRSF1A,VIM	
April Mediated Signaling	7.77E-01	1.19E-01	-1.342	FOS,JUN,NFKBIA,TNFSF13,TRAF5	
Reelin Signaling in Neurons	7.77E-01	9.42E-02	-2.309	AKT1,APOE,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,CDK5,CFL1,MAP2K2,MAPK3,RHOA	
Asparagine N-linked glycosylation	7.76E-01	1.29E-01	-2.000	ALG5,NAGK,NUDT14,PDIA3	
Signaling by CSF1 (M-CSF) in myeloid cells	7.76E-01	1.29E-01	-2.000	CSF1,KRAS,RPS27A,UBC	
MyD88 dependent cascade initiated on endosome	7.76E-01	1.29E-01	-2.000	RPS27A,UBC,UBE2N,UBE2V1	
Macrophage Classical Activation Signaling Pathway	7.68E-01	8.99E-02	-1.604	CD40,GBP2,GBP4,IFNGR1,IRF1,NFKBIA,NOS2,PKM,RBBP4,RBBP7,SDHB,SDHD,TGFB1,TNFSF12,TNFSF13,UQCRC2,YY1	
Opioid Signalling	7.54E-01	1E-01	-3.000	ADCY4,CDK5,GNA11,GNAI2,GNB2,GNG5,PLA2G4A,POMC,PPP1CA	
Erythrocytes take up carbon dioxide and release oxygen	7.53E-01	1.82E-01	NaN	CA2,CA4	
RHO GTPases activate KTN1	7.53E-01	1.82E-01	NaN	RHOA,RHOG	
Alpha-protein kinase 1 signaling pathway	7.53E-01	1.82E-01	NaN	RPS27A,UBC	
Pentose Phosphate Pathway	7.53E-01	1.82E-01	NaN	PGLS,TALDO1	
VDR/RXR Activation	7.52E-01	1.03E-01	NaN	CDKN1A,GTF2B,HES1,KLF4,PDGFA,PSMC5,THBD,YY1	
Vasopressin regulates renal water homeostasis via Aquaporins	7.47E-01	1.16E-01	-2.236	ADCY4,GNAS,GNB2,GNG5,RAB11A	
G-protein beta:gamma signalling	7.41E-01	1.25E-01	-2.000	AKT1,GNB2,GNG5,RHOA	
Glutamate binding, activation of AMPA receptors and synaptic plasticity	7.41E-01	1.25E-01	-2.000	AP2A2,Ap2b1,AP2M1,AP2S1	
Thrombin signalling through proteinase activated receptors (PARs)	7.41E-01	1.25E-01	-2.000	GNA11,GNB2,GNG5,MAPK3	
RANK Signaling in Osteoclasts	7.35E-01	9.89E-02	-2.828	AKT1,Calm1 (includes others),FOS,JUN,MAP2K2,MAP3K8,MAPK3,NFKBIA,TRAF5	
BMP signaling pathway	7.35E-01	9.89E-02	-2.646	ACVRL1,HRAS,JUN,KRAS,MAP2K2,MAPK3,PRKAG1,RASD1,RRAS	
Signaling by MET	7.31E-01	1.01E-01	-2.828	ARF6,HRAS,KRAS,RAB4A,RAB4B,RPS27A,SH3GL1,UBC	
Role of MAPK Signaling in Inhibiting the Pathogenesis of Influenza	7.31E-01	1.01E-01	-1.890	BAX,JUN,MAP2K2,MAPK3,NFKBIA,PLA2G4A,PLAAT3,PRDX6	
Mouse Embryonic Stem Cell Pluripotency	7.22E-01	9.62E-02	-3.000	AKT1,HRAS,ID1,ID2,ID3,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
TAK1-dependent IKK and NF-kappa-B activation	7.19E-01	1.14E-01	-2.236	NFKBIA,RPS27A,UBC,UBE2N,UBE2V1	
SUMOylation of chromatin organization proteins	7.1E-01	1.07E-01	-2.449	RAE1,SEC13,SUMO1,SUMO2,SUMO3,UBE2I	
EGF Signaling	7.1E-01	1.07E-01	-2.449	AKT1,CSNK2B,FOS,HRAS,JUN,MAPK3	
Lactose synthesis	7.09E-01	3.33E-01	NaN	SLC2A1	
MTF1 activates gene expression	7.09E-01	3.33E-01	NaN	CSRP1	
Galactose catabolism	7.09E-01	3.33E-01	NaN	GALT	
NFE2L2 regulating TCA cycle genes	7.09E-01	3.33E-01	NaN	NFE2L2	
Regulation of NFE2L2 gene expression	7.09E-01	3.33E-01	NaN	NFE2L2	
Diphthamide Biosynthesis	7.09E-01	3.33E-01	NaN	EEF2	
Guanine and Guanosine Salvage I	7.09E-01	3.33E-01	NaN	PNP	
Glutathione Biosynthesis	7.09E-01	3.33E-01	NaN	GCLM	
N-acetylglucosamine Degradation I	7.09E-01	3.33E-01	NaN	GNPDA2	
RHO GTPases Activate NADPH Oxidases	7.08E-01	1.36E-01	NaN	CYBA,MAPK3,PIN1	
Putrescine Degradation III	7.08E-01	1.36E-01	NaN	ALDH2,SAT1,SMOX	
eNOS Signaling	6.96E-01	8.97E-02	0.000	ADCY4,AKT1,Calm1 (includes others),CAV1,GNAS,HSP90AB1,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,NOS3,PRKAB1,PRKAG1,STUB1	
Mineralocorticoid Biosynthesis	6.93E-01	1.67E-01	NaN	EBP,HSD3B7	
Arachidonic acid metabolism	6.91E-01	1.11E-01	-2.236	GPX1,GPX4,LTC4S,PLA2G4A,PON2	
Interleukin-10 signaling	6.91E-01	1.11E-01	-2.236	CSF1,ICAM1,IL10RB,IL1R1,TNFRSF1A	
GPER1 signaling	6.91E-01	1.11E-01	-2.236	ADCY4,GNAI2,GNAS,GNB2,GNG5	
Xenobiotic Metabolism PXR Signaling Pathway	6.9E-01	8.72E-02	-3.153	ALDH2,CDK5,ESD,GSTM1,GSTM2,GSTM5,HS3ST1,HSP90AB1,MGST3,NOS2,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,SMOX,SNW1,SRA1	
Chaperone Mediated Autophagy Signaling Pathway	6.86E-01	7.87E-02	0.849	AKT1,ATP6AP1,ATP6AP2,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,BBC3,EEF1A1,EIF4A1,EIF4H,GPX4,HSP90AB1,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,MCL1,NFE2L2,NFKBIA,NOS3,PARK7,PLIN3,PRKAB1,PRKAG1,PSMA1,PSMA2,PSMA3,PSMA4,PSMA5,PSMA6,PSMA7,PSMB1,PSMB10,PSMB2,PSMB3,PSMB4,PSMB5,PSMB6,PSMB8,PSMB9,PSME1,PSME2,RAB11A,RAB11B,STIP1,STUB1,TPT1	
GÎ±q Signaling	6.8E-01	8.82E-02	-3.317	AKT1,Calm1 (includes others),Cdc42,GNA11,GNAI2,GNAS,GNB2,GNG5,MAP2K2,MAPK3,NFKBIA,RHOA,RHOB,RHOC,RHOG	
4-1BB Signaling in T Lymphocytes	6.76E-01	1.18E-01	NaN	JUN,MAP2K2,MAPK3,NFKBIA	
Inhibition of Angiogenesis by TSP1	6.76E-01	1.18E-01	-2.000	AKT1,JUN,NOS3,TGFB1	
BEX2 Signaling Pathway	6.72E-01	9.76E-02	0.000	AKT1,BAD,BBC3,CDKN1A,JUN,LMO2,NFKBIA,SMARCB1	
Post-translational protein phosphorylation	6.7E-01	9.35E-02	-3.162	APOE,CSF1,CST3,GAS6,GOLM1,MFGE8,PDIA6,PRSS23,QSOX1,VWA1	
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I	6.69E-01	1.3E-01	NaN	CMPK1,DTYMK,NME2	
Ribonucleotide Reductase Signaling Pathway	6.67E-01	8.77E-02	-1.807	ACTB,AKT1,ATF4,BAD,CDKN1A,CREB3,E2F4,EIF4EBP1,FOS,H3-3A/H3-3B,JUN,KRAS,MAPK3,SMARCB1,YBX1	
p38 MAPK Signaling	6.64E-01	9.17E-02	-2.530	ATF4,CREB3,DUSP1,H3-3A/H3-3B,HMGN1,HSPB1,IL1R1,PLA2G4A,TGFB1,TNFRSF1A,TRADD	
Synaptic Long Term Depression	6.54E-01	8.59E-02	-3.742	GNA11,GNAI2,GNAS,HRAS,KRAS,MAP2K2,MAPK3,NOS2,NOS3,NPR1,NT5C,PDIA3,PLA2G4A,PLAAT3,PRDX6,RASD1,RRAS	
Orexin Signaling Pathway	6.46E-01	8.4E-02	-4.472	ADCY4,AKT1,ATP6AP1,ATP6AP2,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,Calm1 (includes others),GNAS,GNB2,GNG5,MAPK3,PDIA3,PLA2G4A,PRDM16,PRKAB1,PRKAG1	
Transcriptional Regulation by NPAS4	6.46E-01	1.14E-01	-2.000	CDK5,FOS,MAPK3,NAMPT	
Oxytocin in Brain Signaling Pathway	6.42E-01	8.54E-02	-3.638	AKT1,ATF4,Calm1 (includes others),CREB3,GNA11,GNAI2,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,PLA2G4A,PLAAT3,PRDX6,RASD1,RRAS	
Cytosolic iron-sulfur cluster assembly	6.4E-01	1.54E-01	NaN	CIAO1,CIAO2B	
Glucocorticoid Biosynthesis	6.4E-01	1.54E-01	NaN	EBP,HSD3B7	
IL-22 Signaling	6.32E-01	1.25E-01	NaN	AKT1,IL10RB,MAPK3	
Tumoricidal Function of Hepatic Natural Killer Cells	6.32E-01	1.25E-01	NaN	BAX,CYCS,ICAM1	
The Visual Cycle	6.32E-01	1.25E-01	NaN	DHRS7,RBP1,RDH14	
Methionine Degradation I (to Homocysteine)	6.32E-01	1.25E-01	NaN	MAT2A,MAT2B,PRMT1	
WNT/Î²-catenin Signaling	6.29E-01	8.62E-02	-0.302	AKT1,CSNK1E,CSNK2B,GSK3A,ILK,JUN,PIN1,RPS27A,SOX17,SOX18,SOX7,TGFB1,Ubb,UBC,WNT5A	
Kinetochore Metaphase Signaling Pathway	6.22E-01	9.09E-02	0.000	ANAPC11,ANAPC13,ARPP19,BOD1,BUB3,MAD2L2,PPP1CA,PPP1R11,PPP1R14B,PTTG1	
PCP (Planar Cell Polarity) Pathway	6.19E-01	1E-01	-2.449	JUN,JUNB,JUND,PFN1,RHOA,WNT5A	
Human Embryonic Stem Cell Pluripotency	6.19E-01	8.46E-02	-4.123	ACVRL1,AKT1,HRAS,HSP90AB1,ID1,ID2,ID3,KLF2,KLF4,KRAS,MAP2K2,PDGFA,PDGFB,RASD1,RRAS,TGFB1,WNT5A	
SNARE Signaling Pathway	6.17E-01	8.82E-02	-3.464	ADCY4,Calm1 (includes others),GPAA1,HSPA8,MYL6,NAPA,PRKAG1,RAB11A,RAB8A,SGTA,VAMP3,VTI1B	
G alpha (z) signalling events	6.15E-01	1.04E-01	-2.236	ADCY4,GNAI2,GNAS,GNB2,GNG5	
NOD1/2 Signaling Pathway	6.06E-01	8.47E-02	-3.500	FOS,HSP90AB1,HSPA1A/HSPA1B,Hspa1b,HSPA5,HSPA8,JUN,MAP2K2,MAP3K8,MAPK3,NFKBIA,NOS2,SUGT1,TGFB1,TNFSF12,TNFSF13	
Erythropoietin Signaling Pathway	6.05E-01	8.52E-02	-1.291	AKT1,BAD,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,NOS3,RASD1,RRAS,TGFB1,TNFSF12,TNFSF13	
HOTAIR Regulatory Pathway	6.04E-01	8.59E-02	-1.941	AKT1,CDKN1A,H3-3A/H3-3B,ICAM1,IRF1,LAMTOR5,NFKBIA,RBBP4,RBBP7,RHOC,TGFB1,VIM,WNT5A,YY1	
Cellular Effects of Sildenafil (Viagra)	6.03E-01	8.67E-02	NaN	ACTB,ACTG1,ADCY4,Calm1 (includes others),GNAS,MYL12A,MYL12B,MYL6,NOS3,NPR1,PABPC4,PDIA3,PRKAG1	
Semaphorin Neuronal Repulsive Signaling Pathway	6.03E-01	8.67E-02	-0.277	AKT1,CDK5,CFL1,CFL2,MAP2K2,MYL12A,MYL12B,MYL6,NRP2,PAK4,PRKAG1,RHOA,RRAS	
Retinoate Biosynthesis II	6E-01	2.5E-01	NaN	RBP1	
Heme Degradation	6E-01	2.5E-01	NaN	HMOX2	
Phenylethylamine Degradation I	6E-01	2.5E-01	NaN	ALDH2	
Methylmalonyl Pathway	6E-01	2.5E-01	NaN	MCEE	
Taurine Biosynthesis	6E-01	2.5E-01	NaN	FMO1	
D-glucuronate Degradation I	6E-01	2.5E-01	NaN	AKR1A1	
Proline Biosynthesis I	6E-01	2.5E-01	NaN	PYCR2	
Melatonin Degradation II	6E-01	2.5E-01	NaN	SMOX	
Rapoport-Luebering Glycolytic Shunt	6E-01	2.5E-01	NaN	PGAM1	
Phenylalanine Degradation I (Aerobic)	6E-01	2.5E-01	NaN	QDPR	
Fatty Acid Î²-oxidation III (Unsaturated, Odd Number)	6E-01	2.5E-01	NaN	ECI1	
Platelet homeostasis	5.99E-01	9.3E-02	-2.828	GNAS,GNB2,GNG5,NOS2,NOS3,ORAI1,PLA2G4A,SRI	
Signaling by NTRK2 (TRKB)	5.98E-01	1.2E-01	NaN	CDK5,HRAS,KRAS	
Mitotic Prometaphase	5.97E-01	8.37E-02	-4.123	BUB3,CETN2,CSNK1E,CSNK2B,DCTN2,DCTN3,DYNLL1,MZT1,NUDC,SEC13,SSNA1,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B,YWHAE	
Macrophage Alternative Activation Signaling Pathway	5.95E-01	8.42E-02	-2.000	ATF4,CREB3,CSF1,DUSP1,EIF4EBP1,FOS,H3-3A/H3-3B,IL10RB,IL2RG,JUN,KLF4,MAPK3,NFKBIA,NOS2,TGFB1,TSC22D3	
Leukotriene Biosynthesis	5.92E-01	1.43E-01	NaN	LTC4S,MGST3	
Phenylalanine Degradation IV (Mammalian, via Side Chain)	5.92E-01	1.43E-01	NaN	ALDH2,SMOX	
Nucleosome assembly	5.92E-01	1.02E-01	-2.236	CENPX,MIS18A,NPM1,RBBP4,RBBP7	
HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA)	5.92E-01	8.93E-02	-3.162	PIAS4,POLD4,RPA3,RPS27A,SEM1,SUMO2,UBC,UBE2I,UBE2N,UBE2V2	
ERCC6 (CSB) and EHMT2 (G9a) positively regulate rRNA expression	5.9E-01	1.08E-01	-2.000	CBX3,MBD3,RBBP4,RBBP7	
GÎ±s Signaling	5.77E-01	8.73E-02	-2.828	ADCY4,ATF4,CREB3,GNA11,GNAI2,GNAS,GNB2,GNG5,MAP2K2,MAPK3,PRKAG1	
Signaling by FGFR1	5.7E-01	1E-01	-2.236	HRAS,KRAS,MAPK3,RPS27A,UBC	
WNT ligand biogenesis and trafficking	5.66E-01	1.15E-01	NaN	SNX3,VPS29,WNT5A	
IL-17A Signaling in Gastric Cells	5.66E-01	1.15E-01	NaN	FOS,JUN,MAPK3	
Cysteine Biosynthesis III (mammalia)	5.66E-01	1.15E-01	NaN	MAT2A,MAT2B,PRMT1	
Role of Tissue Factor in Cancer	5.54E-01	8.21E-02	-4.123	AKT1,CFL1,CFL2,CSF1,FOS,GNA11,HRAS,JUN,KRAS,MAP2K2,MAPK3,PDIA6,PLAUR,RASD1,RRAS,TGFB1,TNFRSF1A	
Leptin Signaling in Obesity	5.53E-01	9.21E-02	-2.000	ADCY4,AKT1,MAP2K2,MAPK3,PDIA3,POMC,PRKAG1	
IL-27 Signaling Pathway	5.5E-01	8.59E-02	-2.111	AKT1,CD40,GADD45G,HLA-A,HLA-E,IFNGR1,IL1R1,IRF1,MCL1,NOS2,TNFRSF1A	
Signaling by Activin	5.49E-01	1.33E-01	NaN	DRAP1,MAPK3	
Regulation of cholesterol biosynthesis by SREBP (SREBF)	5.49E-01	1.33E-01	NaN	RAN,SAR1B	
Mismatch Repair	5.49E-01	1.33E-01	NaN	POLD4,RPA3	
Transcriptional regulation by RUNX2	5.48E-01	9.8E-02	-2.236	AKT1,BAX,CDKN1A,HES1,MAPK3	
IL-12 Signaling and Production in Macrophages	5.42E-01	8.09E-02	1.606	AKT1,APOD,APOE,Calm1 (includes others),CD40,FOS,H3-3A/H3-3B,IFNGR1,IL10RB,IRF1,JMJD6,JUN,MAP2K2,MAP3K8,MAPK3,NOS2,PRKAB1,PRKAG1,TGFB1	
Mitochondrial biogenesis	5.4E-01	9.38E-02	-2.449	ALAS1,CYCS,PRKAB1,PRKAG1,SOD2,SSBP1	
Formation of Fibrin Clot (Clotting Cascade)	5.39E-01	1.03E-01	-2.000	C1QBP,PRCP,THBD,VWF	
Regulation of TP53 Expression and Degradation	5.39E-01	1.03E-01	-2.000	AKT1,RPS27A,SGK1,UBC	
Superpathway of Methionine Degradation	5.39E-01	1.03E-01	-2.000	MAT2A,MAT2B,MCEE,PRMT1	
Syndecan interactions	5.36E-01	1.11E-01	NaN	ACTN1,TGFB1,TRAPPC4	
NAD Salvage Pathway II	5.36E-01	1.11E-01	NaN	NT5C,NT5C3B,NT5M	
Bladder Cancer Signaling	5.35E-01	8.62E-02	-2.236	CDKN1A,E2F4,HRAS,KRAS,MAP2K2,MAPK3,PA2G4,RASD1,RASSF1,RRAS	
Regulation of Cellular Mechanics by Calpain Protease	5.34E-01	8.89E-02	-2.236	ACTN1,CAPNS1,EZR,HRAS,KRAS,MAPK3,RASD1,RRAS	
Neuregulin Signaling	5.22E-01	8.55E-02	-2.121	AKT1,BAD,CDK5,HRAS,HSP90AB1,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Pyridoxal 5'-phosphate Salvage Pathway	5.22E-01	9.23E-02	-2.449	CDK5,CDK8,MAP2K2,MAP3K8,MAPK3,SGK1	
NF-ÎºB Activation by Viruses	5.19E-01	8.97E-02	-2.449	AKT1,HRAS,KRAS,MAPK3,NFKBIA,RASD1,RRAS	
Toll-like Receptor Signaling	5.19E-01	8.97E-02	NaN	FOS,JUN,NFKBIA,RPS27A,SIGIRR,Ubb,UBC	
Factors involved in megakaryocyte development and platelet production	5.19E-01	8.79E-02	-2.828	ACTB,CAPZA2,CDK5,EHD1,EHD2,HMG20B,IRF1,RAB5A	
Fcgamma receptor (FCGR) dependent phagocytosis	5.19E-01	8.28E-02	-3.606	ACTB,ACTG1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,BAIAP2,BRK1,CFL1,HSP90AB1,MAPK3,NCK1	
Formation of xylulose-5-phosphate	5.17E-01	2E-01	NaN	AKR1A1	
Formation of lateral plate mesoderm	5.17E-01	2E-01	NaN	FOXF1	
Arsenate Detoxification I (Glutaredoxin)	5.17E-01	2E-01	NaN	PNP	
Proline Biosynthesis II (from Arginine)	5.17E-01	2E-01	NaN	PYCR2	
Pentose Phosphate Pathway (Oxidative Branch)	5.17E-01	2E-01	NaN	PGLS	
Lysine Degradation II	5.17E-01	2E-01	NaN	AASDHPPT	
Lysine Degradation V	5.17E-01	2E-01	NaN	AASDHPPT	
2-oxobutanoate Degradation I	5.17E-01	2E-01	NaN	MCEE	
Trans, trans-farnesyl Diphosphate Biosynthesis	5.17E-01	2E-01	NaN	FDPS	
Galactose Degradation I (Leloir Pathway)	5.17E-01	2E-01	NaN	GALT	
SUMOylation of DNA methylation proteins	5.1E-01	1.25E-01	NaN	SUMO1,UBE2I	
Glutaryl-CoA Degradation	5.1E-01	1.25E-01	NaN	HSD17B10,PARK7	
Superpathway of Citrulline Metabolism	5.1E-01	1.25E-01	NaN	NOS2,NOS3	
Bile Acid Biosynthesis, Neutral Pathway	5.1E-01	1.25E-01	NaN	HSD3B7,SCP2	
D-myo-inositol (1,4,5)-trisphosphate Degradation	5.1E-01	1.25E-01	NaN	IMPA1,INPP5K	
Parkinson's Signaling	5.1E-01	1.25E-01	NaN	CYCS,PARK7	
IL-33 Signaling Pathway	5.05E-01	8.11E-02	-2.840	AKT1,ATF4,CREB3,FOS,ICAM1,ICAM2,JUN,MAP2K2,MAP3K8,MAPK3,NFKBIA,NOS3,PRKAG1,SIGIRR,VCAM1	
HGF Signaling	5E-01	8.33E-02	-2.530	AKT1,CDKN1A,FOS,HRAS,JUN,KRAS,MAP2K2,MAP3K8,MAPK3,RASD1,RRAS	
Role of Osteoclasts in Rheumatoid Arthritis Signaling Pathway	4.97E-01	7.79E-02	-4.379	ADAM15,AKT1,ATF4,BAD,Calm1 (includes others),Cdc42,CREB3,CSF1,FOS,HRAS,IL1R1,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TNFRSF1A,TRAF5	
Phase II - Conjugation of compounds	4.87E-01	8.96E-02	-2.449	ABHD14B,COMT,ESD,MAT2A,MAT2B,TRMT112	
Superpathway of Cholesterol Biosynthesis	4.81E-01	1.03E-01	NaN	EBP,FDPS,PMVK	
Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R)	4.75E-01	1.18E-01	NaN	HRAS,KRAS	
RAN Signaling	4.75E-01	1.18E-01	NaN	RAN,RANBP1	
Isoleucine Degradation I	4.75E-01	1.18E-01	NaN	ECHS1,HSD17B10	
Formation of WDR5-containing histone-modifying complexes	4.72E-01	9.52E-02	-2.000	BOD1,DPY30,MCRS1,TADA3	
PI Metabolism	4.58E-01	8.54E-02	-2.646	ARF1,GDE1,INPP5K,PIP4P1,RAB4A,RAB5A,TNFAIP8L1	
Role of JAK1 and JAK3 in Î³c Cytokine Signaling	4.55E-01	8.7E-02	NaN	HRAS,IL2RG,KRAS,MAPK3,RASD1,RRAS	
Synthesis of Lipoxins (LX)	4.53E-01	1.67E-01	NaN	LTC4S	
Creatine metabolism	4.53E-01	1.67E-01	NaN	GATM	
Pyruvate Fermentation to Lactate	4.53E-01	1.67E-01	NaN	LDHA	
Pentose Phosphate Pathway (Non-oxidative Branch)	4.53E-01	1.67E-01	NaN	TALDO1	
NAD Biosynthesis III	4.53E-01	1.67E-01	NaN	NAMPT	
Assembly and cell surface presentation of NMDA receptors	4.52E-01	9.3E-02	-2.000	TUBA1A,TUBA1B,TUBB2A,TUBB4B	
B Cell Activating Factor Signaling	4.52E-01	9.3E-02	NaN	FOS,JUN,NFKBIA,TRAF5	
Dilated Cardiomyopathy Signaling Pathway	4.49E-01	8E-02	-0.632	ACTB,ACTG1,ADCY4,AKT1,BAD,BAX,CAMK1,GNAS,ILK,MAPK3,MYL6,PRKAG1	
Superpathway of Geranylgeranyldiphosphate Biosynthesis I (via Mevalonate)	4.42E-01	1.11E-01	NaN	FDPS,PMVK	
Regulation of Insulin-like Growth Factor (IGF) transport and uptake by IGFBPs	4.36E-01	8.06E-02	-3.162	APOE,CSF1,CST3,GAS6,GOLM1,MFGE8,PDIA6,PRSS23,QSOX1,VWA1	
Salvage Pathways of Pyrimidine Ribonucleotides	4.36E-01	8.25E-02	-2.828	CDK5,CDK8,CMPK1,MAP2K2,MAP3K8,MAPK3,NME2,SGK1	
Cristae formation	4.32E-01	9.68E-02	NaN	MICOS13,MTX1,TMEM11	
Leukocyte Extravasation Signaling	4.29E-01	7.77E-02	-3.207	ACTB,ACTG1,ACTN1,CLDN5,CYBA,EZR,F11R,GNAI2,ICAM1,MAP2K2,MYL6,RDX,RHOA,VASP,VCAM1	
3-phosphoinositide Degradation	4.29E-01	7.77E-02	-3.742	DUSP1,DUSP11,DUSP23,DUSP8,ILKAP,INPP5K,MDP1,NT5C,NUDT14,NUDT9,PIP4P1,PPP1CA,PPP1R11,PPP1R14B,PTPMT1	
Stearate Biosynthesis I (Animals)	4.24E-01	8.45E-02	NaN	ACOT9,DHRS7,ELOVL1,OSGEP,SIRT2,TECR	
Acetylcholine Receptor Signaling Pathway	4.2E-01	7.73E-02	-1.807	ADCY4,AKT1,APH1A,ATF4,Calm1 (includes others),CREB3,GNA11,GNAI2,MAPK3,NFE2L2,NOS2,PDIA3,PRKAG1,PSEN2,PSENEN	
Hepatic Fibrosis / Hepatic Stellate Cell Activation	4.2E-01	7.73E-02	NaN	BAMBI,BAX,CD40,CSF1,EDN1,ICAM1,IFNGR1,IL1R1,KLF6,MYL6,PDGFA,PDGFB,TGFB1,TNFRSF1A,VCAM1	
Signaling by PDGF	4.19E-01	8.62E-02	-2.236	HRAS,KRAS,NCK1,PDGFA,PDGFB	
MSP-RON Signaling Pathway	4.19E-01	8.62E-02	NaN	ACTB,ACTG1,CSF1,KLK8,NOS2	
TNFR2 Signaling	4.1E-01	9.38E-02	NaN	FOS,JUN,NFKBIA	
Dopamine Degradation	4.1E-01	9.38E-02	NaN	ALDH2,COMT,SMOX	
Melatonin Signaling	4.1E-01	8.33E-02	-2.449	Calm1 (includes others),GNAI2,MAP2K2,MAPK3,PDIA3,PRKAG1	
Role of NFAT in Cardiac Hypertrophy	4.01E-01	7.59E-02	-3.357	ADCY4,AKT1,Calm1 (includes others),CAMK1,GNAI2,GNAS,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,PDIA3,PRKAG1,RASD1,RRAS,TGFB1	
Pentose phosphate pathway	4.01E-01	1.43E-01	NaN	TALDO1	
Arginine Degradation VI (Arginase 2 Pathway)	4.01E-01	1.43E-01	NaN	PYCR2	
Thioredoxin Pathway	4.01E-01	1.43E-01	NaN	TXN	
Phosphatidylcholine Biosynthesis I	4.01E-01	1.43E-01	NaN	CHKB	
Adenine and Adenosine Salvage III	4.01E-01	1.43E-01	NaN	PNP	
Glycoaminoglycan-protein Linkage Region Biosynthesis	4.01E-01	1.43E-01	NaN	B3GAT3	
ATM Signaling	3.99E-01	8E-02	0.000	ATF4,CBX1,CBX3,CDKN1A,CREB3,GADD45G,JUN,NFKBIA	
Wound Healing Signaling Pathway	3.99E-01	7.54E-02	-3.900	FOS,HRAS,IFNGR1,IL1R1,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,PDGFA,PDGFB,RASD1,RRAS,TGFB1,TNFRSF1A,TNFSF12,TNFSF13,TRADD,VIM	
Ion channel transport	3.96E-01	7.65E-02	-3.464	ATP1B3,ATP6AP1,ATP6V0B,ATP6V0C,ATP6V0E1,ATP6V1E1,ATP6V1F,ATP6V1G1,PDZD11,RPS27A,SGK1,SRI,TSC22D3,UBC	
Serotonin Degradation	3.96E-01	8.22E-02	-2.449	ADH5,AKR1A1,ALDH2,B3GAT3,B4GAT1,SMOX	
Cytosolic sensors of pathogen-associated DNA	3.96E-01	8.7E-02	-2.000	LRRFIP1,NFKBIA,RPS27A,UBC	
tRNA Splicing	3.96E-01	8.7E-02	-2.000	GDE1,SMPDL3A,TSEN15,TSEN34	
Sphingolipid metabolism	3.91E-01	8.05E-02	-2.646	CERS2,DEGS2,GLTP,ORMDL2,SMPD2,SPTSSA,VAPA	
MAPK targets/ Nuclear events mediated by MAP kinases	3.89E-01	9.09E-02	NaN	FOS,JUN,MAPK3	
Visual phototransduction	3.88E-01	8.33E-02	-2.236	FNTA,METAP2,NMT1,RBP1,TTR	
NAFLD Signaling Pathway	3.85E-01	7.52E-02	-2.183	AKT1,ATF4,BAX,BBC3,CTSB,FOS,GSK3A,JUN,NFE2L2,PRKAB1,PRKAG1,SOCS2,TGFB1,TNFRSF1A,TNFSF12,TNFSF13,XBP1	
Signaling by Hippo	3.85E-01	1E-01	NaN	YWHAB,YWHAE	
Androgen Biosynthesis	3.85E-01	1E-01	NaN	EBP,HSD3B7	
Role of IL-17F in Allergic Inflammatory Airway Diseases	3.79E-01	8.51E-02	-2.000	ATF4,CREB3,MAP2K2,MAPK3	
Ephrin A Signaling	3.79E-01	8.51E-02	NaN	CFL1,CFL2,EFNA1,RHOA	
Primary Immunodeficiency Signaling	3.73E-01	8.2E-02	NaN	CD40,IL2RG,RFXAP,TAP1,TAP2	
Ovarian Cancer Signaling	3.72E-01	7.59E-02	-2.828	AKT1,E2F4,EDN1,HRAS,KRAS,MAP2K2,MAPK3,PA2G4,PRKAG1,RASD1,RRAS,WNT5A	
Th1 and Th2 Activation Pathway	3.71E-01	7.56E-02	NaN	APH1A,CD40,HLA-A,ICAM1,IFNGR1,IL10RB,IL2RG,IRF1,JUN,PSEN2,PSENEN,S1PR1,TGFB1	
Transcriptional Regulation by E2F6	3.69E-01	8.82E-02	NaN	CBX3,RBBP4,RBBP7	
Triglyceride metabolism	3.69E-01	8.82E-02	NaN	CAV1,PLIN3,PPP1CA	
GPCR-Mediated Integration of Enteroendocrine Signaling Exemplified by an L Cell	3.69E-01	8E-02	0.000	ADCY4,GNA11,GNAI2,GNAS,PDIA3,PRKAG1	
Integration of energy metabolism	3.65E-01	7.77E-02	-2.449	ADCY4,GNA11,GNAI2,GNAS,GNB2,GNG5,SLC2A1,TALDO1	
Senescence Pathway	3.65E-01	7.36E-02	-2.236	AKT1,ANAPC11,ANAPC13,Calm1 (includes others),CAPNS1,CDKN1A,E2F4,EIF4EBP1,GADD45G,HRAS,JUN,KRAS,MAP2K2,MAPK3,PHF1,PPP1CA,RASD1,RRAS,SOD2,SQSTM1,TGFB1,YPEL3	
IL-17 Signaling	3.63E-01	7.49E-02	-3.742	AKT1,FOS,HRAS,HSP90AB1,JUN,KRAS,MAPK3,NOS2,RASD1,RRAS,TGFB1,TNFSF12,TNFSF13,TRAF5	
Retinol Biosynthesis	3.62E-01	8.33E-02	NaN	DHRS7,ESD,RBP1,RDH14	
Interleukin-7 signaling	3.6E-01	9.52E-02	NaN	IL2RG,SOCS2	
RHO GTPases activate PAKs	3.6E-01	9.52E-02	NaN	MYL12B,MYL6	
Regulation of TLR by endogenous ligand	3.6E-01	9.52E-02	NaN	GSDMD,S100A1	
Nucleotide salvage	3.6E-01	9.52E-02	NaN	APRT,GMPR2	
Purine Ribonucleosides Degradation to Ribose-1-phosphate	3.57E-01	1.25E-01	NaN	PNP	
Sphingomyelin Metabolism	3.57E-01	1.25E-01	NaN	SMPD2	
Fc Epsilon RI Signaling	3.54E-01	7.63E-02	-2.121	AKT1,HRAS,INPP5K,KRAS,MAP2K2,MAPK3,PLA2G4A,RASD1,RRAS	
Oxytocin in Spinal Neurons Signaling Pathway	3.51E-01	8.57E-02	NaN	GNA11,NPR1,NT5C	
GPVI-mediated activation cascade	3.51E-01	8.57E-02	NaN	RHOA,RHOB,RHOG	
PRC2 methylates histones and DNA	3.51E-01	8.57E-02	NaN	PHF1,RBBP4,RBBP7	
Coagulation System	3.51E-01	8.57E-02	NaN	PLAUR,THBD,VWF	
IL-9 Signaling	3.51E-01	8.57E-02	NaN	BCL3,IL2RG,SOCS2	
Ethanol Degradation II	3.51E-01	8.57E-02	NaN	ADH5,AKR1A1,ALDH2	
HEY1 Signaling Pathway	3.46E-01	7.45E-02	-2.309	ACVRL1,AKT1,APH1A,BAX,CDKN1A,E2F4,NR2F2,PRKAB1,PRKAG1,PSEN2,PSENEN,TGFB1	
TREM1 Signaling	3.44E-01	7.79E-02	-1.633	AKT1,CD40,CD83,ICAM1,MAPK3,SIGIRR	
Crosstalk between Dendritic Cells and Natural Killer Cells	3.44E-01	7.69E-02	NaN	ACTB,ACTG1,CD40,CD83,HLA-A,HLA-E,IL2RG	
Neuroinflammation Signaling Pathway	3.41E-01	7.26E-02	-4.264	AKT1,APH1A,ATF4,CD40,CREB3,FOS,HLA-A,HLA-E,ICAM1,IFNGR1,IL1R1,JUN,MAPK3,MFGE8,NFE2L2,NOS2,PLA2G4A,PSEN2,PSENEN,SOD2,TGFB1,TNFRSF1A,VCAM1	
Cellular hexose transport	3.36E-01	9.09E-02	NaN	SLC2A1,SLC50A1	
Superpathway of D-myo-inositol (1,4,5)-trisphosphate Metabolism	3.36E-01	9.09E-02	NaN	IMPA1,INPP5K	
Nitric Oxide Signaling in the Cardiovascular System	3.35E-01	7.5E-02	-2.121	AKT1,Calm1 (includes others),CAV1,HSP90AB1,MAP2K2,MAPK3,NOS3,NPR1,PRKAG1	
MIF-mediated Glucocorticoid Regulation	3.33E-01	8.33E-02	NaN	MAPK3,NFKBIA,PLA2G4A	
NR1H2 and NR1H3-mediated signaling	3.32E-01	8E-02	-2.000	APOD,APOE,GPS2,PLTP	
PD-1, PD-L1 cancer immunotherapy pathway	3.24E-01	7.48E-02	1.134	AKT1,CSNK2B,HLA-A,HLA-E,IFNGR1,IL2RG,TGFB1,TNFRSF1A	
DDX58/IFIH1-mediated induction of interferon-alpha/beta	3.21E-01	7.59E-02	-2.449	HSP90AB1,NFKBIA,PIN1,RPS27A,UBC,UBE2D3	
Abacavir ADME	3.2E-01	1.11E-01	NaN	ABCG2	
Interleukin-1 processing	3.2E-01	1.11E-01	NaN	GSDMD	
Interleukin-9 signaling	3.2E-01	1.11E-01	NaN	IL2RG	
Sucrose Degradation V (Mammalian)	3.2E-01	1.11E-01	NaN	ALDOA	
Phosphatidylethanolamine Biosynthesis II	3.2E-01	1.11E-01	NaN	CHKB	
Leucine Degradation I	3.2E-01	1.11E-01	NaN	HMGCL	
Folate Transformations I	3.2E-01	1.11E-01	NaN	MTHFS	
PXR/RXR Activation	3.19E-01	7.69E-02	-2.236	AKT1,ALAS1,GSTM1,GSTM2,PRKAG1	
Activation of IRF by Cytosolic Pattern Recognition Receptors	3.19E-01	7.69E-02	-1.342	CD40,JUN,NFKBIA,PIN1,PPIB	
Th1 Pathway	3.16E-01	7.38E-02	-3.000	APH1A,CD40,HLA-A,ICAM1,IFNGR1,IL10RB,IRF1,PSEN2,PSENEN	
Signaling by NODAL	3.15E-01	8.7E-02	NaN	DRAP1,MAPK3	
Nephrin family interactions	3.15E-01	8.7E-02	NaN	ACTN1,NCK1	
Tryptophan Degradation III (Eukaryotic)	3.15E-01	8.7E-02	NaN	HSD17B10,PARK7	
Vitamin-C Transport	3.15E-01	8.7E-02	NaN	SLC2A1,TXN	
ISGylation Signaling Pathway	3.15E-01	7.41E-02	-0.707	CHMP5,EIF4E2,IL10RB,IRF1,KRAS,RTN4,SQSTM1,UBE2N	
Multiple Sclerosis Signaling Pathway	3.14E-01	7.21E-02	-3.500	BAX,CAPNS1,DUSP1,GAS5,HLA-A,HLA-E,IFNGR1,IRF1,MAPK3,RBBP4,RBBP7,TGFB1,TNFRSF1A,TNFSF12,TNFSF13,YY1	
Xenobiotic Metabolism CAR Signaling Pathway	3.1E-01	7.22E-02	-2.673	ALDH2,FMO1,GSTM1,GSTM2,GSTM5,HS3ST1,HSP90AB1,MAP2K2,MAPK3,MGST3,NOS2,RACK1,SNW1,SRA1	
Th2 Pathway	3.1E-01	7.3E-02	-1.414	APH1A,CD40,HLA-A,ICAM1,IL2RG,JUN,PSEN2,PSENEN,S1PR1,TGFB1	
Role of PI3K/AKT Signaling in the Pathogenesis of Influenza	3.07E-01	7.58E-02	-1.342	AKT1,GNAI2,MAP2K2,MAPK3,NFKBIA	
Hepatic Cholestasis	3.07E-01	7.17E-02	-3.000	ADCY4,AKT1,Calm1 (includes others),HSD3B7,IL1R1,JUN,MAP2K2,MAPK3,NFKBIA,NOS2,PRKAG1,TGFB1,TNFRSF12A,TNFRSF1A,TNFSF12,TNFSF13	
Apoptotic execution phase	3.04E-01	7.69E-02	-2.000	BCAP31,FNTA,HMGB2,VIM	
Regulation of the Epithelial-Mesenchymal Transition Pathway	3.03E-01	7.18E-02	NaN	AKT1,APH1A,HRAS,ID2,KRAS,MAP2K2,MAPK3,PSEN2,PSENEN,RASD1,RHOA,RRAS,TGFB1,WNT5A	
White Adipose Tissue Browning Pathway	3.02E-01	7.25E-02	-3.162	ADCY4,ATF4,CREB3,CTBP2,GNAS,LDHA,NPR1,PRDM16,PRKAB1,PRKAG1	
NoRC negatively regulates rRNA expression	3E-01	7.89E-02	NaN	SAP18,SAP30L,SIN3B	
Cell Cycle Regulation by BTG Family Proteins	3E-01	7.89E-02	NaN	BTG1,E2F4,PRMT1	
Role of NANOG in Mammalian Embryonic Stem Cell Pluripotency	2.99E-01	7.26E-02	-2.449	ACVRL1,AKT1,HRAS,KRAS,MAP2K2,MAPK3,RASD1,RRAS,WNT5A	
Collagen biosynthesis and modifying enzymes	2.96E-01	7.46E-02	-2.236	COLGALT1,CRTAP,P4HA2,PPIB,SERPINH1	
Mitotic Roles of Polo-Like Kinase	2.96E-01	7.46E-02	0.000	ANAPC11,ANAPC13,HSP90AB1,PTTG1,TGFB1	
Sulfur amino acid metabolism	2.95E-01	8.33E-02	NaN	FMO1,TXN2	
Other interleukin signaling	2.95E-01	8.33E-02	NaN	CSF1,IL10RB	
Glycogen metabolism	2.95E-01	8.33E-02	NaN	RPS27A,UBC	
Growth hormone receptor signaling	2.95E-01	8.33E-02	NaN	MAPK3,SOCS2	
Class B/2 (Secretin family receptors)	2.93E-01	7.29E-02	-2.646	ADGRE5,GNAS,GNB2,GNG5,RAMP2,RAMP3,WNT5A	
Small Cell Lung Cancer Signaling	2.93E-01	7.29E-02	NaN	AKT1,CYC1,CYCS,E2F4,NFKBIA,PA2G4,TRAF5	
POU5F1 (OCT4), SOX2, NANOG repress genes related to differentiation	2.88E-01	1E-01	NaN	TSC22D1	
Caspase activation via Dependence Receptors in the absence of ligand	2.88E-01	1E-01	NaN	DAPK3	
Ketone body metabolism	2.88E-01	1E-01	NaN	HMGCL	
Prostanoid Biosynthesis	2.88E-01	1E-01	NaN	PTGES3	
Calcium Transport I	2.88E-01	1E-01	NaN	ANXA5	
Pancreatic Adenocarcinoma Signaling	2.82E-01	7.14E-02	-1.633	AKT1,BAD,CDKN1A,E2F4,KRAS,MAP2K2,MAPK3,PA2G4,TGFB1	
Cholesterol biosynthesis	2.76E-01	8E-02	NaN	EBP,FDPS	
Signaling by Erythropoietin	2.76E-01	8E-02	NaN	HRAS,KRAS	
Ethanol Degradation IV	2.76E-01	8E-02	NaN	ALDH2,GPX7	
Role of Osteoblasts, Osteoclasts and Chondrocytes in Rheumatoid Arthritis	2.76E-01	7.02E-02	NaN	ACVRL1,AKT1,BAD,Calm1 (includes others),CSF1,CSNK1E,FOS,IL1R1,JUN,MAPK3,NFKBIA,TGFB1,TNFRSF1A,TRADD,TRAF5,WNT5A	
p53 Signaling	2.74E-01	7.14E-02	-0.447	AKT1,BAX,BBC3,CDKN1A,GADD45G,JUN,ST13	
Transcriptional Regulation by VENTX	2.71E-01	7.5E-02	NaN	ANAPC11,ANAPC16,UBE2S	
Pyrimidine Ribonucleotides Interconversion	2.71E-01	7.5E-02	NaN	CMPK1,NME2,PGP	
Dopamine-DARPP32 Feedback in cAMP Signaling	2.67E-01	6.99E-02	-1.387	ADCY4,ATF4,Calm1 (includes others),CDK5,CREB3,CSNK1E,GNAI2,GNAS,PDIA3,PPP1CA,PPP1R11,PPP1R14B,PRKAG1	
Interleukin-3, Interleukin-5 and GM-CSF signaling	2.67E-01	7.27E-02	-2.000	IL2RG,INPP5K,RPS27A,UBC	
Antioxidant Action of Vitamin C	2.62E-01	7.02E-02	2.236	MAPK3,NFKBIA,PDIA3,PLA2G4A,PLAAT3,PRDX6,SLC2A1,TXN	
Phenylalanine and tyrosine metabolism	2.6E-01	9.09E-02	NaN	QDPR	
Ketogenesis	2.6E-01	9.09E-02	NaN	HMGCL	
Oleate Biosynthesis II (Animals)	2.6E-01	9.09E-02	NaN	CYB5A	
Purine Nucleotides De Novo Biosynthesis II	2.6E-01	9.09E-02	NaN	IMPDH2	
Integrin cell surface interactions	2.6E-01	7.06E-02	-2.449	BSG,F11R,ICAM1,ICAM2,VCAM1,VWF	
Estrogen-mediated S-phase Entry	2.59E-01	7.69E-02	NaN	CDKN1A,E2F4	
Folate Signaling Pathway	2.55E-01	7.14E-02	-2.000	CDKN1A,KLF4,MAPK3,MAT2A	
Cell Cycle Control of Chromosomal Replication	2.55E-01	7.14E-02	-2.000	CDK5,CDK8,CDK9,RPA3	
Triacylglycerol Biosynthesis	2.55E-01	7.14E-02	NaN	ELOVL1,OSGEP,PLPP5,SIRT2	
Regulation of beta-cell development	2.44E-01	7.14E-02	NaN	AKT1,HES1,SNW1	
DAP12 interactions	2.44E-01	7.14E-02	NaN	HLA-E,HRAS,KRAS	
Role of IL-17A in Arthritis	2.44E-01	7.02E-02	NaN	MAP2K2,MAPK3,NFKBIA,NOS2	
Integrin signaling	2.43E-01	7.41E-02	NaN	AKT1,VWF	
Fatty acyl-CoA biosynthesis	2.43E-01	7.41E-02	NaN	PPT2,TECR	
Apelin Liver Signaling Pathway	2.43E-01	7.41E-02	NaN	EDN1,GSK3A	
Peptide hormone biosynthesis	2.36E-01	8.33E-02	NaN	POMC	
GP1b-IX-V activation signalling	2.36E-01	8.33E-02	NaN	VWF	
Tryptophan catabolism	2.36E-01	8.33E-02	NaN	SLC3A2	
Hematopoiesis from Multipotent Stem Cells	2.36E-01	8.33E-02	NaN	CSF1	
Î³-glutamyl Cycle	2.36E-01	8.33E-02	NaN	GCLM	
Signaling by ALK	2.28E-01	7.14E-02	NaN	IL2RG,PTN	
Glyoxylate metabolism and glycine degradation	2.28E-01	7.14E-02	NaN	LIAS,NDUFAB1	
Trafficking and processing of endosomal TLR	2.15E-01	7.69E-02	NaN	CTSB	
Platelet Aggregation (Plug Formation)	2.15E-01	7.69E-02	NaN	VWF	
Transcriptional regulation of testis differentiation	2.15E-01	7.69E-02	NaN	FOXL2	
Cleavage and Polyadenylation of Pre-mRNA	2.15E-01	7.69E-02	NaN	NUDT21	
Cholesterol Biosynthesis I	2.15E-01	7.69E-02	NaN	EBP	
Cholesterol Biosynthesis II (via 24,25-dihydrolanosterol)	2.15E-01	7.69E-02	NaN	EBP	
Cholesterol Biosynthesis III (via Desmosterol)	2.15E-01	7.69E-02	NaN	EBP	
UDP-N-acetyl-D-galactosamine Biosynthesis II	2.15E-01	7.69E-02	NaN	GNPDA2	
Carnitine metabolism	1.96E-01	7.14E-02	NaN	MID1IP1	
Regulation of TP53 Activity through Association with Co-factors	1.96E-01	7.14E-02	NaN	AKT1	
Glutamate and glutamine metabolism	1.96E-01	7.14E-02	NaN	PYCR2	
Interleukin-15 signaling	1.96E-01	7.14E-02	NaN	IL2RG	
Aspirin ADME	1.96E-01	7.14E-02	NaN	BSG	
Acyl-CoA Hydrolysis	1.96E-01	7.14E-02	NaN	ACOT9	
Mevalonate Pathway I	1.96E-01	7.14E-02	NaN	PMVK	
Colanic Acid Building Blocks Biosynthesis	1.96E-01	7.14E-02	NaN	GALT	
Neurovascular Coupling Signaling Pathway	-0E00	4.31E-02	-2.530	Calm1 (includes others),NOS3,NPR1,NT5C,P2RY1,PLA2G4A,PLAAT3,PRDX6,PRKAG1,RHOA	
Pulmonary Healing Signaling Pathway	-0E00	6.53E-02	-1.941	CFL1,CFL2,HRAS,KRAS,MAPK3,NFKBIA,PRKAB1,PRKAG1,RASD1,RRAS,TGFB1,TNFRSF1A,WNT5A	
IL-13 Signaling Pathway	-0E00	6.03E-02	-2.646	AKT1,DUSP1,JUN,MAPK3,PDGFA,RHOA,TGFB1	
CDX Gastrointestinal Cancer Signaling Pathway	-0E00	4.46E-02	1.667	AKT1,FOS,JUN,MAP2K2,MAPK3,TGFB1,TNFSF12,TNFSF13,WNT5A	
Pathogen Induced Cytokine Storm Signaling Pathway	-0E00	4.31E-02	-4.000	FOS,FTH1,FTL,GSDMD,IFNGR1,IL1R1,IRF1,JUN,MAPK3,NOS2,SLC2A1,TGFB1,TNFRSF1A,TNFSF12,TNFSF13,TRADD	
Role of Chondrocytes in Rheumatoid Arthritis Signaling Pathway	-0E00	6.38E-02	-3.000	CEBPD,FOS,IL1R1,JUN,MAPK3,NOS2,PRKAB1,PRKAG1,TNFRSF1A	
Role of Osteoblasts in Rheumatoid Arthritis Signaling Pathway	-0E00	5.74E-02	-1.941	ACVRL1,AKT1,CSNK1E,CTSB,CTSC,CTSD,CTSF,CTSH,CTSZ,MAPK3,TGFB1,TNFSF12,TNFSF13,WNT5A	
S100 Family Signaling Pathway	-0E00	5.18E-02	-5.060	ADGRE5,AKT1,ANXA2,ATF4,BCL3,BSG,CACYBP,Calm1 (includes others),CCRL2,CDKN1A,COPS5,CREB3,CTSD,EZR,FOS,GNA11,GPR4,IL10RB,ILK,JUN,MAP2K2,MAP3K8,MAPK3,NOS2,P2RY1,PDIA3,PLA2G4A,PRKAG1,RHOA,S100A1,S100A10,S100A13,S100A16,S1PR1,S1PR4,TGFB1,Tpm1,TPM3,VCAM1,WNT5A	
Amyotrophic Lateral Sclerosis Signaling	-0E00	5.17E-02	-0.816	BAX,CAPNS1,CYCS,GPX1,RAB5A,SSR4	
Activin Inhibin Signaling Pathway	-0E00	6.42E-02	-2.138	AKT1,BAMBI,CDKN1A,FOS,IL1R1,JUN,MAP2K2,MAPK3,NFKBIA,PMEPA1,RHOA,SOX17,TGFB1,TNFRSF1A	
WNK Renal Signaling Pathway	-0E00	5.66E-02	NaN	AKT1,ANAPC11,Calm1 (includes others),ELOC,SGK1,SUGT1	
GABAergic Receptor Signaling Pathway (Enhanced)	-0E00	4.32E-02	-0.816	ADCY4,GNAI2,GNB2,GNG5,PRKAG1,SLC38A2	
Glutaminergic Receptor Signaling Pathway (Enhanced)	-0E00	6.46E-02	-4.583	ADCY4,AKT1,ATF4,BAD,Calm1 (includes others),CREB3,GNAI2,GNAS,GPAA1,MAPK3,NAPA,PDIA3,PLA2G4A,PLAAT3,PRDX6,PRKAG1,SLC38A2,SLC38A5,TGFB1,VAMP3,VTI1B	
NFKBIE Signaling Pathway	-0E00	1.34E-02	-1.633	CD40,NFKBIA,TNFRSF1A,TNFSF12,TNFSF13,TRADD	
LPS/IL-1 Mediated Inhibition of RXR Function	-0E00	5.45E-02	-0.447	ALAS1,ALDH2,APOE,FMO1,GSTM1,GSTM2,GSTM5,HS3ST1,IL1R1,JUN,MGST3,PLTP,SMOX,TNFRSF1A	
G alpha (i) signalling events	-0E00	2.71E-02	-2.646	ADCY4,GNAI2,GNAS,GNB2,GNG5,POMC,S1PR4	
Neurotransmitter release cycle	-0E00	5E-02	NaN	ARL6IP5,SLC38A2	
Fertilization	-0E00	3.85E-02	NaN	CD9	
Meiotic synapsis	-0E00	3.64E-02	NaN	ACD,UBE2I	
PIP3 activates AKT signaling	-0E00	6.43E-02	-3.000	AKT1,BAD,CDKN1A,GSK3A,IER3,MAPK3,PDGFA,PDGFB,RHOG	
Potassium Channels	-0E00	1.94E-02	NaN	GNB2,GNG5	
Circadian Clock	-0E00	6.78E-02	NaN	CSNK1E,PPP1CA,RPS27A,UBC	
BMAL1:CLOCK,NPAS2 activates circadian gene expression	-0E00	3.7E-02	NaN	NAMPT	
Caspase activation via Death Receptors in the presence of ligand	-0E00	6.25E-02	NaN	TRADD	
Signaling by SCF-KIT	-0E00	6.98E-02	NaN	GRAP,HRAS,KRAS	
Collagen degradation	-0E00	1.64E-02	NaN	CTSB	
Degradation of the extracellular matrix	-0E00	6.06E-02	-2.000	ADAM15,BSG,CAPNS1,HTRA1	
Extracellular matrix organization	-0E00	4.72E-02	-2.236	ADAM15,PDGFA,PDGFB,TGFB1,TTR	
Antimicrobial peptides	-0E00	5.88E-02	NaN	ATOX1,PDZD11	
Glycerophospholipid biosynthesis	-0E00	4.04E-02	-2.000	CHKB,CSNK2B,PLA2G4A,PLAAT3	
DAG and IP3 signaling	-0E00	2.44E-02	NaN	ADCY4	
Elastic fibre formation	-0E00	4.55E-02	NaN	LTBP4,TGFB1	
Telomere Maintenance	-0E00	6.85E-02	-2.236	ACD,NHP2,NOP10,POLD4,RPA3	
Glycosaminoglycan metabolism	-0E00	3.75E-02	NaN	B3GAT3,B4GAT1,HYAL2	
Complement cascade	-0E00	1.48E-02	NaN	CD81,CFH	
Pre-NOTCH Expression and Processing	-0E00	6.58E-02	-2.236	JUN,LFNG,MFNG,SNW1,TMED2	
Bile acid and bile salt metabolism	-0E00	3.23E-02	NaN	HSD3B7	
Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell	-0E00	4.46E-02	-3.000	CD34,CD40,CD81,HLA-A,HLA-E,ICAM1,ICAM2,NPDC1,VCAM1	
Signaling by BMP	-0E00	3.85E-02	NaN	ACVRL1	
Assembly of collagen fibrils and other multimeric structures	-0E00	3.28E-02	NaN	CD151,CTSB	
Cell surface interactions at the vascular wall	-0E00	5.69E-02	-3.464	ATP1B3,BSG,CAV1,ESAM,F11R,GAS6,HRAS,KRAS,PPIA,SLC3A2,TGFB1,THBD	
Generic Transcription Pathway	-0E00	2.34E-02	-3.162	CDK8,MED10,MED4,MED7,MED8,NR2F6,NRBP1,SNW1,ZNF706,ZNF771	
Phase I - Functionalization of compounds	-0E00	5.88E-02	-2.449	ADH5,ALDH2,FDX1,FDX2,POMC,SMOX	
Synthesis of Prostaglandins (PG) and Thromboxanes (TX)	-0E00	6.67E-02	NaN	PTGES3	
Binding and Uptake of Ligands by Scavenger Receptors	-0E00	2.68E-02	NaN	APOE,FTH1,FTL	
Activation of gene expression by SREBF (SREBP)	-0E00	4.88E-02	NaN	FDPS,PMVK	
DNA Damage/Telomere Stress Induced Senescence	-0E00	5.36E-02	NaN	ACD,ASF1A,CDKN1A	
Transcriptional regulation of pluripotent stem cells	-0E00	5.88E-02	NaN	KLF4	
Class A/1 (Rhodopsin-like receptors)	-0E00	1.89E-02	-2.449	CCRL2,EDN1,GPR4,P2RY1,POMC,S1PR1	
Netrin-1 signaling	-0E00	4E-02	NaN	EZR,NCK1	
NCAM signaling for neurite out-growth	-0E00	6.56E-02	-2.000	HRAS,KRAS,MAPK3,PRNP	
Costimulation by the CD28 family	-0E00	2.56E-02	NaN	AKT1,MAP3K8	
Striated Muscle Contraction	-0E00	5.56E-02	NaN	TPM3,VIM	
Peroxisomal lipid metabolism	-0E00	4.55E-02	NaN	SCP2	
Rap1 signalling	-0E00	6.25E-02	NaN	YWHAB	
G alpha (q) signalling events	-0E00	3.45E-02	-2.449	EDN1,GNA11,GNB2,GNG5,GPR4,P2RY1	
G alpha (12/13) signalling events	-0E00	6.25E-02	-2.236	GNB2,GNG5,RHOA,RHOB,RHOC	
G alpha (s) signalling events	-0E00	5.52E-02	-2.828	ADCY4,GNAI2,GNAS,GNB2,GNG5,POMC,RAMP2,RAMP3	
Transport of bile salts and organic acids, metal ions and amine compounds	-0E00	3.61E-02	NaN	BSG,SLC31A1,SLC6A6	
Transport of inorganic cations/anions and amino acids/oligopeptides	-0E00	4.81E-02	-2.236	SLC38A2,SLC38A5,SLC3A2,SLC6A6,SRI	
SIRT1 negatively regulates rRNA expression	-0E00	3.45E-02	NaN	TAF1D	
Interleukin-12 family signaling	-0E00	5E-02	NaN	VAMP7	
Activation of kainate receptors upon glutamate binding	-0E00	6.67E-02	NaN	GNB2,GNG5	
Interleukin-2 family signaling	-0E00	4.35E-02	NaN	IL2RG,INPP5K	
O-linked glycosylation	-0E00	5.41E-02	-2.449	B4GAT1,C1GALT1C1,POFUT2,SBSPON,ST6GALNAC2,ST6GALNAC4	
Signaling by Retinoic Acid	-0E00	2.27E-02	NaN	RDH14	
Cardiac conduction	-0E00	3.08E-02	-2.000	ATP1B3,NPR1,ORAI1,SRI	
TNFs bind their physiological receptors	-0E00	6.9E-02	NaN	TNFRSF1A,TNFSF13	
Surfactant metabolism	-0E00	4.35E-02	NaN	CTSH	
Nonhomologous End-Joining (NHEJ)	-0E00	6.12E-02	NaN	PIAS4,UBE2N,UBE2V2	
Interleukin-6 family signaling	-0E00	4.17E-02	NaN	IL11RA	
rRNA processing	-0E00	6.25E-02	NaN	HSD17B10,PRORP	
Keratinization	-0E00	1.4E-02	NaN	CAPNS1,JUP,KLK8	
Mitotic Prophase	-0E00	5.83E-02	-2.449	ARPP19,BANF1,EMD,MAPK3,RAE1,SEC13	
Activation of the pre-replicative complex	-0E00	3.03E-02	NaN	RPA3	
Resolution of Abasic Sites (AP sites)	-0E00	5.26E-02	NaN	POLD4,RPA3	
Platelet Adhesion to exposed collagen	-0E00	6.67E-02	NaN	VWF	
RET signaling	-0E00	4.88E-02	NaN	DOK4,PDLIM7	
Interleukin-20 family signaling	-0E00	3.85E-02	NaN	IL10RB	
GABA synthesis, release, reuptake and degradation	-0E00	5.26E-02	NaN	HSPA8	
RUNX1 regulates megakaryocyte differentiation and platelet function	-0E00	5.17E-02	NaN	DPY30,PRMT1,SIN3B	
Nucleotide catabolism	-0E00	6.67E-02	NaN	NT5C,NT5M	
Transcriptional Regulation by MECP2	-0E00	3.17E-02	NaN	GPS2,SGK1	
Meiotic recombination	-0E00	2.08E-02	NaN	RPA3	
FOXO-mediated transcription of cell death genes	-0E00	6.25E-02	NaN	BBC3	
FOXO-mediated transcription of oxidative stress, metabolic and neuronal genes	-0E00	6.67E-02	NaN	POMC,SOD2	
Transcriptional regulation of granulopoiesis	-0E00	1.96E-02	NaN	CDKN1A	
EGR2 and SOX10-mediated initiation of Schwann cell myelination	-0E00	3.45E-02	NaN	PMP22	
Heme signaling	-0E00	2.13E-02	NaN	NFE2L2	
Retinoid metabolism and transport	-0E00	6.82E-02	NaN	APOE,RBP1,TTR	
GABA receptor activation	-0E00	6.67E-02	-2.000	ADCY4,GNAI2,GNB2,GNG5	
Formation of paraxial mesoderm	-0E00	4.35E-02	NaN	SNW1	
Kinesins	-0E00	6.56E-02	-2.000	TUBA1A,TUBA1B,TUBB2A,TUBB4B	
Formation of definitive endoderm	-0E00	5.56E-02	NaN	SOX17	
LXR/RXR Activation	-0E00	6.5E-02	-0.378	APOD,APOE,ECHS1,IL1R1,NOS2,PLTP,TNFRSF1A,TTR	
Autism Signaling Pathway	-0E00	5.84E-02	-3.300	AKT1,ALDH2,BCKDK,EIF4EBP1,HLA-A,HLA-E,HRAS,KRAS,MAP2K2,MAPK3,PRKAG1,RASD1,RHEB,RRAS,TGFB1,TNFSF12,TNFSF13,WNT5A	
BBSome Signaling Pathway	-0E00	4.7E-02	-3.838	ADGRE5,BBIP1,CCRL2,CCT2,CCT3,CCT4,CCT5,CCT6A,CCT7,CCT8,GPR4,IFT20,P2RY1,PHF1,POMC,PRKAG1,RAB5A,RAB8A,RHOA,S1PR1,S1PR4,TCP1,XBP1	
WNT/SHH Axonal Guidance Signaling Pathway	-0E00	6.04E-02	-1.667	ADCY4,ARF6,ILK,PRKAG1,WNT5A,YWHAB,YWHAE,YWHAH,YWHAQ	
TR/RXR Activation	-0E00	6.25E-02	-2.121	AKT1,BCL3,ENO1,GPS2,H3-3A/H3-3B,NCOA4,SLC2A1,UCP2	
Role of BRCA1 in DNA Damage Response	-0E00	5E-02	NaN	ACTB,CDKN1A,E2F4,SMARCB1	
Role of RIG1-like Receptors in Antiviral Innate Immunity	-0E00	2.17E-02	NaN	NFKBIA	
Role of Pattern Recognition Receptors in Recognition of Bacteria and Viruses	-0E00	3.21E-02	NaN	EIF2S1,MAPK3,TGFB1,TNFSF12,TNFSF13	
Role of NFAT in Regulation of the Immune Response	-0E00	1.93E-02	-3.357	AKT1,Calm1 (includes others),CSNK1E,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,GSK3A,HLA-A,HRAS,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,ORAI1,RASD1,RRAS	
FcÎ³RIIB Signaling in B Lymphocytes	-0E00	9.42E-03	-2.000	AKT1,HRAS,KRAS,RASD1,RRAS	
CCR5 Signaling in Macrophages	-0E00	1.6E-02	-2.236	Calm1 (includes others),FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,JUN	
Calcium-induced T Lymphocyte Apoptosis	-0E00	6.52E-03	NaN	Calm1 (includes others),HLA-A,ORAI1	
Cytotoxic T Lymphocyte-mediated Apoptosis of Target Cells	-0E00	9.41E-03	NaN	CYC1,CYCS,HLA-A,HLA-E	
Airway Pathology in Chronic Obstructive Pulmonary Disease	-0E00	3.39E-02	NaN	APOD,TGFB1,TNFSF12,TNFSF13	
CTLA4 Signaling in Cytotoxic T Lymphocytes	-0E00	4.11E-02	0.000	AKT1,AP1M1,AP1S1,AP1S2,AP2A2,Ap2b1,AP2M1,AP2S1,ARF1,BCL10,CLTA,CLTB,FOS,GSK3A,H2-T22,HLA-A,HLA-E,HRAS,JUN,KRAS,MAPK3,NCK1,RASD1,RRAS,TGFB1	
IL-15 Production	-0E00	2.44E-02	NaN	EPHB4,IRF1,TIE1	
Airway Inflammation in Asthma	-0E00	6.06E-02	NaN	IFNGR1,TGFB1	
T Helper Cell Differentiation	-0E00	1.49E-02	NaN	CD40,HLA-A,IFNGR1,IL10RB,IL2RG,TGFB1,TNFRSF1A	
CD28 Signaling in T Helper Cells	-0E00	2.71E-02	-3.464	AKT1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BCL10,Calm1 (includes others),FOS,HLA-A,JUN,MAP2K2,NFKBIA	
IL-15 Signaling	-0E00	1.52E-02	-2.828	AKT1,HRAS,IL2RG,KRAS,MAP2K2,MAPK3,RASD1,RRAS	
Role of Cytokines in Mediating Communication between Immune Cells	-0E00	1.85E-02	NaN	TGFB1	
Dendritic Cell Maturation	-0E00	2.01E-02	-3.464	AKT1,ATF4,CD40,CD83,CREB3,HLA-A,HLA-E,ICAM1,MAPK3,NFKBIA,PDIA3,TNFRSF1A	
Neuropathic Pain Signaling in Dorsal Horn Neurons	-0E00	4.95E-02	-2.236	CAMK1,FOS,MAPK3,PDIA3,PRKAG1	
Factors Promoting Cardiogenesis in Vertebrates	-0E00	4.58E-02	-2.449	ACVRL1,ATF4,CREB3,PDIA3,RHOA,TGFB1,WNT5A	
Cardiomyocyte Differentiation via BMP Receptors	-0E00	3.7E-02	NaN	ACVRL1	
ICOS-ICOSL Signaling in T Helper Cells	-0E00	1.38E-02	-2.449	AKT1,BAD,Calm1 (includes others),CD40,HLA-A,IL2RG,NFKBIA	
Molecular Mechanisms of Cancer	-0E00	6.31E-02	-4.899	ACVRL1,ADCY4,ADGRE5,AKT1,APH1A,BAD,BAX,BBC3,CCRL2,Cdc42,CDKN1A,CDKN2D,CYCS,DIABLO,E2F4,EDN1,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,GPR4,GSK3A,HES1,HRAS,ID1,IL10RB,IL11RA,IL1R1,IL2RG,JUN,KRAS,LAMTOR3,MAP2K2,MAPK3,NFKBIA,P2RY1,PA2G4,PAK4,PDGFB,PRKAG1,PSEN2,PSENEN,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,S1PR1,S1PR4,TGFB1,WNT5A	
Lipid Antigen Presentation by CD1	-0E00	1.45E-02	NaN	AP2A2,Ap2b1,AP2M1,AP2S1,ARF6,PDIA3	
Maturity Onset Diabetes of Young (MODY) Signaling	-0E00	5.06E-02	NaN	APOD,APOE,GAPDH,UCP2	
Role of CHK Proteins in Cell Cycle Checkpoint Control	-0E00	3.45E-02	NaN	CDKN1A,E2F4	
Role of OCT4 in Mammalian Embryonic Stem Cell Pluripotency	-0E00	4.35E-02	NaN	NR2F2,NR2F6	
Growth Hormone Signaling	-0E00	4.23E-02	NaN	FOS,MAPK3,SOCS2	
CREB Signaling in Neurons	-0E00	5.93E-02	-4.379	ADCY4,ADGRE5,AKT1,ATF4,Calm1 (includes others),CCRL2,CREB3,GNA11,GNAI2,GNAS,GNB2,GNG5,GPR4,GTF2B,HRAS,KRAS,MAP2K2,MAPK3,P2RY1,PDGFB,PDIA3,POLR2C,POLR2D,POLR2E,POLR2F,POLR2G,POLR2I,POLR2J,POLR2K,POLR2L,PRKAG1,RASD1,RRAS,S1PR1,S1PR4,TGFB1	
Type I Diabetes Mellitus Signaling	-0E00	2.55E-02	-2.121	CYC1,CYCS,HLA-A,HLA-E,HSPD1,IFNGR1,IL1R1,IRF1,NFKBIA,NOS2,SOCS2,TNFRSF1A,TRADD	
Basal Cell Carcinoma Signaling	-0E00	1.39E-02	NaN	WNT5A	
Allograft Rejection Signaling	-0E00	8.2E-03	NaN	CD40,H2-T22,HLA-A,HLA-E	
Autoimmune Thyroid Disease Signaling	-0E00	6.54E-03	NaN	CD40,HLA-A,HLA-E	
Graft-versus-Host Disease Signaling	-0E00	4.48E-03	NaN	HLA-A,HLA-E	
Type II Diabetes Mellitus Signaling	-0E00	6.54E-02	-1.414	AKT1,MAPK3,NFKBIA,PKM,PRKAB1,PRKAG1,SMPD2,SOCS2,TNFRSF1A,TRADD	
p70S6K Signaling	-0E00	2.94E-02	-2.887	AKT1,BAD,BCAP31,EEF2,GNAI2,HRAS,IL2RG,KRAS,MAP2K2,MAPK3,PDIA3,RASD1,RRAS,YWHAB,YWHAE,YWHAH,YWHAQ	
G Protein Signaling Mediated by Tubby	-0E00	1.5E-02	-2.646	GNA11,GNAI2,GNAS,GNB2,GNG5,NAMPT,NCK1	
Communication between Innate and Adaptive Immune Cells	-0E00	5.36E-03	NaN	CD40,CD83,HLA-A,HLA-E,TNFSF13	
Systemic Lupus Erythematosus Signaling	-0E00	3.38E-02	NaN	AKT1,CD40,FOS,HLA-A,HLA-E,HRAS,JUN,KRAS,LSM1,LSM10,LSM12,LSM2,LSM3,LSM5,LSM6,LSM7,LSM8,MAPK3,PRPF40B,RASD1,RRAS,SF3B4,SNRNP27,SNRNP40,SNRPB,SNRPB2,Snrpc,SNRPD1,SNRPD2,SNRPD3,Snrpe,SNRPF,Snrpg,SNU13,TXNL4A,ZCRB1	
CDC42 Signaling	-0E00	3.3E-02	-4.000	ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAIAP2,CDC42EP5,CFL1,CFL2,FOS,H2-T22,HLA-A,HLA-E,JUN,MYL12A,MYL12B,MYL6,PAK4	
FAK Signaling	-0E00	3.65E-02	-4.218	ADGRE5,AKT1,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BAD,CAPNS1,CCRL2,ECM1,EFNA1,FOS,GIT1,GPR4,GSK3A,HRAS,IL10RB,IL11RA,IL1R1,IL2RG,JUN,KRAS,MAP2K2,MAPK3,NCK1,P2RY1,PAK4,RASD1,RHOA,RRAS,S1PR1,S1PR4,SH3GL1,SOCS2,TGFB1,USF1	
Retinoic acid Mediated Apoptosis Signaling	-0E00	3.33E-02	NaN	CYCS,IRF1	
Phospholipase C Signaling	-0E00	2.14E-02	-3.771	ADCY4,ATF4,Calm1 (includes others),Cdc42,CREB3,GNAS,GNB2,GNG5,HRAS,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,PEBP1,PLA2G4A,RASD1,RHOA,RHOB,RHOC,RHOG,RRAS,TGM2	
Altered T Cell and B Cell Signaling in Rheumatoid Arthritis	-0E00	5.33E-03	NaN	CD40,CSF1,HLA-A,TGFB1,TNFSF13	
Granzyme B Signaling	-0E00	6.25E-02	NaN	CYCS	
B Cell Development	-0E00	4.1E-03	NaN	CD40,HLA-A	
Breast Cancer Regulation by Stathmin1	-0E00	5.39E-02	-3.053	ADGRE5,ATF4,CAMK1,CCRL2,CREB3,E2F4,GNB2,GNG5,GPR4,HRAS,JUN,KRAS,MAP2K2,MAPK3,P2RY1,PDGFB,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,RASD1,RHOA,RRAS,S1PR1,S1PR4,STMN1,TGFB1,TUBA1A,TUBA1B,TUBB,TUBB2A,TUBB4B	
Neuroprotective Role of THOP1 in Alzheimer's Disease	-0E00	5.74E-02	-1.000	HLA-A,HLA-E,HTRA1,KLK8,PRKAG1,PRSS23,YWHAE	
Regulation of IL-2 Expression in Activated and Anergic T Lymphocytes	-0E00	3.03E-02	-2.673	BCL10,Calm1 (includes others),FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,PABPC4,RASD1,RRAS,TGFB1,TOB1	
Role of WNT/GSK-3Î² Signaling in the Pathogenesis of Influenza	-0E00	3.85E-02	NaN	CSNK1E,NCOA4,WNT5A	
NUR77 Signaling in T Lymphocytes	-0E00	1.56E-02	-1.342	Calm1 (includes others),CYCS,H2-T22,HLA-A,HLA-E,MAP2K2,MAPK3,SIN3B	
PKCÎ¸ Signaling in T Lymphocytes	-0E00	1.97E-02	-3.162	BCL10,FOS,HLA-A,HRAS,JUN,KRAS,MAP3K8,MAPK3,NFKBIA,RASD1,RRAS	
Role of Lipids/Lipid Rafts in the Pathogenesis of Influenza	-0E00	4.35E-02	NaN	FDPS	
Role of Hypercytokinemia/hyperchemokinemia in the Pathogenesis of Influenza	-0E00	1.16E-02	NaN	S1PR1	
Antiproliferative Role of TOB in T Cell Signaling	-0E00	9.39E-03	0.000	PABPC1,PABPC4,TGFB1,TOB1	
OX40 Signaling Pathway	-0E00	1.26E-02	NaN	H2-T22,HLA-A,HLA-E,JUN,NFKBIA,TRAF5	
PI3K Signaling in B Lymphocytes	-0E00	2.72E-02	-3.742	AKT1,ATF4,BCL10,Calm1 (includes others),CD40,CD81,FOS,HRAS,JUN,KRAS,MAP2K2,MAPK3,NFKBIA,PDIA3,RASD1,RRAS	
Extrinsic Prothrombin Activation Pathway	-0E00	6.25E-02	NaN	THBD	
Intrinsic Prothrombin Activation Pathway	-0E00	4.76E-02	NaN	KLK8,THBD	
Cyclins and Cell Cycle Regulation	-0E00	5.81E-02	1.000	CDKN1A,CDKN2D,E2F4,PA2G4,TGFB1	
Assembly of RNA Polymerase III Complex	-0E00	6.67E-02	NaN	GTF3A	
IL-17A Signaling in Airway Cells	-0E00	5.97E-02	-1.000	AKT1,MAP2K2,MAPK3,NFKBIA	
Role of JAK1, JAK2 and TYK2 in Interferon Signaling	-0E00	3.85E-02	NaN	IFNGR1	
Role of JAK2 in Hormone-like Cytokine Signaling	-0E00	4.84E-02	NaN	FOS,POMC,SOCS2	
Hematopoiesis from Pluripotent Stem Cells	-0E00	2.24E-03	NaN	CSF1	
Transcriptional Regulatory Network in Embryonic Stem Cells	-0E00	6.1E-02	-3.162	AKT1,HRAS,KLF4,KRAS,MAP2K2,MAPK3,RASD1,RRAS,TGFB1,WNT5A	
nNOS Signaling in Neurons	-0E00	6.38E-02	NaN	Calm1 (includes others),CAPNS1,RASD1	
nNOS Signaling in Skeletal Muscle Cells	-0E00	2.08E-02	NaN	Calm1 (includes others)	
GADD45 Signaling	-0E00	5E-02	NaN	CDKN1A,GADD45G,TGFB1	
Heparan Sulfate Biosynthesis	-0E00	4.44E-02	NaN	ALDH2,B3GAT3,HS3ST1,PRDX6	
Retinoate Biosynthesis I	-0E00	4.65E-02	NaN	RBP1,RDH14	
Thyroid Hormone Metabolism II (via Conjugation and/or Degradation)	-0E00	4.76E-02	NaN	B3GAT3,B4GAT1	
Nicotine Degradation III	-0E00	3.33E-02	NaN	B3GAT3,B4GAT1	
Chondroitin Sulfate Degradation (Metazoa)	-0E00	6.25E-02	NaN	HYAL2	
Heparan Sulfate Biosynthesis (Late Stages)	-0E00	3.61E-02	NaN	ALDH2,HS3ST1,PRDX6	
Pyrimidine Ribonucleotides De Novo Biosynthesis	-0E00	6.98E-02	NaN	CMPK1,NME2,PGP	
D-myo-inositol-5-phosphate Metabolism	-0E00	6.57E-02	-3.464	DUSP1,DUSP11,DUSP23,DUSP8,ILKAP,MDP1,NT5C,NUDT14,NUDT9,PIP4P1,PPP1CA,PPP1R11,PPP1R14B	
Melatonin Degradation I	-0E00	3.12E-02	NaN	B3GAT3,B4GAT1	
Î³-linolenate Biosynthesis II (Animals)	-0E00	5.26E-02	NaN	CYB5A	
Triacylglycerol Degradation	-0E00	5.17E-02	NaN	ABHD16A,ALDH2,PRDX6	
Phospholipases	-0E00	5.8E-02	NaN	PDIA3,PLA2G4A,PLAAT3,PRDX6	
Estrogen Biosynthesis	-0E00	2.17E-02	NaN	HSD17B10	
Chondroitin Sulfate Biosynthesis	-0E00	3.28E-02	NaN	B3GAT3,HS3ST1	
Dermatan Sulfate Biosynthesis	-0E00	3.17E-02	NaN	B3GAT3,HS3ST1	
1D-myo-inositol Hexakisphosphate Biosynthesis II (Mammalian)	-0E00	5.88E-02	NaN	INPP5K	
tRNA Charging	-0E00	2.56E-02	NaN	LARS2	
Dermatan Sulfate Biosynthesis (Late Stages)	-0E00	2E-02	NaN	HS3ST1	
Phosphatidylglycerol Biosynthesis II (Non-plastidic)	-0E00	3.33E-02	NaN	PTPMT1	
Dermatan Sulfate Degradation (Metazoa)	-0E00	5.88E-02	NaN	HYAL2	
D-myo-inositol (1,4,5,6)-Tetrakisphosphate Biosynthesis	-0E00	6.59E-02	-3.317	DUSP1,DUSP11,DUSP23,DUSP8,ILKAP,MDP1,NT5C,NUDT14,NUDT9,PPP1CA,PPP1R11,PPP1R14B	
Nicotine Degradation II	-0E00	4.41E-02	NaN	B3GAT3,B4GAT1,FMO1	
Superpathway of Inositol Phosphate Compounds	-0E00	5.93E-02	-3.606	DUSP1,DUSP11,DUSP23,DUSP8,ILKAP,INPP5K,MDP1,NT5C,NUDT14,NUDT9,PIP4P1,PPP1CA,PPP1R11,PPP1R14B	
Valine Degradation I	-0E00	5E-02	NaN	ECHS1	
D-myo-inositol (1,3,4)-trisphosphate Biosynthesis	-0E00	5.88E-02	NaN	INPP5K	
D-myo-inositol (3,4,5,6)-tetrakisphosphate Biosynthesis	-0E00	6.59E-02	-3.317	DUSP1,DUSP11,DUSP23,DUSP8,ILKAP,MDP1,NT5C,NUDT14,NUDT9,PPP1CA,PPP1R11,PPP1R14B	
3-phosphoinositide Biosynthesis	-0E00	5.77E-02	-3.317	DUSP1,DUSP11,DUSP23,DUSP8,ILKAP,MDP1,NT5C,NUDT14,NUDT9,PPP1CA,PPP1R11,PPP1R14B	
Methylglyoxal Degradation III	-0E00	6.45E-02	NaN	AKR1A1,DHRS7	
Histamine Degradation	-0E00	4.76E-02	NaN	ALDH2	
Chondroitin Sulfate Biosynthesis (Late Stages)	-0E00	1.89E-02	NaN	HS3ST1	
Superpathway of Melatonin Degradation	-0E00	4.35E-02	NaN	B3GAT3,B4GAT1,SMOX	
Pregnenolone Biosynthesis	-0E00	4.55E-02	NaN	FDX1	
Acetone Degradation I (to Methylglyoxal)	-0E00	2.38E-02	NaN	DHRS7	
Fatty Acid Î±-oxidation	-0E00	4.76E-02	NaN	ALDH2	
Oxidative Ethanol Degradation III	-0E00	1.79E-02	NaN	ALDH2	
DNA damage-induced 14-3-3Ï Signaling	-0E00	6.52E-02	NaN	AKT1,BAD,CDKN1A	
Agranulocyte Adhesion and Diapedesis	-0E00	6.19E-02	NaN	ACTB,ACTG1,CD34,CLDN5,EZR,GNAI2,ICAM1,ICAM2,IL1R1,MYL6,RDX,TNFRSF1A,VCAM1	
Granulocyte Adhesion and Diapedesis	-0E00	4.76E-02	NaN	CLDN5,EZR,GNAI2,ICAM1,ICAM2,IL1R1,RDX,TNFRSF1A,VCAM1	
Role of p14/p19ARF in Tumor Suppression	-0E00	3.33E-02	NaN	NPM1	
Sperm Motility	-0E00	5.45E-02	-2.646	Calm1 (includes others),EPHB4,GNA11,GNAI2,GNAS,GNB2,GNG5,NPR1,PDIA3,PLA2G4A,PLAAT3,PRDX6,PRKAG1,TIE1	
TEC Kinase Signaling	-0E00	2.6E-02	-3.000	ACTB,ACTG1,Cdc42,FOS,GNA11,GNAI2,GNAS,GNB2,GNG5,PAK4,RHOA,RHOB,RHOC,RHOG,TNFSF12	
BER (Base Excision Repair) Pathway	-0E00	6.82E-02	NaN	ARL6IP5,MAP2K2,MAPK3	
WNT/Ca+ pathway	-0E00	6.06E-02	-2.000	ATF4,CREB3,PDIA3,WNT5A	
SAPK/JNK Signaling	-0E00	1.99E-02	-2.121	DUSP8,GNB2,GNG5,HNRNPK,HRAS,JUN,KRAS,RASD1,RRAS,TRADD	
Cardiac Î²-adrenergic Signaling	-0E00	6.67E-02	-0.707	ADCY4,GDE1,GNA11,GNAI2,GNAS,GNB2,GNG5,PPP1CA,PPP1R11,PPP1R14B,PRKAG1,SMPDL3A	
FGF Signaling	-0E00	5.81E-02	-2.236	AKT1,ATF4,CREB3,HRAS,MAPK3	
IL-4 Signaling	-0E00	2.25E-02	-3.051	AKT1,ATF4,CREB3,EIF4EBP1,GNAI2,HRAS,IL2RG,KRAS,MAPK3,RASD1,RRAS,TGFB1,TGM2	
B Cell Receptor Signaling	-0E00	3E-02	-2.828	AKT1,ATF4,BAD,BCL10,Calm1 (includes others),CFL1,CFL2,CREB3,GSK3A,HRAS,INPP5K,JUN,KRAS,MAP2K2,MAP3K8,MAPK3,NFKBIA,RASD1,RRAS	
Phototransduction Pathway	-0E00	3.7E-02	NaN	NPR1,PRKAG1	
Sonic Hedgehog Signaling	-0E00	3.23E-02	NaN	PRKAG1	
cAMP-mediated signaling	-0E00	5.93E-02	-3.051	ADCY4,ATF4,Calm1 (includes others),CAMK1,CREB3,DUSP1,GDE1,GNAI2,GNAS,LAMTOR3,MAP2K2,MAPK3,S1PR1,SMPDL3A	
Glutamate Receptor Signaling	-0E00	4.55E-02	NaN	Calm1 (includes others),GNB2,GNG5	
NF-ÎºB Signaling	-0E00	2.98E-02	-3.500	AKT1,BCL10,CD40,CSNK2B,HRAS,IL1R1,KRAS,MAP3K8,NFKBIA,RASD1,RRAS,SIGIRR,TNFRSF1A,TRADD,TRAF5,UBE2N,UBE2V1	
T Cell Receptor Signaling	-0E00	2.92E-02	-3.000	AKT1,BCL10,Calm1 (includes others),FOS,GSK3A,H2-T22,HLA-A,HLA-E,HRAS,ICAM1,JUN,KRAS,MAP2K2,MAPK3,NCK1,NFKBIA,RASD1,RRAS	
G-Protein Coupled Receptor Signaling	-0E00	4.84E-02	-4.802	ADCY4,ADGRE5,AKT1,ATF4,Calm1 (includes others),CCRL2,CREB3,DUSP1,FOS,GDE1,GNA11,GNAI2,GNAS,GNB2,GNG5,GPR4,HRAS,JUN,KRAS,MAP2K2,MAP3K8,MAPK3,MYL12A,MYL12B,MYL6,NFKBIA,P2RY1,PAK4,PRKAG1,RASD1,RRAS,S1PR1,S1PR4,SMPDL3A	
GPCR-Mediated Nutrient Sensing in Enteroendocrine Cells	-0E00	5.93E-02	-1.890	ADCY4,GNA11,GNAI2,GNAS,GNG5,PDIA3,PRKAG1	
Gustation Pathway	-0E00	1.98E-02	-2.000	ADCY4,ORAI1,P2RY1,PRKAG1	
Phagosome Formation	-0E00	4.89E-02	-5.145	ADGRE5,AKT1,AP1M1,AP1S1,AP1S2,ARF6,ARPC1A,ARPC1B,ARPC2,ARPC3,ARPC4,ARPC5L,BCL10,CCRL2,CFL1,CFL2,GPR4,HRAS,KRAS,MAP2K2,MAPK3,MYL12A,MYL12B,MYL6,P2RY1,PAK4,PLA2G4A,PLAAT3,PRDX6,RASD1,RHOA,RRAS,S1PR1,S1PR4	
Inflammasome pathway	-0E00	5E-02	NaN	CTSB	
Osteoarthritis Pathway	-0E00	6.36E-02	-0.832	ACVRL1,ANXA2,ANXA5,ATF4,CREB3,DDIT4,HES1,HTRA1,IL1R1,NAMPT,NOS2,PRKAB1,PRKAG1,TGFB1,TNFRSF1A	
GP6 Signaling Pathway	-0E00	3.94E-02	-1.000	AKT1,Calm1 (includes others),GSK3A,NCK1,RHOG	
Th17 Activation Pathway	-0E00	4.13E-03	NaN	HSP90AB1,IL1R1	
SPINK1 Pancreatic Cancer Pathway	-0E00	5E-02	NaN	CTSB,KLK8,TGFB1	
Endocannabinoid Neuronal Synapse Pathway	-0E00	6.04E-02	-0.707	ADCY4,GNA11,GNAI2,GNB2,GNG5,MAPK3,NDUFS2,PDIA3,PRKAG1	
Apelin Pancreas Signaling Pathway	-0E00	4.35E-02	NaN	PRKAB1,PRKAG1	
Cardiac Hypertrophy Signaling (Enhanced)	-0E00	6.83E-02	-5.048	ADCY4,AKT1,Calm1 (includes others),EDN1,EIF2B2,EIF2B4,EIF4EBP1,GDE1,GNA11,GNAI2,GNAS,GNB2,GNG5,GSK3A,HRAS,HSPB1,IL10RB,IL11RA,IL1R1,IL2RG,JUN,KRAS,MAP2K2,MAP3K8,MAPK3,NPR1,PDIA3,PRKAG1,RASD1,RHOA,RRAS,SMPDL3A,TGFB1,TNFRSF1A,TNFSF12,TNFSF13,WNT5A	
T Cell Exhaustion Signaling Pathway	-0E00	2.12E-02	0.000	AKT1,FOS,HLA-A,HLA-E,HRAS,IL10RB,JUN,KRAS,MAPK3,RASD1,RRAS,TGFB1	
IL-23 Signaling Pathway	-0E00	4.35E-02	NaN	AKT1,NFKBIA	
Systemic Lupus Erythematosus in T Cell Signaling Pathway	-0E00	4.04E-02	-1.177	AKT1,ATF4,Cdc42,CREB3,EZR,FOS,GNAI2,H2-T22,HLA-A,HLA-E,HRAS,JUN,KRAS,MAP2K2,MAPK3,NOS2,NOS3,ORAI1,RAB4A,RASD1,RDX,RHOA,RHOB,RHOC,RHOG,RRAS	
Systemic Lupus Erythematosus in B Cell Signaling Pathway	-0E00	2.9E-02	-3.710	AKT1,BAD,BCL10,Calm1 (includes others),CD40,FOS,HRAS,IFNGR1,INPP5K,JUN,KRAS,MAP2K2,MAPK3,MCL1,RASD1,RRAS,SHF,TGFB1,TNFSF12,TNFSF13,TRAF5	
Regulation of the Epithelial Mesenchymal Transition in Development Pathway	-0E00	4.6E-02	-2.000	APH1A,PSEN2,PSENEN,WNT5A	
Calcium Signaling	-0E00	4.09E-02	-2.449	ATF4,Calm1 (includes others),CAMK1,CREB3,MAPK3,MYL6,PRKAG1,Tpm1,TPM3	
Complement System	-0E00	5.41E-02	NaN	C1QBP,CFH	
